Implementation of point-of-care testing: current applications and the impact on patient experience by Miller, Louise Kimberley
IMPLEMENTATION OF POINT-OF-CARE TESTING: CURRENT 
APPLICATIONS AND THE IMPACT ON PATIENT EXPERIENCE 
 
 
 
 
 
 
LOUISE KIMBERLEY MILLER 
 
 
 
A thesis submitted in partial fulfilment of the requirements of the 
Manchester Metropolitan University for the degree of Doctor of 
Philosophy 
 
 
 
Science and Engineering 
Manchester Metropolitan University 
 
 
January 2016 
 ii 
 
 
 
Contents  
Contents .......................................................................................................................... i 
Thesis abstract ............................................................................................................... v 
List of Tables ................................................................................................................. vi 
List of Figures ............................................................................................................... viii 
List of Appendices .......................................................................................................... x 
List of Abbreviations ...................................................................................................... xi 
Acknowledgments ......................................................................................................... xiii 
Chapter One: Introduction .................................................................................... 1 
1.1 Overview of chapters ............................................................................................ 1 
1.2 World health .......................................................................................................... 3 
1.3 The National Health Service.................................................................................. 4 
1.3.1 History of the National Health Service (NHS) ............................................................... 4 
1.3.2 The new NHS ................................................................................................................ 6 
1.3.3 Current challenges faced by the NHS ........................................................................... 7 
1.4 Pathology testing .................................................................................................. 8 
1.5 Point-of-Care Testing ............................................................................................ 9 
1.5.1 POCT in the new NHS ................................................................................................ 10 
1.6 NHS Health Checks ............................................................................................ 11 
Chapter Two: Point-of-Care Testing literature review ........................................ 13 
2.1. Introduction ........................................................................................................ 13 
2.2 Applications of POCT .......................................................................................... 15 
2.2.1 Example applications of POCT in hospital care .......................................................... 15 
2.2.2 Applications of POCT in emergency care ................................................................... 16 
2.2.3 Applications of POCT in primary care ......................................................................... 17 
2.2.4 Applications of POCT in the community ...................................................................... 20 
2.3.1 Lateral flow immunochromatographic assays ............................................................. 25 
2.3.2 Biosensors ................................................................................................................... 27 
2.3.4 Microfluidics ................................................................................................................. 30 
2.3.5 Spectrophotometry ...................................................................................................... 30 
2.3.6 Blood gas and pH analysis .......................................................................................... 32 
2.3.5 Haematological particle analysis ................................................................................. 32 
2.4 Patient satisfaction with POCT ............................................................................ 33 
2.5 Patient management of condition ........................................................................ 36 
  ii 
2.6 Impact of POCT on healthcare professionals ...................................................... 38 
2.6.1 Prescribing ................................................................................................................... 39 
2.7 Considerations relating to POCT ......................................................................... 39 
2.7.1 Analytical performance and quality of POCT ............................................................... 40 
2.7.2 Training in POCT ......................................................................................................... 47 
2.7.3 Cost of POCT ............................................................................................................... 50 
2.8 Conclusion .......................................................................................................... 52 
Chapter Three: On-site pathology testing in primary care: current positioning of 
Point-of-Care Testing in the UK .......................................................................... 54 
Abstract .................................................................................................................... 54 
3.1 Introduction ......................................................................................................... 55 
3.2 Method ................................................................................................................ 57 
3.2.1 Designing the questionnaire ........................................................................................ 57 
3.2.2 Piloting the questionnaire ............................................................................................. 58 
3.2.3 Questionnaire Launch .................................................................................................. 58 
3.2.4 Telephone survey ........................................................................................................ 59 
3.3 Results ................................................................................................................ 60 
3.3.1 amendments arising from the pilot ............................................................................... 60 
3.3.2 Participant characteristics ............................................................................................ 60 
3.3.3 Awareness of POCT .................................................................................................... 60 
3.3.4 POCT tests used in primary care ................................................................................. 60 
3.3.5 POCT operators ........................................................................................................... 61 
3.3.6 Training in POCT ......................................................................................................... 62 
3.3.7 Consideration of quality ............................................................................................... 62 
3.3.8 Attitudes towards the use and adoption of POCT........................................................ 62 
3.3.9 Future use of POCT in primary care ............................................................................ 63 
3.3.10 Anecdotal evidence .................................................................................................... 64 
3.4 Discussion .......................................................................................................... 65 
3.4.1 Strengths and limitations .............................................................................................. 65 
3.5 Conclusion .......................................................................................................... 67 
Chapter 4: Point-of-Care Testing in the community setting ................................ 68 
Abstract .................................................................................................................... 68 
4.1 Introduction ......................................................................................................... 69 
4.1.1 Public Health & the NHS Health Check ....................................................................... 69 
4.1.2 Delivering NHS Health Checks in the community ........................................................ 70 
4.1.2.1 Cholestech LDX ........................................................................................................ 73 
  iii 
4.1.2.2 The Health Bus ......................................................................................................... 73 
4.1.3 Salford Demographics ................................................................................................. 74 
4.1.4 Published research ...................................................................................................... 76 
4.1.5 Rationale for current study .......................................................................................... 78 
4.1.6 Research aims............................................................................................................. 78 
4.2 Methods .............................................................................................................. 79 
4.2.1 Questionnaire design and pilot .................................................................................... 79 
4.2.2 Recruitment and follow-up ........................................................................................... 83 
4.2.3 Conducting Health Checks and collecting data........................................................... 84 
4.3 Results ................................................................................................................ 87 
4.3.1 Participant characteristics ........................................................................................... 87 
4.3.2 Baseline Health Check Results ................................................................................... 89 
4.3.2.2 Baseline referrals ..................................................................................................... 92 
4.3.3 Follow-up Health Check results................................................................................... 93 
4.3.4 Questionnaire results .................................................................................................. 97 
4.3.5 Results of participants aged 40+ subgroup ............................................................... 107 
4.3.6 Statistical analysis (all participants) .......................................................................... 110 
4.3.7 Statistical analysis (participants aged 40+) ............................................................... 114 
4.4 Discussion ........................................................................................................ 116 
4.4.1 Criticisms of the Health Check procedure ................................................................. 120 
4.4.2 Strengths and weaknesses of the study ................................................................... 122 
4.5 Conclusion ........................................................................................................ 125 
Chapter 5: The influence of workplace Health Checks on health behaviour .... 126 
Abstract .................................................................................................................. 126 
5.1 Introduction ....................................................................................................... 127 
5.2 Methods ............................................................................................................ 130 
5.2.1 Design of interview questions and prompts .............................................................. 130 
5.2.2 Pilot ............................................................................................................................ 132 
5.2.3 Sampling and data collection .................................................................................... 132 
5.2.4 Analysis ..................................................................................................................... 133 
5.3 Results .............................................................................................................. 135 
5.3.1 Result of pilot ............................................................................................................. 135 
5.3.2 Uptake and characteristics ........................................................................................ 135 
5.3.3 Stimuli of positive health behaviour changes ............................................................ 136 
5.3.3.1 Availability............................................................................................................... 137 
5.3.4 Indicators of negative health behaviour changes or no changes .............................. 145 
5.3.5 Participant opinion on NHS Health Checks ............................................................... 152 
5.4 Discussion ........................................................................................................ 157 
  iv 
5.4.1 Limitations of the study .............................................................................................. 159 
5.5 Conclusion ........................................................................................................ 160 
Chapter Six: Analytical and operator performance of a Point-of-Care Testing 
device used in the community setting ............................................................... 161 
Abstract .................................................................................................................. 161 
6.1 Introduction ....................................................................................................... 162 
6.1.1 The POCT device ...................................................................................................... 163 
6.2 Methods ............................................................................................................ 168 
6.2.1 Setting and participants ............................................................................................. 168 
6.2.2 Testing process .......................................................................................................... 168 
6.2.3.1 Comparator ............................................................................................................. 172 
6.3 Results .............................................................................................................. 174 
6.3.1 Accuracy and repeatability ......................................................................................... 174 
6.3.2 Total cholesterol results ............................................................................................. 178 
6.3.3 HDL cholesterol results .............................................................................................. 179 
6.3.4 TC/HDL results........................................................................................................... 179 
6.3.5 Glucose results .......................................................................................................... 179 
6.3.6 Clinical significance .................................................................................................... 189 
6.4 Discussion ........................................................................................................ 195 
6.4.1 Limitations of the study .............................................................................................. 198 
6.5 Conclusion ........................................................................................................ 200 
Chapter Seven: Overall discussion and conclusion .......................................... 201 
References ....................................................................................................... 211 
 
 
  
  v 
Thesis abstract 
 
Introduction: Point-of-Care Testing (POCT) also widely known as Near Patient 
Testing (NPT), is pathology testing performed at or near the site of patient care, 
offering several advantages over traditional pathology testing: it is portable, 
provides rapid results, uses smaller sample sizes and can be used for patient 
self-testing (PST). Due to these differences, it is conceivable that the 
implementation of POCT in place of laboratory testing could have an impact on 
patient experience; therefore, the aim of this research was to investigate this 
impact. The specific objectives of the study are to identify where and how POCT 
is currently used, to assess its impact on patient outcome and experience within 
a community setting and to evaluate its performance in the community setting.  
Methods: A survey was performed to gain insight on the extent to which POCT is 
used within UK primary care, how well established it is and general attitudes 
toward its use. A cross-sectional study, employing both quantitative and 
qualitative methods was conducted with patients receiving local authority 
provided NHS Health Checks in the community, where POCT is used to 
measure cholesterol and glucose. The analytical and operator performance of 
the POCT used was also assessed.  
Results: UK primary care staff were aware of POCT; 86% of respondents 
reporting that their surgery used some form of POCT on a regular basis. It 
appeared, however, that POCT operators were not always trained and that the 
quality of results obtained was not always considered. The use of POCT in 
community-based NHS Health Checks was well received and enabled the 
screening of individuals who would not normally access healthcare. However, 
the programme as a whole did not instigate significant improvements in the 
cardiovascular health of the participants, unless the participant was referred for 
further testing. The POCT used produced results that were significantly different 
from the reference value, producing clinically significant changes in outcome.  
Conclusion: The use of POCT should be tightly managed in every setting, 
including the community. This management should include regular quality 
checks to ensure patient results are accurate and that clinical management 
decisions are appropriate.  
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Chapter One: Introduction  
1.1 Overview of chapters 
 
This thesis details the findings of four original research studies. The studies 
focus on the use of Point-of-Care Testing (POCT) outside the hospital setting. 
 
Chapter One - Introduction 
This introductory chapter provides a context in which to read the thesis, as well 
as a rationale behind the research undertaken.   
 
Chapter Two – Literature review  
A comprehensive review of POCT related literature. This chapter covers topics 
including: POCT technology; world healthcare systems; applications of POCT; 
advantages of POCT; disadvantages of POCT and quality considerations.  
 
Chapter Three – POCT within primary care 
This chapter reports the results of a survey and focus group of primary care staff. 
The study aimed to gather data on how well established POCT is in primary care 
in the UK. Key areas of interest included: which test parameters were carried out 
using POCT; which staff members operated the POCT equipment; training 
received by POCT operators; awareness of quality issues and general attitudes 
towards the use of POCT within primary care.  
 
Chapter Four – NHS Health Checks: POCT in the community setting 
The aim of the research reported in this chapter was to explore the patient 
impact of NHS Health Checks provided in the community by non-medical staff. 
With the increasing promotion of community healthcare, it is import to assess the 
impact that this may have on the patient. This open-label study was conducted 
with a local authority’s health improvement service. Participants recruited to this 
study received a Health Check as per normal care and then an additional Health 
Check at least 12 weeks later. The primary outcome was the change in the 
participant Qrisk2 (10 year cardiovascular disease risk) score. Questionnaires 
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were also used to assess participant well-being; health behaviours and 
experience of the Check.  
 
Chapter Five – The influence of workplace Health Checks on health behaviour 
28 semi-structured interviews were conducted with participants of the community 
Health Check study (Chapter Four). The aim of this qualitative research was to 
explore and understand the factors that influence lifestyle choices and to assess 
whether receiving an NHS Health Check had any effect on those choices.  
 
Chapter Six – Analytical and operator performance of POCT in the community 
This chapter reports the findings of a study that assessed the analytical and 
operator performance of the POCT used to deliver the Health Checks in the 
community. Known external quality assessment (EQA) samples were tested by 
three groups: health improvement staff in the community setting; expert user in 
the community setting and expert user in the laboratory setting. The results were 
compared to the all laboratory trimmed mean (ALTM) to give an overall picture of 
analytical performance. Shift tables were used to display any clinical significance 
arising from variation in results.   
 
Chapter Seven – Overall discussions and conclusions  
Key points and findings of the chapters are drawn together in this final chapter. 
Recommendations are made for the future use of POCT.  
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1.2 World health 
 
The picture of global health has changed. In 1990, the three leading risk factors 
for disease burden were childhood underweight, air pollution from solid fuels and 
tobacco smoking, including second hand smoke. Disease burden is a 
measurement of the impact of a health problem, taking in to account several 
indicators including cost, morbidity and mortality. Disease burden is often 
discussed in terms of quality-adjusted life years (QALYs) or disability-adjusted 
life years (DALYs), both terms quantify the number of years lost due to disease 
(YLL).  
By 2010, tobacco smoking is still one of the leading risk factors, however, the 
other two leading risk factors have changed and now include high blood pressure 
and alcohol consumption (Lim et al., 2012). These three risk factors are 
modifiable, therefore theoretically it should be possible to reduce global disease 
burden by making healthy lifestyle changes.  
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1.3 The National Health Service  
 
1.3.1 History of the National Health Service (NHS)  
The NHS was founded in 1948 under a Labour government. It was based on the 
recommendations of the Beveridge Report, chaired by the economist Sir William 
Beveridge. The report recommended the “comprehensive health and 
rehabilitation services for prevention and cure of disease” and stated: “Medical 
treatment covering all requirements will be provided for all citizens by a national 
health service” (Beveridge, 1942).  
Over the years, the NHS has seen many changes; some of the main changes 
are displayed in Figure 1.1. In 1973, under the reforms, regional, area and 
District Heath Authorities (DHAs) replace regional hospital boards, taking over 
public health and other services from local authorities in the process (Webster, 
1996). DHAs, which were responsible for both the finances and the provision of 
services in the NHS, were replaced in 2002 with primary care trusts (PCTs) and 
strategic health authorities (SHAs), which provided regional management for the 
NHS and oversaw the work of primary care trusts (PCTs). 
303 PCTs were established and given responsibility for approximately 80% of 
the NHS budget. In 2005, a government paper outlined plans create changes in 
the way that services are commissioned using local clinicians in the design of 
services. The aim of the paper was to roll-out practice-based commissioning; 
develop primary care trusts (PCTs) to support practice-based commissioning; 
and to review the functions of strategic health authorities (SHAs) to support 
commissioning and contract management (Department of Health, 2005).  
In 2006, Strategic health authorities (SHAs) were reduced from 28 to 10 and 
many primary care trusts merged to form 152 from 303.  
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Figure 1.1 timeline displaying development of the NHS, with particular reference to 
structural and strategic changes, as well as cardiovascular disease 
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1.3.2 The new NHS  
As shown in Figure 1.1, all SHAs and PCTs were abolished on 1 April 2013 as 
part of the coalition government reforms of the NHS. With the new NHS system, 
NHS England is responsible for purchasing primary care services and some 
specialised services. Clinical Commissioning Groups (CCGs) commission most 
of the hospital and community NHS services in the local areas for which they are 
responsible.  
Many of the recent structure and culture changes within the NHS came about as 
a result of the Health and Social Care Act (2012) and the Francis Report (2013), 
which detailed the inquiry into failings at Mid-Staffordshire NHS Foundation 
Trust.  
The Health and Social Care Act 2012 proposed to create an independent NHS 
Board, increase GPs’ powers to commission services, strengthen the role of the 
Care Quality Commission, cut the number of health bodies e.g. Primary Care 
Trusts and Strategic Health Authorities and promote innovation (Department of 
Health, 2012). 
The Francis Report was commissioned in 2010 following failings at the Mid 
Staffordshire NHS Foundation Trust between 2005 and 2009. The report 
addresses a range of issues, including: the recruitment, training and competency 
of staff; the regulation of care services; the science of quality measurement; the 
degree to NHS staff feel empowered and the role of public voice (Francis, 2013). 
A subsequent report, published in 2014 by the Nuffield Trust, highlights the 
problems faced in trying to implement the recommendations made in financial 
and resource limited times (Thorlby et al., 2014). Evidence suggests that the 
recent cuts to healthcare budgets may widen the gap of health inequalities 
between the poor and the affluent in the UK (Barr et al., 2014).  
 
In October 2014, the 5 Year Forward View (5YFV) was published, which sets out 
NHS England’s strategy for the NHS for the next five years. The document 
emphasises a movement towards a new relationship with patients and public, 
where prevention and self-management is key and again encourages expansion 
and strengthening of primary and community care. It also highlights a £30bn 
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funding gap that cannot be closed without more funding, alongside further action 
on demand and efficiency (NHS England, 2014).  
 
 
1.3.3 Current challenges faced by the NHS 
In recent years the NHS has been criticised for failing to meet standards, 
particularly within emergency care, hospital care and general practice.   
The cause of these failings is multifaceted.  
Over the last 30 years, average life expectancy in the UK has increased from 
70.8 to 79.1 years for men and 76.8 to 82.2 years for women (ONS, 2015), this 
increase creates an ageing population. Whilst the population living longer is a 
positive factor, it also means that that there is an increased section of the 
population that is living with one or more conditions, which are often complex, 
requiring on-going, specialist care.  
There appears to be an increasing issue with people adopting unhealthy 
lifestyles. Consuming excess alcohol; having a poor diet; physical inactivity and 
smoking are all lifestyle choices that greatly increase the risk of developing 
disease, such as diabetes or heart disease. The National Child Measurement 
Programme (NCMP) measures the height and weight of around one million 
school children in England every year. In 2014/15, 19.1% of children aged 10-11 
were obese and a further 14.2% were overweight (PHE, 2016). These numbers 
have been steadily rising over the past 20 years (van Jaarsveld and Gulliford, 
2014), suggesting that the problem is set to continue.  
Accident and Emergency (A&E) departments are under increasing pressure from 
rising numbers of patients who do not actually require emergency treatment, 
resulting in a 35% increase in attendances over the past 10 years (The king’s 
Fund, 2015). This problem has arisen from several factors including attendees 
suffering with mental health problems who cannot access support elsewhere; 
difficulties in discharging elderly and frail patients who may not have support at 
home once ready for discharge due to cuts in social care budgets and patients, 
particularly those aged 18 to 34, who bypass GP services as they cannot make 
an appointment that fits around work (Citizens Advice Bureau, 2014). It is 
thought that these issues played a large part in the poor performance of A&E 
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departments against their target of 95 per cent of patients spending no longer 
than four hours in A&E (The King’s Fund, 2015).  
In the early days of the NHS, the main objective was to tackle disease. Today, 
patients expect so much more from the service, from mental health and social 
care, contraception, antenatal and maternity services, vaccination programmes 
and the fast, efficient processing of our medication and appointments.  
1.4 Pathology testing  
 
Pathology is described by the Royal College of Pathologists to be the “science at 
the heart of modern medicine” which aims to explain why and how people fall ill 
and reveal targets for their treatment (RCPath, 2013). Using laboratory tests, it is 
possible to define the success or failure of both the progress and the final 
outcome of that treatment.  
Diagnostic testing has been around for hundreds of years, with some of the 
earlier examples including examination of urine and faeces (Price et al., 2004).  
The results of pathology tests are extremely important, it is estimated that they 
affect around 60-70% clinical management decisions including the prescription of 
medication, admissions, referrals and discharge from hospital (Forsman, 1996; 
Seddon et al., 2001).  
 
In 2008, following a report of the review of the NHS pathology services in 
England, chaired by Lord Carter of Coles, it was estimated that 70–80% of all 
health care decisions affecting diagnosis or treatment are influenced by 
laboratory results (Carter, 2008). The report focussed on improving quality and 
patient safety, improving efficiency and identifying the mechanisms for delivering 
change and recommended that the consolidation of pathology services would 
achieve many of the intended outcomes. At the time of issue of the report, over 
500 million clinical biochemistry and 130 million haematology tests were carried 
out, over 50 million microbiology requests were processed and over 13 million 
histopathology slides and 4 million cytology slides were examined each year with 
around 35-45% requested through primary care. This frequency had increased 
around 10% each year between the years of 2005 to when the report was done, 
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2008. This increase is thought to continue exponentially over the next few years, 
the number of tests done in 2013 would have been approximately 805million for 
biochemistry, 209 million haematology and 80 million microbiology tests. 
 
The United States has led a movement toward the consolidation of laboratories 
into ‘core laboratories’ and ‘laboratory service networks’.  This has since spread 
throughout Europe and has taken effect in the UK (Price et al., 2004). After a 
review of the NHS pathology services, Lord Carter of Coles (2008) suggested 
that pathology services in England be consolidated. Today, hospital trusts in the 
East of England the East and West Midlands are adopting a ‘hub and spoke’ 
approach to pathology testing where larger ‘hub’ laboratories process the 
routine, non-urgent samples and smaller ‘spoke’ laboratories deal with the urgent 
samples (Illman, 2013). This ‘hub and spoke’ model is widely used across the 
more developed countries. There are currently 240 full-service pathology 
laboratories in the United Kingdom, it has been suggested that they could be 
reduces to 60 in a 10 year period if the ‘hub and spoke’ model was used 
countrywide (Illman, 2013). With a decreased provision of lab 
 
1.5 Point-of-Care Testing 
 
Point-of-Care Testing (POCT), also widely known as Near Patient Testing (NPT), 
is pathology testing performed at or near the site of patient care, in a location 
distinct from a normal hospital laboratory with the quick availability of results 
(Khunti, 2010; Cramb, 2004). POCT makes use of miniaturised versions of 
laboratory technologies, making many clinical pathology based tests available in 
a range of settings. The tests can be performed by a range of users, including 
laboratory staff, healthcare staff and patients, making use of a wide variety of 
instruments. Through the availability of rapid results, POCT enables immediate, 
informed decisions relating to patient care. Compared to laboratory testing, the 
flexibility provided by POCT in test location and test operator means that POCT 
is ideal for use in a much wider range of settings and scenarios. POCT is used in 
many areas, including: surgical theatres, intensive care, accident and emergency 
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(A&E), general wards, general practice, home visits, sports medicine, patient 
self-testing and the general community.  
 
1.5.1 POCT in the new NHS 
The NHS reforms aim to create a focus on quality and improving outcomes whilst 
increasing the accountability of the NHS; strengthening clinical leadership; 
shifting responsibility and decision making for public health to local authorities; 
promoting outsourcing of services and creating a competitive market place 
(Department of Health, 2012; National Health Service, 2013).  
The Health and Social Care Act (2012) highlights “Evolving clinical practice and 
technology means that some services that previously could only be provided in 
an acute hospital can now be provided in a local health centre, GP surgery or 
even the patient’s own home” (Department of Health, 2012). 
POCT has the ability to accommodate many of the above aims as it can facilitate 
more community based care whilst still providing effective pathology testing. 
POCT could also add competition to the market place where the NHS 
commissions external companies to provide pathology services to the NHS, for 
example IntraHealth, a primary healthcare company separate to the NHS. 
IntraHealth has an anticoagulation monitoring service for INR, which has been 
adopted by some NHS primary care sites, particularly in the North East of 
England (IntraHealth, 2013).  
 
Another aim of the NHS reforms is to reduce spending. Lord Carter of Coles 
(2008) reported that £2.5 billion was spent on pathology testing per year, with the 
likelihood that pathology testing was set to rise in frequency by around 10% per 
annum this figure can only be larger today. The largest portion of this annual 
spend is on staffing. POCT could help reduce spending in this particular part of 
the budget, as a smaller workforce would be required. The NHS already employs 
the majority of POCT users in the primary care setting as nurses, GPs and 
healthcare assistants.  
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1.6 NHS Health Checks 
 
This chapter has highlighted the global problem that is CVD, the priority of 
prevention over cure and the pressure to treat patients outside the hospital 
setting. One programme that incorporates these three themes is the NHS Health 
Check scheme.  
The theoretical basis of screening centres around the identification of 
unrecognised disease or defect by the application of testing. The objective is to 
distinguish between apparently well individuals who are likely to have a disease 
and those who probably do not (Wilson and Jungner, 1968).  
In 2009, the NHS Health Check (NHSHC) programme was implemented in the 
UK. The programme screens for risk factors of cardiovascular disease (CVD), 
diabetes, kidney disease and some forms dementia in 40-74 year olds, making it 
a type of ‘case-finding’ screening. The scheme aims to prevent CVD by 
identifying modifiable risk factors e.g. hypercholesterolaemia or hypertension and 
advising the patient on how to reduce their risk, either through lifestyle changes 
or prescription of relevant drugs. 
An NHSHC involves questions around lifestyle and family medical history; 
assessment of alcohol intake; measurement of glucose and cholesterol levels; 
height, weight and waist circumference; blood pressure assessment; pulse 
reading and calculation of CVD risk score using a risk calculator. The scheme is 
primarily implemented within primary care where eligible patients are invited to 
the Check by their GP practice or they are checked opportunistically during a GP 
or nurse consultation.  
In April 2013, local authorities (LAs) became responsible for public health 
services. Some LAs provide community NHS Health Checks through their health 
service, which employs non-medical staff, trained specifically to perform NHS 
Health Checks, utilising POCT for the analysis of cholesterol and glucose levels, 
in a variety of locations e.g. supermarkets and workplaces.  
 
It is because of the availability of POCT that screening programmes involving 
analysis of blood samples, like NHS Health Checks, can be brought into the 
community. The advantage of performing Health Checks in this way is that it 
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frees up clinician time, as well as having a greater chance of accessing ‘hard-to-
reach’ patients who would not normally attend primary care and therefore would 
not receive an opportunistic Health Check from their GP.  
 
Although there is a plethora of evidence that supports identification and 
modification of CVD risk factors in reducing the morbidity and mortality of CVD 
(Espeland, 2007; Lakka et al., 2002; Turner et al., 1998), the NHSHC scheme 
has come under criticism for being a waste of time and money, a cause of 
unnecessary worry and a task that some healthcare professionals have little 
interest in performing (Krogsbøll et al., 2012; Capewell et al., 2015). Chapters 
Four, Five and Six of this thesis investigate the outcomes of NHSHCs performed 
in the community setting as well as the quality of the POCT used to perform 
them.  
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Chapter Two: Point-of-Care Testing literature review 
2.1. Introduction  
 
This chapter reports relevant literature concerned with Point-of-Care Testing 
(POCT), with particular reference to its advantages, disadvantages, applications 
and current technologies. 
 
Point-of-Care Testing (POCT), also widely known as Near Patient Testing (NPT), 
is pathology testing performed at or near the site of patient care, in a location 
distinct from a normal hospital laboratory with the quick availability of results 
(Khunti, 2010; Cramb, 2004). The tests can be performed by a range of users, 
from patients to laboratory staff, using a range of instruments.  
POCT represents one of the fastest growing segments of the diagnostics market 
(Kazmierczak, 2011), with the most common POCT tests are glucose, urine 
dipstick, INR, D-dimer, haemoglobin and lipid profile tests (Liikanen and Lehto, 
2013). Typically, a good POCT device should have the following characteristics: 
short time to results (< 15 minutes), portable, require only sample volumes, 
multifunctional, use self-contained reagents, self-calibrated and ability to connect 
to other systems or networks (Sista et al., 2008).  
 
POCT provides many advantages over laboratory based testing. As most 
devices enable a quick turnaround time from sample collection to provision of 
results, faster informed clinical decisions can be made, which could be vital in an 
emergency setting. In a non-emergency setting, this attribute is considered very 
convenient as a patient can be tested and the results discussed in one 
consultation. This is convenient for both the healthcare professional and patient, 
freeing up appointment time and reducing the number of appointment visits for 
the patient, for example in the primary care setting. Rapid results can also 
reduce worry for the patient, as the wait for test results can sometimes be 
stressful. The prospect of a less stressful wait for results could encourage more 
patients to be tested for sexually transmitted diseases (STDs) and therefore 
impact on the transmission of STDs. A study by Horwood et al. (2015) surveyed 
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a cohort of men-who-have-sex-with-men (MSM) (n=134). The survey reported 
that 84% would be more likely to be tested for HIV, 91% more likely tested for 
gonorrhoea, 90% more likely tested for chlamydia and 90% more likely tested for 
syphilis if the tests were available as rapid POCT (Horwood et al., 2015).  
 
As POCT negates the need for many of the steps required in traditional 
laboratory testing, illustrated in Figures 2.1 and 2.2. Time-dependent changes in 
labile analytes, analytes that regularly or continuously undergo change, such as 
lactate and glucose can be avoided (Kazmierczak, 2011) through the use of 
POCT due to the simpler testing method.  
Through avoiding some of these steps, it is also possible that POCT could avoid 
some of the errors typically associated with laboratory testing. Inappropriate 
sample preparation can occur in the laboratory, often POCT devices are 
automated and so sample preparation is performed internally (Drenk, 2001). 
Misidentification of patients is also far less likely with POCT as it is often 
performed with the patient present.  
 
POCT can provide greater patient comfort than laboratory testing. Typically, 
POCT devices only require a small sample size e.g. 2-3 drops of capillary blood, 
negating the need for large volumes of blood or plasma, which when analysed in 
the laboratory are traditionally obtained by venepuncture, which patients can find 
uncomfortable or even traumatic and time consuming.  
 
As most POCT devices are designed to be portable, employing features that are 
easy to use, the range of locations and situations in which testing can take place 
is vast when compared to laboratory testing. These features enable testing to 
take place in the community setting, performed by non-healthcare or laboratory 
staff.   
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2.2 Applications of POCT 
 
Table 2.1 summarises the locations in which POCT can be utilised and the 
potential benefits that it may provide. Due to the portable nature of POCT, it can 
also be used in prison and military settings e.g. for drugs of abuse and sports 
medicine e.g. lactate as a measure of athletic performance (Price et al., 2004).  
 
Location Application Potential benefit 
Intensive care 
unit (ICU) 
Monitor vital parameters  Early recognition of life-
threatening conditions, Improving 
mortality and morbidity.  
Reduce length of stay 
Operating 
theatre 
Monitoring during operative 
procedures e.g. 
Coagulation testing in cardiac surgery, 
anaesthetics  
Reduce post-operative care 
requirement 
Convert to day care 
A&E Testing for rapid triage and treatment Quicker to diagnose and initiate 
treatment, reduced length of stay 
in A&E 
Ambulance Pre-hospital testing e.g. cardiac 
markers, blood gases 
 
Faster triage through A&E 
Earlier intervention 
 
Primary care Management of long term conditions Convenience and patient comfort 
Community Screening and management of long 
term conditions 
Better access to relevant 
population 
Home Management of long term conditions Better awareness of condition 
Motivation to manage condition 
Avoid need to attend hospital 
Avoid cost of transport 
Avoid time off work 
 
Table 2.1 Summary of locations and scenarios in which POCT can be applied, 
with reference to potential benefits.  
 
2.2.1 Example applications of POCT in hospital care 
Generally, the laboratory staff of a hospital will manage the POCT. Some 
hospitals have POCT coordinators whose role is specifically to manage the 
POCT undertaken across the hospital. As shown in Table 2.1, POCT has many 
applications within the hospital setting, with the advantages it provides being put 
to best use in critical situations, where fast turnaround times are key.  
In neonatal intensive care, blood sampling for laboratory testing is a major cause 
of blood loss and anaemia in neonatal intensive care. Mahieu et al. (2012) found 
that, compared with laboratory testing, the use of POCT decreased the total 
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blood taken for electrolyte testing by 23.7% and 22.2% for bilirubin testing. In 
addition, fewer very low birth weight infants (VLBWI) required blood transfusion 
(38.9% vs. 50%, p < 0.05) as the number of transfusion/infants decreased by 
48% (1.57 vs. 2.53, p < 0.01) (Mahieu et al., 2012).  
 
In the operating theatre, excessive blood loss, that requires transfusion of blood 
products, sometimes occurs in patients undergoing cardiac surgery, in particular 
cardiopulmonary bypass. Blood loss and transfusion requirements in these 
patients may be reduced with a better control of heparin treatment and its 
reversal. POCT can provide the rapid results required to make faster clinical 
management decisions and avoid unnecessary blood transfusions (Prisco et al., 
2003). This avoidance of unnecessary transfusions has been shown to provide 
significant benefits with respect to clinical outcomes (Weber et al., 2012).  
 
2.2.2 Applications of POCT in emergency care  
As previously explained in Chapter One, emergency departments are facing 
huge amounts of pressure to meet targets and are quite often failing due to a 
number of constraints. Early recognition and treatment of illness are directly 
linked to the survival rate of critically ill patients (Rooney and Schilling, 2014). 
For this reason, POCT could greatly improve a patient’s chance of survival due 
to the rapid availability of test results. Examples of POCT tests in the emergency 
setting include cardiac markers, blood lactate and coagulation. Cardiac markers, 
such as Troponins, are tested as an indicator of myocardial injury. A study 
conducted by Than et al. (2012) reported that POCT returned results 42.1 
minutes quicker than the laboratory, on average (Than et al., 2014). Similarly, a 
randomised controlled trail conducted by Goodacre et al. (2011) found a 20% 
greater discharge rate during the initial evaluation process when POCT was 
performed compared to laboratory testing (Goodacre et al., 2011).  
Elevated blood lactate levels are sensitive marker of impaired tissue perfusion 
and anaerobic metabolism in patients with suspected sepsis (Scott  et al., 2012).   
A study by Goyal et al. (2010) found that the use of POCT with a capillary blood 
sample saved 151 minutes on average compared to whole-blood lactate levels 
that were taken at the discretion of the treating physician (Goyal et al., 2010).  
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Immediate assessment of coagulation status, for example by performing 
international normalised ratio (INR), partial thromboplastin time, haemoglobin, 
and/or platelet count tests has been shown to aid the initiation of thrombolysis 
therapy for those suspected of suffering an ischemic stroke (Lahr et al., 2013). 
Studies have shown that POCT is produces coagulation results 30 to 50 minutes 
quicker than the laboratory (Walter et al., 2011; Weber et al., 2013).  
 
In all cases, this fast TAT results in quicker clinical management decision, which, 
in the emergency setting has a positive impact on clinical outcomes. For 
example, patients who receive initiation of sepsis treatment within the first 3 to 6 
hours after admission to the emergency department have improved mortality 
rates of 16% (Dellinger et al., 2013; Rivers et al., 2001). Although test for test 
POCT often proves to be more expensive than laboratory testing, the benefits 
that POCT provides appear to outweigh any downsides. It is thought that the 
development of POCT will change the way in which emergency medicine is 
practiced (Rooney and Schilling, 2014). 
 
 
2.2.3 Applications of POCT in primary care  
Healthcare for common and chronic conditions is mostly provided by primary 
care (Seddon et al., 2001) and so it is important to make sure appropriate 
pathology provisions are available in this setting as well as in secondary care.  
Typical POCT tests that may be performed in primary care include: urine dipstick 
testing, blood glucose and coagulation e.g. international normalised ratio (INR). 
However, there is little documentation of which POCT are used in primary care 
and who performs them, hence the research undertaken in Chapter Thee.  
 
Figures 2.1 and 2.2 are two models of how pathology testing in primary care can 
be organised.  
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Figure 2.1: Diagram of how the traditional model of pathology laboratory testing 
operates within primary care. The blue line represents an additional step, which may be 
taken if the GP practice cannot take venous sample(s).  
 
The traditional model of pathology testing has been in place for many years and 
is highly organised. The quality of results is generally high because laboratories 
have to be Clinical Pathology Accreditation (CPA) inspected, they run internal 
quality checks, and they take part in external quality control schemes where 
results are compared nationally and internationally.  
 
The pathology staff are highly trained, a biomedical scientist must now have an 
undergraduate degree in biomedical science or closely related subject, relevant 
experience in working in a laboratory and they must also be registered with the 
Health and Care Professions Council (HCPC). Registration with the HCPC 
requires completion of an academic programme plus a period of training in an 
Institute approved laboratory (IBMS, 2013). Additionally, due to the fact that 
pathology laboratories have a high throughput of tests using large mainline 
analysers, the traditional model is relatively cost effective on a cost per test 
basis.   
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There are some drawbacks to the traditional model of pathology testing. Not all 
sites of primary care are situated close to the main hospital laboratory, meaning 
that the availability of pathology testing can be limited or that the process can 
take a longer period of time due to greater transport times being required.  
Generally, due to the nature of the traditional model of pathology testing, results 
are not obtained as quickly as they are in POCT. In some cases, this delay of 
results can be detrimental because it can have a knock on effect of delaying the 
recognition or treatment of a condition. In turn this could lead to a plethora of 
negative outcomes such as more appointments/hospital admissions, longer 
hospital stays, worsening of the patient’s condition and undue worry and upset. 
The majority of sample processing errors occur within the pre-analytical phase 
(specimen collection and pre-analytical sample handling), this is mainly down to 
incorrect information on the request form (Turner et al., 2013) or individual or 
system defects (Da Rin, 2009). By comparison POCT can avoid some of these 
potential errors because no request forms are required. However, central 
laboratories can also overcome some of these potential errors by using 
advanced information technology and 
robotics. In some hospitals the 
implementation of such technology has 
been shown to improve accuracy and 
clinical efficiency of the laboratories and 
resulted in an all-round reduction in 
errors (Da Rin, 2009). 
 
 
 
Figure 2.2: Model of POCT procedure within primary care 
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2.2.4 Applications of POCT in the community 
Due to POCT generally being transportable and easy to use, it is increasingly 
being used in screening initiatives, such as the NHS Health Checks, and at 
home by patients, especially those with long-term conditions, for example 
diabetes.  
 
Patient self-testing (PST) 
When a device is deemed to be simple and have a low risk for erroneous results 
by the Food and Drug Administration (FDA) Clinical Laboratory Improvement 
Amendments of 1988 (CLIA-88) then it can be CLIA waived. For a test to be 
classified as ‘simple’ it must be fully automated and provide a direct read-out of 
results, without interpretation (Corbin et al., 2012). A CLIA waived device can be 
operated by individuals without a professional pathology testing (FDA, 2014).  
When a device is CLIA waived it is also approved for home use. This means it 
can be used for patient self-testing (PST), also known as patient self-monitoring.  
PST is particularly useful for patients with chronic conditions that are prescribed 
long-term medication because it allows the patient to self-test and monitor at 
their convenience. For example, patients with diabetes can monitor their glucose 
levels using a variety of hand-held glucometers, this is known as self-monitoring 
of blood glucose (SMBG). Monitoring glucose levels gives the opportunity to 
achieve specific levels of glycemic control and prevents hypoglycaemia. The 
main aim of self-monitoring blood glucose is to maintain a more constant glucose 
level by collecting detailed information about blood glucose levels at many time 
points. The availability of blood glucose values can help aid the adjustment of a 
therapeutic regimen (Benjamin, 2002).  
For patients with diabetes mellitus type 1, studies have shown that increased 
self-monitoring is directly correlated with improved health outcomes, for example, 
reduction of HbA1c (Evans, 1999). A systematic review by Welschen et al. 
(2005) examines 6 randomised, control trials and concludes that SMBG groups 
show a statistically significant decrease of 0.39% HbA1c compared to control 
groups, in patients with diabetes mellitus type 2, not treated by insulin. A 
decrease of  0.39% in HbA1c is expected to reduce the risk of microvascular 
complications by approximately 14% (Stratton, 2000). 
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However, other studies conducted have produced varying findings. An article 
analyzing data from the third National Health and Nutrition Examination Survey 
(NHANES III) concluded that, for patients with diabetes mellitus type 2, there 
was little correlation between SMBG frequency and glycemic control (Harris, 
2001). However, the credibility of the NHANES III study design has also been 
questioned as it was a cross-sectional analysis of patient behaviour and 
glycemic control, therefore, a cause-and-effect relationship would be difficult to 
determine.  
Patient self-adjustment  
In certain cases, some patients can adjust their medication themselves 
according to the results they generate using their POCT device, this is known as 
self-adjustment.  
Programmes such as Dose Adjustment For Normal Eating (DAFNE), for patients 
with diabetes mellitus type 1, train patients in how to estimate the carbohydrate 
in each meal and to inject the right dose of insulin. A randomised control trail 
conducted by the DAFNE study group (2002) found that DAFNE training 
produced significant improvements in glycaemic control, well-being, quality of life 
and treatment satisfaction (DAFNE, 2002).  
POCT can be utilised by patients taking anti-coagulants, e.g. Warfarin. POCT 
devices are used to measure international normalised ratio (INR), this is a 
derivative of a prothrombin time test, used to determine the clotting tendency of 
blood.  
A systematic review by (Heneghan et al., 2006) reported that simple self-
monitoring tests could reduce the risk of stroke by half in thousands of people 
who are medicated with warfarin. Patients who are capable of performing self-
monitoring and self-adjusting together are less likely to have a thrombolytic event 
and have lower mortality rates than those who only self-monitor. However, 
Heneghan (2006) warns that not all patients are suitable for self-monitoring and 
that those who are identified as capable should be properly educated in the 
procedure (Heneghan et al., 2006). A 2 year randomised control trial assessing 
100 patients found that approximately two thirds of patients are suitable for 
anticoagulant self-management (Sidhu, 2001), this is a significant portion of the 
warfarin prescribed population.  
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There are other factors to consider on implementation of PST. A systemic review 
by Connock et al. (2007) suggests that PST is actually more expensive than 
normal care in some cases, estimating the adoption of patient self-monitoring of 
anticoagulation therapy would cost the NHS an additional £8–14 million per 
annum (Connock et al., 2007).  
 
Screening initiatives 
POCT is increasingly being used in a range of community locations, from 
pharmacies to supermarkets to busses. The general idea is that the POCT 
operator, e.g. pharmacist, identifies at-risk patients and refers them to the next 
level of care for possible diagnosis and treatment (Rodis and Thomas, 2006).  
Screening initiatives that take place in the community, rather than primary care 
setting aim to capture ‘hard-to-reach’ patients who would not normally visit their 
GP.  
Blood glucose and cholesterols are measured using POCT in the community by 
local authority health services as a means of delivering NHS Health Checks. 
Originally, NHS Health Checks were exclusively delivered in general practice by 
healthcare professionals. In 2013, local authorities were given a budget to spend 
on health. Some local authorities have used some of this budget on providing 
Health Checks in community locations, for example supermarkets, workplaces 
and on bespoke health busses. It would not be possible to deliver Health Checks 
by this method without the provision of POCT. Chapters Four, Five and Six 
investigate the impact of these Health Checks on the patients that receive them 
as well as assessing the quality of the POCT results produced.  
 
2.3 POCT Technology 
 
POCT can perform many of the tests that are offered in a laboratory, only it 
makes use of miniaturisation of the technology in order to give automation and 
integration of several processes on one single device (Mugele and Baret, 2005).  
POCT was originally used for to blood chemistry, electrolytes, blood gases, 
clotting and pregnancy testing. More recently, POCT has now been extended to 
drugs of abuse, cardiac markers, and infectious diseases (Sista et al., 2008). 
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Table 2.2 displays some of the main POCT test available, categorised in 
accordance with their clinical application.  
 
Clinical application Parameters available as POCT tests 
Acute-phase proteins C-Reactive Protein (CRP) 
Allergy in-vitro 
diagnostics 
Allergy specific Immunoglubulin E (IgE) 
Blood gasses Acidity (PH), partial pressure of carbon dioxide (pCO2), Partial 
pressure of oxygen (pO2) 
Cardiac markers Troponin T (TnT), Troponin I (TnI), myoglobin, Creatin kinase MB 
isoenzyme (CK-MB), B-type Natriuretic Peptide (BNP/NT-pro-BNP) 
Coagulation Activated clotting-time (ACT), activated partial thrombo-plastin time 
(aPTT), prothrombin time (PT, INR), D-dimer, platelet function tests, 
ex-vivo bleeding time 
Diabetes mellitus Glucose, Glycated haemoglobin (HbA1c), microalbumin, continuous 
glucose monitoring 
Drug monitoring  Therapeutic drugs, alcohol, amphetamines, barbiturates, 
benzodiazepines, cannabinoids, cocaine, methadone, opiates 
Electrolytes Sodium (Na
+
), Potassium (K
+
), Chloride (Cl
-
), Calcium (Ca
++
ion), 
Magnesium (Mg
++
ion) 
Enzymes Amylase, alkaline phosphatase, Creatine kinase (CK), aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), Gamma-
glutamyl transferase (γ-GT) 
Fertility Human chorionic gonadotropin (hCG), Luteinising hormone (LH) 
follicle stimulating hormone (FSH) and sperm count 
Haematology Haemoglobin, haematocrit, erythrocytes, leukocytes, thrombo-cytes, 
CO-Oximetry 
Infectious agents 
 
Human immunodeficiency virus (HIV), infectious mononucleosis, 
Chlamydia trachomatis, Trichomonas vaginalis, Plasmodium 
falciparum and vivax, Influenza A and B, Steptococcus A and B 
Metabolites Cholesterol, HDL-cholesterol, triglycerides, creatinine, urea, uric 
acid, bilirubin, lactate, ammonia 
Rheumatology Antibodies against mutated citrullinated vimentin (anti-MCV) 
Urine diagnostics Urine strips (pH, protein, glucose, ketones, bilirubin, uro-bilinogen, 
nitrite, leukocytes, erythrocytes), microalbumin, NMP22 bladder 
carcinoma check 
Table 2.2 Table displaying many of the current tests available as POCT, categorised in 
accordance with their clinical application.   
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POCT tests can broadly be divided into three different platforms: non-
instrumental systems, portable analysers and bench-top analysers.  
 
Type 1: Non-instrumental systems where the equipment is often disposable, 
such as a reagent test strip, and can measure single or multiple analyte(s) and 
may also include some procedural controls. The strips are composed of a porous 
matrix that has been infused with dried reagents. These are qualitative tests that 
determine a plus/minus or positive/negative result. Detection in these tests 
ranges from chemical indicator reactions to immunological reactions (Luppa et 
al. 2011). Examples of these tests include pregnancy tests, urine dipsticks and 
tests for the detection of infectious agents.  
 
Type 2: Small portable analysers, which can often be held in one hand are 
quantitative test devices which often have the majority of the test occurring on 
the disposable test strips needed for each test, the reader is simply used for the 
determination and output of results (Luppa et al. 2011). Examples of these 
devices include blood glucose meters, cholesterol checks and coagulation 
monitors that can test parameters such as the international normalised ratio 
(INR). Most of the hand held POCT devices operate using closed continuous 
flow through channels that are either etched into a solid surface such as silicon 
or are moulded from polymeric materials into a matrix (Mugele and Baret, 2005). 
 
Type 3: Large, bench-top analysers that are less portable and designed for use 
in small laboratories and clinics often test for multiple analytes. These analysers 
tend to use more complex analytical principals, including: particle counting for 
haematology, spectrophotometric substrate and enzyme-activity measurement, 
sensor-based blood gas analysis and immunoassays (Luppa et al. 2011).  
 
Advancements in detection, recognition, fluidics, transduction and analytical 
processing have made testing for parameters such as those in Table 2.2 
possible as POCT.  
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2.3.1 Lateral flow immunochromatographic assays  
Lateral flow immunochromatographic assays or Lateral flow assays (LFAs) are 
designed to confirm the presence or absence of a compound or a derivative of it. 
The analyte is recognised through the use of its antibodies.  
LFAs consist of strips of a carrier material which contains dry reagents that are 
activated by applying a liquid sample and results are usually given with a simple 
‘positive/negative’ display. LFAs are simple and easy to use, with high sensitivity 
and selectivity (Posthuma-Trumpie et al., 2009). 
The most common examples of POCT that use LFAs include pregnancy testing, 
testing for infection by specific pathogens, testing for organ failure e.g. heart or 
kidneys and tests for drugs of abuse.  
LFAs are often referred to as “dipsticks" but this is an incorrect use of the term as 
real dipstick assays do not facilitate the flow of liquid through a membrane like an 
LFA does, instead they are based on immunoblotting principles (Posthuma-
Trumpie et al., 2009).  
 
The principal behind LFAs is the movement of a liquid along a strip of polymeric 
material whilst moving through various zones that contain attached molecules 
that interact with the analyte. Figure 2.3 illustrates the operating sits of a typical 
LFA.  
 
Figure 2.3 A typical POCT ‘sandwich format’ lateral flow immunochromatographic assay 
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Typically an LFA will consist of an application window where the sample will be 
introduced. The sample then runs along the application pad, through the 
conjugate release pad, the site at which the labeled analyte or recognition 
element(s) are dried. The labels used are made of very small (15-800 nm) 
coloured/florescent nanoparticles that can move with ease through the 
membrane and designed for optical detection. The nanoparticles are often made 
of colloidal gold, a suspension of small particles of gold in a liquid (Lim et al., 
2012; Byzova et al., 2010) or less often they are liposomes which are dyed with 
fluorescent or bioluminescent materials, the advantage of this is that the can 
allow a quantitation of the response as sell as the normal visualisation 
(Posthuma-Trumpie et al., 2009).  
After it has been through the conjugation pad, the sample runs along the 
membrane strip, using capillary force, where it encounters the detection zone. 
The detection zone consists of a test line and control line. At the test line there is 
an antibody to the analyte and so here the sample analyte and labeled analyte 
from the conjugate pad compete for the binding sites of the antibody. A response 
is seen, in this case a visible deposit, if the sample analyte is captured (Gordon 
and Michel, 2012) this is demonstrated in Figure 2.4. At the control line there is 
an antispecies immunoglobulin G, a response here confirms that the sample has 
flowed through the strip sufficiently.  
Because the captured label concentrates sufficiently above the background of 
unbound label to become visible, no wash step is required (Gordon and Michel, 
2012).   
In addition, it is possible to have more than two strips in the detection zone, they 
can be used to measure multiple analytes or give semi quantitative results 
(Posthuma-Trumpie et al., 2009).  
There is also an absorbent pad attached to the end of the membrane strip, this is 
used to maintain the movement of the liquid towards it (Posthuma-Trumpie et al., 
2009).  
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Figure 2.4 Diagram of a LFA detection zone. The image on the left with the analyte 
present gives an increasing signal; the image on the right with an absence of analyte will 
not provide a signal.  
 
Depending on the analyte used, an LFA can be used to detect or monitor; 
infectious agents such as influenza and Streptococcus pneumonia; metabolic 
disorders such as renal disease and diabetes; toxic compounds such as 
sulfadimidine which is an antibacterial, as well as the detection of other factors 
such as human chorionic gonadotropin (hCG) for pregnancy testing (Posthuma-
Trumpie et al., 2009).  
More sophisticated examples of a POCT LFA include detection of cardiac 
markers like CK-MB. Whole blood or plasma can be applied, which then 
migrates through a filter into a reaction chamber containing dry fluorescent-
labelled antibodies. The sample remains in the chamber for a time determined by 
a reaction gate. The reaction gate then becomes hydrophilic on contact with the 
sample. After this, the liquid migrates by capillary action to a reagent reservoir 
through channels that pass the capture antibodies. The results are read in an 
automatic reader and given on-screen (Gordon and Michel, 2012). 
2.3.2 Biosensors  
The technology behind POCT often involves the use of biosensors (Luppa et al., 
2011). Biosensors are classified by the International Union of Pure and Applied 
Chemistry (IUPAC) as analytical devices that detect analytes using “specific 
biochemical reactions mediated by isolated enzymes, immunosystems, tissues, 
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organelles or whole cells to detect chemical compounds usually by electrical, 
thermal or optical signals” (IUPAC, 1997). Figure 2.5 illustrates the basic set up 
of a POCT system that uses biosensors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Diagram illustrating the operation of biosensors in POCT  
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Biosensors have been developed for many POCT tests.  
Over the past 50 years, biosensors for blood glucose have been frequently 
developed and improved. Glucose biosensors account for approximately 85% of 
the market (Yoo and Lee, 2010).  
 
As illustrated in Figure 2.5, there are three main parts of a biosensor: the 
biological recognition elements that differentiate the target molecules in the 
presence of various chemicals, the transducer that converts the bio-recognition 
event into a measurable signal and the signal processing system that converts 
the signal into a readable form (Updike and Hicks, 1967; Hiratsuka et al., 2008). 
Transducers can be classified into five main groups: electrochemical, optical, 
thermometric, piezoelectric, and magnetic. Glucose biosensors tend to be 
electrochemical.  
Electrochemical sensors can be subdivided into potentiometric, amperometric or 
conductometric types (Pearson et al., 2000; Thévenot et al., 2001; Habermuller 
et al., 2000). Enzymatic amperometric glucose biosensors are the most common 
devices commercially available. Amperometric sensors monitor currents 
generated when electrons are exchanged between a biological system and an 
electrode (Turner et al., 1999).  
 
Glucose measurements are based on interactions with one of three enzymes: 
hexokinase, glucose oxidase (GOx) or glucose-1-dehydrogenase (Price, 2003).  
Whilst hexokinase is often used as the reference method for measuring glucose 
using spectrophotometry in the laboratory setting, GOx is the standard enzyme 
for biosensors in POCT (Bankar et al., 2009).   
 
Example of the process of glucose measurement by biosensor 
Immobilised GOx catalyses the oxidation of β-D-glucose by molecular oxygen 
producing gluconic acid and hydrogen peroxide, using the redox cofactor, flavin 
adenine dinucleotide (FAD). FAD is the initial electron acceptor and is reduced to 
FADH2, as shown below. 
 
  
30 
 
Glucose + GOx + FAD → Glucolactone + GOx  (FADH2) 
 
FADH2 reacts with oxygen, thereby regenerating it, leading to the formation of 
hydrogen peroxides, as shown below. 
 
GOx + FADH2 + O2 → GOx – FAD + H2 O2 
 
Hydrogen peroxide is oxidized at a catalytic anode (see below). The electrode 
recognizes the number of electron transfers, and this electron flow is proportional 
to the number of glucose molecules present in blood.  
 
H2O2 → 2H
+
 + O2 + 2e 
 
Glucose is sensed electrochemically, either by measuring oxygen consumption, 
measuring the amount of hydrogen peroxide produced by the enzyme reaction or 
by using a diffusible or immobilised mediator to transfer the electrons from the 
GOx to the electrode (Yoo and Lee, 2010).  
 
 
2.3.4 Microfluidics
 
POCT tests using microfluidics require no sample preparation and produce 
results in a short time period. Because of microfluidics use in POCT technology, 
fluid handling has evolved from passive capillarity in absorbent matrices, such as 
nitrocellulose or fused silica, to the use of active fluid handling (Sista et al., 
2008). Some POCT devices can actively drive fluids through channels to perform 
testing for electrolytes, metabolites, blood gases, coagulation and more recently, 
immunoassays.  
 
 
2.3.5 Spectrophotometry 
Spectrophotometry is the mainstay of automated clinical chemistry analysis and 
is based on two principles: that substances absorb light at different wavelengths 
and that the amount of light absorbed is proportional to the amount of substance 
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present (Arneson and Brickell, 2007). Beer’s law states that A = a b c, Where A 
is absorbance, a is absorptivity, b is the length of the light path through the 
substance and c is the concentration of the substance.   
Absorption units represent the light absorbed by the subject substance only and 
therefore an increase or decrease in light absorbed in proportional to the 
concentration of the substance.  
Typical components of a bench-top POCT device that conducts 
spectrophotometry are: light source, monochromator, sample well, photodetector 
and output screen.  
Figure 2.6 illustrates the set up of a typical spectrophotometer. The light source 
emits light in visible or ultraviolet wavelength ranges. The monochromator is 
used to eliminate unwanted wavelengths and allow desired light to reach the 
sample, typically this could be a filter or a prism. The photodetector detects the 
light that is transmitted through the sample and converts the light energy into 
electrical energy and the readout component displays the concentration 
(Arneson and Brickell, 2007).  
In POCT, spectrophotometry is used to measure substrate and enzyme-activity. 
An example of this is the measurement of creatinine as a biomarker for chronic 
kidney disease (CKD). Creatinine goes through the Jaffe reaction to form a 
yellow/brown coloured product or chromogen, as below: 
 
Picrid acid + NaOH + creatinine                yellow/brown chromogen 
 
The chromogen formed is measured for its ability to absorb visible light (Arneson 
and Brickell, 2007).  
 
Figure 2.6 Basic components of a spectrophotometer  
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2.3.6 Blood gas and pH analysis  
Blood pH, partial pressure of oxygen (PO2), partial pressure of carbon dioxide 
(PCO2) and oxygen saturation (SO2) are detected using a series of electrodes 
and spectrophotometric methods (Luppa et al. 2011). For example, SO2 is 
measured as oxyhaemoglobin vs. total haemoglobin by a spectrophotometer, 
measuring multiple absorbance readings at various wavelengths (Arneson and 
Brickell, 2007).  Compared to laboratory blood gas analysers, POCT blood gas 
analysers require little maintenance and are simple to use, with ongoing 
calibration and validation.  
Some analysers may also have the addition of a CO-oximetery unit.  
 
CO-oximetry  
A CO-oximeter can identify the oxygen carrying state of haemoglobin in a blood 
specimen and is helpful in defining the causes of conditions such as hypoxia and  
hypoxaemia. A CO-oximetry unit uses multi-wavelength spectrophotometry to 
measure the typical absorption spectra of the different haemoglobin species. 
Oxyhaemoglobin can be distinguished from carboxyhaemoglobin and can 
determine the oxyhaemoglobin saturation, which is the percentage of 
oxygenated haemoglobin compared to the total amount of haemoglobin (Luppa 
et al. 2011). In the case of a patient that presents with carbon monoxide 
poisoning (CO), the CO-oximeter will detect the levels of each haemoglobin and 
will report the oxyhaemoglobin saturation as markedly reduced.  
 
 
2.3.5 Haematological particle analysis  
The technology used in the POCT bench-top analysers (type 3) harnesses 
traditional techniques for the counting of haematological particles, namely 
cytometry. Flow cytometry can measure multiple characteristics of individual 
haematological particles flowing single file in a stream. Light scattering at 
different angles can distinguish differences in size and internal complexity and 
light emitted from fluorescently labelled antibodies can identify a range of cell 
surfaces and cytoplasmic antigens (Brown and Wittwer, 2000).  
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A full or complete blood count (CBC) can be performed by a number of bench-
top POCT anlaysers, providing counts for: white blood cell (WBC); red blood cell 
(RBC); haemoglobin (HGB); Haematocit (HCT); mean cell volume (MCV); mean 
cell haemoglobin (MCH); mean cell haemoglobin concentration (MCHC); 
platelets (PLT); lymphocyte count (LYM); lymphocyte percentage (LYM%); total 
content of monocytes, basophils, and eosinophils (MXD#); relative content of 
monocytes, basophils, and eosinophils (MXD%);  total content of neutrophils 
(NEUT#); relative content of neutrophils (NEUT%); relative distribution width of 
red blood cells by volume, standard deviation (RDW-SD); relative distribution 
width of red blood cells by volume, coefficient of variation (RDW-CV) and mean 
platelet volume (MPV) (Price et al., 2004).  
Haematology POCT, in particular the measuremt of haemoglobin, may be useful 
in primary care, A&E and intensive care settings.  
 
2.4 Patient satisfaction with POCT 
 
The opinion of the patient is becoming increasingly more important as the new 
NHS reforms come into place, with investigations into patient satisfaction in 
healthcare on the rise from the late 1960s (Sitzia and Wood, 1997).  
 
POCT can offer a more convenient testing service to the patient, with less call for 
follow up and hospital appointments, without the need for phlebotomy. There is 
sometimes a reduced cost to the patient also through negating the need to travel 
to different sites and appointments.  
 
A large multicentre, randomised, controlled trial conducted by (Laurence et al., 
2010) aimed to determine if patients were more satisfied with POCT than 
standard laboratory testing. In the study Laurence et al. (2010) included patients 
who visited their GP for diabetes, hyperlipidaemia and/or anticoagulant therapy. 
This trial was part of a larger study funded by the Australian government which 
aimed to determine the safety, clinical effectiveness, cost-effectiveness and 
satisfaction of POCT in general practice. A total of 3,010 participants in the 
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intervention group had their samples taken and analysed in practice using POCT 
devices. Participants in the control group (n=1,958) had their samples either 
taken in practice, at a collection centre or at the local laboratory and their 
samples were then analysed at the laboratory. A total of 4,573 participants were 
requested to complete a questionnaire in which they rated how strongly they 
agreed/disagreed to several statements relating to their satisfaction with the 
sample collection process, their confidence in the process and the result, the 
cost, their convenience and the management of their disease. On analysis of the 
data returned, Laurence et al. (2010) found that the POCT group generally 
showed higher levels of satisfaction with the sampling process and a higher level 
of agreement with the statement ‘I would rather have blood taken by a finger 
prick than a needle in my arm’ than seen in the control group (p<0.001). The 
intervention group also reported higher satisfaction in not having to travel to a 
different site (p=0.009). However results also showed that participants in the 
control group were seen to have more confidence in the hygiene of a laboratory 
compared to any site of POCT. 
 
Shephard (2006) details the results of a questionnaire used at assess the 
acceptance of national Quality Assurance for Aboriginal Medical Services 
(QAAMS) HbA1c POCT service by doctors, POCT operators and diabetic 
patients (Shephard, 2006). 41 doctors, 65 POCT operators and 161 patients with 
diabetes completed the questionnaire. >97% of patients were ‘very satisfied’ with 
the convenience of POCT and thought the finger prick sample to be less painful 
than venepuncture. Over 90% also reported their visit to the doctor to be ‘more 
useful’ as a result of the POCT, with more that 95% stating that they wanted 
POCT to continue as part of their diabetes management.  
However, not all studies on patient satisfaction with POCT have reported 
favourable results. A study conducted by Stone et al. (2007) aimed to assess the 
acceptability of and satisfaction of patients and health professionals with POCT 
for glycosylated haemoglobin (HbA1c) in primary care (Stone et al., 2007). A 
questionnaire was used to assess satisfaction with diabetes care in two groups:  
intervention/POCT and control group/usual laboratory test. Stone et al. (2010) 
found that the 344 patients (n=184 intervention, 160 control) that were assessed 
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using the questionnaire had similar overall scores for diabetes care (P = 0.507). 
There was also no statistically significant difference between groups for 
questions relating to information about results (P = 0.698) and arrangements for 
giving blood samples (P = 0.886). 
Some anecdotal evidence arising from semi-structured interviews include:  
“Well normally you are waiting and wondering, you 
know, waiting for 10 days or a fortnight, wondering if 
it's gone up or down” – an intervention group patient  
“Yes, I do think it does make a difference, because 
you can instigate changes in treatment there and 
then and discuss it with the patient and discuss what 
options are available to them. Sometimes it's a 
complete surprise, you’re expecting it to be quite 
good and in fact it comes back a bit too high and 
you've got, you've got a chance to do it there and 
then rather than waiting” – opinion of a practice 
nurse  
 
A study comparing POCT to laboratory International Normalised Ratio (INR) 
analysis for anticoagulant therapy monitoring (Shiach et al., 2002) found, using 
pre and post intervention of POCT questionnaires, that there was no significant 
difference in satisfaction between POCT and laboratory services, participants 
were generally satisfied with both the POCT and laboratory based services.  
Shiach et al. (2002) also investigated the turnaround time between the two 
different testing processes. For the hospital laboratory based service, patients, 
on average, spend 33 minutes in the car commuting and had a 33-minute wait to 
be seen. For the POCT based service, the average time to commute was 13 
minutes with only a 9-minute wait to be seen.  
 
Many of the studies that assess patient satisfaction use surveys and 
questionnaires to collect data. This method of data gathering may have some 
drawbacks as discovered in a study by Cohen et al. (1996) which examined the 
consistency of survey estimates of patient satisfaction in a healthcare 
  
36 
 
environment and found that the wording of a question can have a marked 
difference on the response. For example, they found that greater patient 
satisfaction is conveyed when asking the patient if they agree with a negative 
description of their experience compared to when they are asked if they agree 
with a positive (Cohen et al., 1996).  
Unfortunately, there is no ‘gold-standard’ method of assessing patient 
satisfaction. Two administrations of a questionnaire may yield different results for 
different reasons or a combination of reasons e.g. the patient’s views on their 
healthcare has changed and/or the questionnaire has evoked a different 
response (Fitzpatrick, 1991).  
Five social-psychological variables were 
2.5 Patient management of condition 
 
It is thought that POCT could facilitate greater patient self-management of 
conditions through motivating patients to learn more about their illness and how 
to manage it. This is achieved through the availability of immediate results during 
medical consultation and/or the ability for patients to test themselves at home.   
 
Laurence et al. (2010) found that participants in the POCT group showed higher 
levels of agreement than the control group with the following statements: ‘I have 
confidence in the information given by my GP regarding my pathology test 
result’,  ‘having immediate feedback of the test result was important as it 
allowed/would allow me to discuss the management of my condition with my GP’ 
and ‘I am/would be more motivated to look after my condition because of regular 
POCT testing’.  
Shepherd (2006) found that over 90% of patients reported that their self-
motivation to control their diabetes increased as a result of the POCT (Shephard, 
2006) 
 
It is thought that increased patient motivation to manage chronic conditions 
should be reflected in better therapeutic control, and that therefore better 
therapeutic control would be seen in those using POCT. However, research has 
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provided different results in this area, with some studies finding POCT to be 
more effective than normal care (Muchmore et al., 1994; Guerci et al., 2003; 
Martin et al., 2005) and others finding little difference (Allen et al., 1990; Farmer 
et al., 2007) to regular pathology testing.  
 
Therapeutic control is often measured by how long patients can stay within target 
ranges for their condition. For example the target international normalised ratio 
(INR) range for a patient with a venous thromboembolism such as deep vein 
thrombosis (DVT) is 2.0 to 3.0 for two consecutive days (Hyers et al., 2001).   
Cleas et al. (2005) conducted a randomised clinical trial in which 66 GP practices 
were separated into 4 groups. Each group received education on oral 
anticoagulation, anticoagulation files, and patient information booklets; the 
second group additionally received feedback every 2 months on their 
anticoagulation performance; the third group used POCT devices to determine 
their INR in the doctor's office or at the patient's home; and the fourth group 
received Dawn AC computer assisted advice for adapting oral anticoagulation. 
Dawn AC is a software package designed to help healthcare professionals 
monitor patients taking potentially dangerous drugs, such as warfarin.  
Therapeutic control was measured by the time spent in target INR range and 
adverse events relating to anticoagulant therapy were recorded, both of these 
factors were then compared to baseline data. A significant increase was seen in 
percentage of time within 0.5 INR from target, from 49.5% at baseline to 60% 
after intervention in all groups. However, no specific group had more improved 
results than another. From this it is possible to conclude that the use of a POCT 
device was no more effective than providing the patient with educational 
materials relating to oral anticoagulation (Cleas et al., 2005).  
 
A study by Shiach et al. (2002) had similar findings. A randomised group of 
patients had their INR investigated using POCT and was compared to a different 
randomised group that had their INRs checked using a mainline laboratory 
analyser. Shiach et al. found that the mean percentage of time within the target 
range was almost identical for both groups (P = 0.2).  
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Other studies have reported similar finding when assessing POCT for other 
parameters. O’Kane et al. (2008) did not find any significant difference between 
a POCT self-monitoring group and a control group on HbA1c results in patients 
with newly diagnosed type 2 diabetes mellitus (O’Kane et al., 2008).  
 
It is difficult to determine the cause of the changes in these studies as they adopt 
differing methodologies and factors such as patient behaviour and therapy 
adherence are not accounted for. A systematic review of the evidence conducted 
by Welschen et al. (2005), however, concludes that POCT for self-monitoring of 
blood glucose provides a statistically and clinically significant decrease in HbA1c 
compared with control (Welschen et al., 2005).  
2.6 Impact of POCT on healthcare professionals 
 
It is also important to consider the impact that the implementation of POCT may 
have on healthcare professionals.  
 
A study assessing the thoughts and opinions of healthcare staff before and after 
implementation of POCT found that satisfaction rates more than doubled after 
POCT was introduced. Over 95% of doctors assessed using a questionnaire 
agreed that POCT provided a convenient service for them and >90% stated 
having immediate results contributed positively to patient care and they would be 
comfortable in continuing with a POCT service (Shephard, 2006). The doctors 
were seen to report that the programme was ‘more effective and impressive to 
the patient’, that it is ‘positive on patient outcomes’ and that it is beneficial to 
have the results available at the time of consultation as many of their patients do 
not return for follow up appointments. Healthcare professionals participating in 
this study thought that the HbA1c POCT aided community awareness of 
diabetes. An increased awareness of disease could lead to better management 
of disease.   
 
POCT is particularly useful for clinicians in ruling out suspected acute conditions, 
such as DVT. POCT D-dimer tests can be conducted in primary care or 
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outpatient clinics for patients with suspected DVT. Studies have shown that this 
can reduce the need for referral to secondary care of almost 50% (Büller et al., 
2009; Geersing et al., 2009), which inevitably saves the NHS money, especially 
if the patient would have otherwise been referred onto a consultant led DVT 
clinic.  
 
2.6.1 Prescribing  
In recent years, the prescription of antibiotics has come under close scrutiny due 
to the growing problem of antibiotic resistance. In 2015, new NICE guidance was 
published on antimicrobial stewardship, with threat of being presented before the 
General Medical Council (GMC) if not adhered to by clinicians (NICE, 2015).  
 
Patients suspected of lower respiratory tract infections can be tested using 
POCT for C-reactive protein (CRP) in primary care. CRP is an acute-phase 
protein, which increases in serum during infection and tissue damage (Black et 
al., 2004). As respiratory tract infections account for between 80 and 90% of all 
prescribed antibiotics in primary care (Van Bijnen et al., 2014), ruling out 
suspected respiratory tract infections could reduce this number, causing a 
substantial effect on the overall number of antibiotic prescriptions.  
 
A study conducted by Cals et al. (2009) compared the use of POCT to traditional 
laboratory testing for C-reactive protein (CRP). The results showed a reduction in 
the number of prescriptions for antibiotics in patients being assessed for lower 
respiratory tract infections (Cals et al., 2009). In this study, general practitioners 
in the POCT CRP group prescribed antibiotics to 31% of patients compared with 
53% in the control group (P=0.02).  
 
2.7 Considerations relating to POCT 
 
Although POCT has many advantages over laboratory testing, there are some 
issues that may need addressing in order for POCT to be used more confidently 
and in greater frequency.  
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2.7.1 Analytical performance and quality of POCT 
Pathology test results generated by mainline laboratory analysers are seen as 
the ‘gold standard’ for production of reliable results. POCT tests may be more 
prone to error than their laboratory equivalents.   
It has been proposed that these errors may arise from operator-related errors.  
A major concern is that, even with adequate training, POCT is susceptible to 
error due to the fact that many users are not laboratory based staff, they are 
mostly clinicians working in busy environments whose main concern is patient 
care and not analysis of samples (O'Kane et al., 2011). 
 
Errors 
Although the requirement of fewer steps in the testing process for POCT could 
mean that there is less chance of error when compared with laboratory testing, 
POCT has created new challenges and sources of potential errors (Plebani, 
2009). The definition of error in laboratory testing has been defined as: “a defect 
occurring at any part of the laboratory cycle, from ordering tests to reporting 
results and appropriately interpreting and reacting to these” (Bonini et al., 2002).  
 
There is little published literature on errors in POCT. One seminal paper by 
Meier and Jones (2005), however, identifies three main sources of POCT errors: 
operator incompetence, non-adherence to procedures, and the use of 
uncontrolled reagent/equipment (Meier and Jones, 2005). The paper also 
considers three amplifiers of POCT error: inconsistent regulation, rapid result 
availability and immediate therapeutic implications.  
As highlighted in section 2.7.2, training is of paramount importance to ensure 
quality and accuracy in POCT. A 2000-2001 study of waived POCT found that 
19% of testing personnel had been neither trained nor evaluated in the 
performance of the assays that they carried out (Hassan et al., 2003). The same 
study discovered that 25% of test operators failed to follow manufacturer's 
directions, and 7% of operators did not perform required calibrations. With 
regards to use of reagents, 32% failed to perform quality control (QC), and 20% 
ignored manufacturer directions by physically separating internal QC test fields 
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from patient test fields in card format tests and 6% used expired reagents and 
kits (Hassan et al., 2003).   
Although rapid availability if results is generally seen as a positive, there is also 
potential for medical errors to be made on the basis of erroneous results. In a 
study of stat (immediately or without delay) test errors published in 1997, of 189 
clinician-discovered errors, 70% of the errors had no effect on patient care, 
19.6% stimulated further inappropriate investigation, and 6.3% led to 
inappropriate initiation or modification of therapy (Plebani and Carraro, 1997).  
 
In 2003, Gerald Kost proposed a classification system of error classification for 
POCT (Kost, 2003). Kost (2003) divided the POCT process into pre-analytic, 
analytic, and post-analytic phases.  
 
Pre-analytical errors 
Excessive ordering and mistiming of tests can cause error. Test interpreters can 
become overwhelmed by the plethora of laboratory results when too many tests 
have been ordered. A mistimed test, in which test results become out of sync 
with therapeutic interventions, can result in interpreters reacting to transient or 
recent pathophysiologic states, rather than to a patient's current 
pathophysiologic status. 
Although POCT is often performed near to the patient, misidentification of the 
patient can still occur. For example, emergency department staff asked to 
perform POCT on a patient in a specific location, e.g. bed 8, who, in such a 
challenging and fast-paced environment, actually turns out to be a different 
patent on whose encounter sheet the tests results are written. 
In some outpatient settings, test specimens are batch processed e.g. urine tests. 
If containers or swabs are not labelled on collection, examples of consequent 
errors tend to result in patients receiving prognoses for other patients and 
potentially receiving therapy for a condition that they do not have and conversely, 
the patient who actually has the condition does not receive treatment.  
  
42 
 
Misidentification of patients and/or absence of patient results can also cause 
error when uploading on to patient records where results fail to reach the 
permanent record or reach the wrong record.  
Specimen collection for POCT can be erroneous, specifically when inappropriate 
or inconsistent specimen type or volumes are collected and are applied to the 
device's testing surface or reaction chamber.   
Error detection schemes such as delta checking are not often used in POCT 
(Kazmierczak, 2011) as automatic availability of both to previous results and the 
automated statistical analysis, and so erroneous results could be generated and 
go unidentified. Delta checking is a quality control method that compares present 
and previous test results and detects whether the difference between the two 
results exceeds pre-defined criteria. If the difference is smaller than the pre-
defined criteria, the result is automatically reported; however, if the difference 
exceeds the pre-defined criteria, the result requires manual confirmation by 
laboratory personnel (Sheiner et al., 1979; Ladenson, 1975).  
 
It is difficult for the operator to assess specimen quality, e.g. checking for 
clotting, in the small sample volumes required by POCT and the reaction sites of 
POCT are often opaque, meaning that the operator cannot quality asses the 
reaction. Both of these attributes are not assessed by the POCT device itself and 
so this could result in error (Kost, 2003; Meier and Jones, 2005).  
 
Analytical errors 
Some POCT devices require calibration. Opportunities for error at this stage 
include missing out this calibration step and misreporting of the calibration data. 
This could lead to the developments of defects in specimen/reagent interactions. 
Errors in these interactions include: patient-related native interferences (for 
example non- specific agglutinins in precipitation slide tests), specimen-related 
non-target influences (e.g. drugs causing spurious results in electrolyte channels 
of handheld chemistry POCT devices), or specimen-reagent, combination-
related matrix effects. However, it is impossible to separate native, non-target, 
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and matrix sources of error inside the closed design of POCT devices (Meier and 
Jones, 2005).  
Errors may also occur at result generation. For example, results that are 
generated outside a POCT method's validated range may not be reliable. Lack of 
QC in waived POCT, operator failure to recognise out-of-control QC, and the 
absence of other performance-control monitors can all lead to uncontrolled 
acceptance of invalid results.  
 
Post-analytical errors 
Errors may still occur post-result. Defects can occur during formatting of reports, 
value reporting and report management. Report management includes report 
verification, preservation, storage, and retrieval. If report generated uses 
incorrect units of measure, for example, misinterpretation of results could occur, 
potentially leading to inappropriate clinical management decisions. In addition to 
this, as POCT generally reports results on a small screen, human error can 
occur and results can be misread.  
In some circumstances, results are not recorded in an appropriate manner, with 
some POCT results disappearing from the patient record due to human 
forgetfulness (Salka and Kiechle, 2003).  
Report management is an important final step, which can also go wrong. Failure 
to correlate initially generated results with subsequently preserved reports leaves 
users unaware of discrepancies e.g. there could be differences between a POCT 
output and the patient record (Meier and Jones, 2005).   
 
Quality error rates 
There is little published information on POCT quality error rate (Plebani, 2009). 
Information on the quality error rate can help inform risk-benefit appraisal of 
POCT introduction and can inform preventative measures to reduce quality error 
rates (O'Kane et al., 2011). Although true quality error rates are difficult to assess 
in any testing system due to potential lack of recognition of errors and 
discrepancies in recording said errors, a study conducted by O’Kane et al. (2011) 
aimed to investigate the POCT quality error rate in a secondary care setting. Two 
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of the hospitals used in this study had 24 hour a day pathology laboratory 
access, whilst the other hospital that took part had 9 am – 5 pm pathology 
laboratory access and so used POCT in the remaining hours. O’Kane et al. 
(2011) found 225 quality query reports logged against 407,704 POCT tests in a 
14 month period. The rate of reports varied between tests with 0.65% of HbA1c 
tests warranting a quality query report and 0% blood ketones warranting a quality 
query report. Each report was scored on the basis of the actual effect of the 
defect on patient care and the worst-case potential outcome that might arise 
from the defect. Results suggested that the actual effect of the defect tended to 
have minimal or no impact on patient care. However, the potential effect was 
scored much higher with 41% at significant adverse outcome level. Compared to 
laboratory testing, the potential effect score for POCT is lower on average 
(O'Kane et al., 2008). It was reported that the majority of errors occurred in the 
analytical stage of testing.  
Other studies on this topic adopted alterative methodologies and therefore 
cannot be directly compared. However, the POCT quality error rate in the 
O’Kane et al. (2011) study is comparatively higher than studies that have 
assessed quality error rates in laboratories (which vary between 0.012% and 
0.6%) (Plebani and Carraro, 1997; Carraro and Plebani, 2007; Bonini et al., 
2002; Sirota, 2005; O'Kane et al., 2008). There is reasonable potential for the 
error rate to be higher than reported as, in some instances, the POCT user may 
not always log an error report because, for example, they are too busy. 
Nevertheless, the data presented by O’Kane et al. (2011) provides a good insight 
into the trends of quality error reporting. For instance, clinicians may be more 
tolerant of quality errors for tests that they do not deem to be as critical as 
others, like initial urine dipsticks where patients will often proceed to have many 
more definitive blood tests. This study also highlights the difference in nature of 
the POCT and laboratory errors; POCT errors tend to be analytical e.g. lack of 
barcodes, whereas laboratory tends to be pre and post-analytical e.g. 
misidentification of patients, sampling, preparation and packaging of samples. 
The kind of POCT errors may be overcome in the future by improvements in 
POCT management and training.   
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Analytical performance 
In order to be safe to use and appropriate to base clinical management decisions 
on, POCT should produce results that are agreeable with the reference standard 
results produced in the laboratory. As well as manufacturer assessment, there 
have been numerous independent studies assessing the analytical performance 
of a range of POCT devices. There appears to be conflicting evidence for the 
accuracy and reliability of POCT (Murata et al., 2015; Shiach et al., 2002; Clerico 
et al., 2005; Panz et al., 2004; Storti et al., 2004; Carey, 2006).  
 
A randomised cross-over trail conducted by Shiach et al. (2002) compared 
POCT to laboratory results for INR testing (Shiach et al., 2002). The study 
investigated 39 patients on long-term warfarin treatment that had received 
anticoagulant treatment at the hospital anticoagulant clinic before transfer to the 
community clinic. Each patient was randomly assigned to one of two groups, 
group 1 (n=19) using POCT monitoring in the first phase and moving on to 
laboratory monitoring in the second phase and group 2 (n=20) using laboratory 
monitoring in the first phase and POCT monitoring in the second phase. Each 
phase lasted 6 months with tests being run on both systems in each group for 
comparison only, dosage was based on the named phase i.e. in phase 1, group 
1 had their INRs tested with both POCT and laboratory analyser but it was only 
the POCT result taken into account for prescribing.  
Using INR results (n=465) from both POCT and laboratory analysis Shiach et al. 
(2002) found that the difference between the two methods increased as the 
average INR increased, as illustrated in the Bland-Altman plot below in Figure 
2.7.  
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Mean relative deviation was used to assess the level of agreement between the 
INR results. The mean relative deviation was less than 10% for INR below 4.0, 
yet for INR results above 4.0 it was 12.6%, this is less satisfactory. However, as 
there were few INR results >4.0, this disagreement in results is unlikely to be 
clinically significant.  
 
 
 
 
 
 
 
 
 
Figure 2.7 Bland-Altman illustrating the difference between POCT and laboratory INR 
results, indicating proportional bias, from (Shiach et al., 2002).  
 
A study by Murata et al. (2015) assessed the performance of POCT vs. 
laboratory analysis in the measurement of a metabolic panel. The study 
concluded that most POCT results showed agreement with laboratory results, 
with the exception of sodium, carbon dioxide, AST and bilirubin (Murata et al., 
2015).  
 
Clerico et al. (2005) compared five POCT assays for B-type Natriuretic Peptide 
(BNP) and found that the POCT devices could differentiate between healthy 
patients and severe heart disease patients but did not differentiate between 
healthy patients and those with mild cardiac problems (Clerico et al., 2005). A 
study by Storti et al. (2004) showed that POCT had similar analytical 
performance but different clinical results to laboratory for BNP (Storti et al., 
2004).  
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Panz et al. (2004) compared two POCT testing devices with laboratory analysis 
for cholesterol testing. Whilst the findings of this study suggest that the POCT 
devices were in close agreement with the reference values (p<0.0001), there 
was also an underreporting of total cholesterol and LDL cholesterol, placing 
some of the results in incorrect risk categories (Panz et al., 2004). In a similar 
study, Carey et al. (2006) compared a POCT device with laboratory testing for 
cholesterol. This study concluded that the POCT was safe and appropriate to 
use in clinical practice, with no significant differences between POCT and 
laboratory. There was, however, some overestimation of triglycerides and 
underestimation of HDL cholesterol (Carey et al., 2006).  
 
It would appear that the analytical performance of POCT varies depending on a 
number of factors including sample type and parameter tested. Chapter Six 
assesses the analytical performance of cholesterol and glucose POCT in the 
community setting.     
 
2.7.2 Training in POCT 
As stated in the Royal College of Pathologists guidelines on the use of POCT, 
the user must be formally trained in the use of the devices to ensure a good 
quality of results and an understanding of their clinical significance (Cramb, 
2004). 
In contrast to the laboratory setting where there is a greater time between results 
obtained and reporting of results, POCT provides almost immediate results 
which can be dangerous to the patient if those results are erroneous and clinical 
management decisions are made on the basis of them (O'Kane et al., 2011). 
Erroneous results could arise from simple procedural errors, a lack of training or 
a lack of understanding in the bioscience underlying POCT (Kyriacos et al., 
2005). This is why training of the POCT users is paramount, as it should reduce 
the likelihood of generating erroneous results.   
Although POCT is often accessible to a wide variety of users, in the clinical 
setting it is usually carried out by a range of healthcare professionals, for 
example healthcare assistants, nurses and physicians, who possess a range of 
qualifications and have differing levels of understanding (Liikanen and Lehto, 
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2013).  
Although training is highly recommended to ensure accurate results (Goodwin, 
2008; Montagnana et al., 2009) it is not specified how this training should be 
delivered. 
 
Belsey et al. (1987) investigated glucose POCT training of 2100 nurses in an 
inpatient setting. The training intervention in this study consisted of a self-
learning videotape, demonstration technique, tests and option of re-training by 
the diabetes nurse-educator (Belsey et al., 1987). Results suggested that the 
training improved the reliability the glucose POCT test results.  
 
A randomised controlled trial conducted by Hansen (1998) compared the quality 
of training by laboratory staff to that of nursing staff in urine dipstick POCT. 262 
nurses in an inpatient setting were trained in this investigation. It was seen that 
the nurses performed urine dipsticks and quality controls significantly better 
when trained by laboratory educators, compared to nursing staff (Hansen, 1998).  
 
As training can be time consuming and expensive, studies have been conducted 
to assess whether alternatives to face-to-face training are appropriate and 
effective. Knapp et al. (2011) compared the efficacy for two different kinds of 
training of rapid POCT HIV testing on 36 nurses in an outpatient setting. One 
group received in-person training, consisting of activation kits, lectures and 
webcam with a health science researcher. The other group received online 
training consisting of activation kits; Internet learning and live meeting supported 
by webcam technology. This study concluded that not only is online distant 
learning more cost effective that in-person training but is also just as effective in 
transferring knowledge (Knapp et al., 2011).  
 
An interactive two-step training and management model was assessed by (Lehto 
et al., 2011) for POCT glucose testing in secondary care. A POCT coordinator 
was designated along with a contact person from each clinical department.  
In a quiet and fit for purpose environment, the POCT coordinator trained contact 
persons from each department, spending 60–90 minutes on training each 
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contact person. The training involved: factors contributing to test results; error 
sources; uncertainty of measurements and the consequences of false results. 
The POCT coordinator also included some department specific factors, for 
example, in the Intensive Care Unit (ICU), for patients with poor peripheral 
circulation, it was essential to pay attention to skin puncture specimens.  
Once the contact person felt confident in the use of POCT for glucose testing, 
they then went on to train other nurses in their unit this is known as cascade 
training. If competence in the procedure was obtained, a “driving license” for 
POCT glucose testing certificate was signed by both the contact person and the 
trained nurse, 49 nurses achieved this in the space of 5 months.  
POCT glucose results were later reviewed together with the patients’ other 
laboratory results. Upon assessment Lehto et al. (2011) discovered that after 
training, clinical staff achieved an analytical precision comparable to that of the 
laboratory personnel and were able to maintain this standard. Imprecision within 
all personnel groups was low, indicating a similar quality of glucose 
measurements. Staff trained in this study were also asked to complete a 
questionnaire, which revealed that the nurses were very satisfied with the clinical 
contact persons’ prerequisites for training. 96% of the nurses thought that the 
contact persons had adequate knowledge of sample collection and the POCT 
device. In the opinion of the respondents, the quality of their glucose 
measurements was improved. The majority of nurses agreed that understanding 
the significance of quality control was the most valuable item of training. 
However, 39% of the nurses trained said that they did not feel sufficiently trained 
in the maintenance of the equipment and 32% were not motivated by the training 
to do glucose testing (Lehto et al., 2011).  
 
In countries where POCT is more frequently used, such as Australia, 
programmes such as the national Quality Assurance for Aboriginal Medical 
Services (QAAMS) have been set up, providing continuing education; training; 
competency assessment and support services for all health workers using POCT 
equipment (Shephard, 2006). Although the UK does have these services 
available, they tend to come from different sources, which all have different 
agendas, e.g. industry. It is possible that training, quality assurance and support 
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would be more effective if provided by one body.  
 
2.7.3 Cost of POCT 
The cost of POCT not only includes the cost of the devices and reagents but the 
cost of maintenance, training and local laboratory support meaning that POCT is 
more expensive than central laboratory testing.  
On the other hand, to the NHS as a whole, the implementation of POCT could 
actually save money as explained in the 2008 report of the review of the NHS 
pathology services in England, chaired by Lord Carter of Coles because £2.5 
billion spent per year on pathology testing is accounted for by the workforce 
(Coles, 2008) and so even though POCT may seem more expensive than a 
laboratory on a test for test basis, this may not be the case as the cost of 
employing the pathology staff is not taken into account.   
 
In a study by Cals et al. (2011) concentrating on C-reactive protein (CRP) for 
investigation of lower respiratory tract infections the total mean cost per patient in 
4 groups: group one, patients receiving normal care (non-POCT); group two, 
patients receiving care with POCT; group three, patients receiving care with GPs 
who had been given enhanced communication training and group four, patients 
receiving care using POCT from GPs who had been given enhanced 
communication training was calculated. The results showed the mean total cost 
of a patient in group one, receiving normal care (non-POCT) was €35.96, the 
total mean cost of a patient in group two, receiving care with POCT was €37.58, 
the total mean cost of a patient in group three was €25.61 and the total mean 
cost of a patient in group four was €37.78. Cost calculations included medication 
(both prescribed and over the counter), physician visits (including GP 
appointments, out of hours GP consultation and hospital outpatients/emergency 
department), diagnostics tests, testing costs (reagents and time of the healthcare 
professional) and training costs.  
Even though these finding show that using POCT for CRP equated to being  
€1.62 more expensive than the laboratory, other cost savings were made 
through using POCT as less prescriptions were given to patients, thereby 
reducing prescribing costs.  
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A follow-on study from the Belgian improvement study on oral anticoagulant 
therapy by had a primary aim of studying the cost effectiveness of interventions 
(Claes et al., 2006). The intervention groups consisted of:  
Group A: Oral anticoagulation education and patient information booklets 
Group B: Oral anticoagulation education and patient information booklets and 
bimonthly performance feedback  
Group C: Oral anticoagulation education and patient information booklets and 
use of INR POCT  
Group D: Oral anticoagulation education and patient information booklets and 
computer assisted advice for adapting treatment.  
This study used activity-based costing techniques in the medium of 
questionnaires to assess the costs per patient per month in the different 
intervention groups. Cost-effectiveness was expressed as cost per additional day 
within a 0.5 range from INR target. Costs included the dispensing and explaining 
of the information booklets and filling in the anticoagulation files for all the 
intervention groups at the patient level. In group B and D supplementary costs 
are generated at the study level e.g. creating of a patient file for group B or 
setting-up, collecting, and introducing patient information in the computer 
assistance programme for group D. For group C costs at the GP level are related 
to the usage of the POCT device and test strips.  
Results of this study suggest that POCT is less expensive than normal care, 
saving  €17.05 per patient per month.   
 
 
Limitations of this review 
This paper considered and included research from across the world. This is not 
ideal as other countries adopt different healthcare systems and have different 
geographies and demographics. POCT could have generated more positive 
results in other countries, for example Shepherd (2006) found that over 95% of 
POCT operators found POCT to be more convenient than the existing lab 
service. This study was conducted in Australian aboriginal communities where 
there is little or no laboratory provision (Shephard, 2006).  
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There was wide variation in the methodologies of the papers considered, many 
conducting different study types, using different interventions, assessing different 
populations, using different follow-up periods and measuring different outcomes. 
This variation in methodologies of the studies, along with gaps in the research is 
the reason an effective meta-analysis could not be conducted.  
2.8 Conclusion 
 
A vast number of laboratory tests are available as POCT. This availability allows 
for testing to be performed in a number of settings, providing rapid results, 
without the need for qualifications in medical diagnostics. The introduction of 
POCT, however, should be considered on a case-by-case basis, as it may not be 
appropriate in all settings, for example where laboratory testing provides results 
in an appropriate timeframe and is comparatively inexpensive.  
Occurrences of error and/or poor analytical performance of POCT may be off-
putting to those using POCT or those looking to adopt it. Still, strategies for error 
prevention involving checking, testing and monitoring have been proposed to 
overcome some of these issues (Meier and Jones, 2005).  
The benefits of using POCT in emergency and remote setting have long been 
established. Nevertheless, the future of POCT in the UK is likely to be decided 
by the way in which the NHS and other healthcare providers evolve to meet 
current and future challenges. Pressure to provide more healthcare outside of 
hospitals is just one of the current challenges; POCT could be instrumental in the 
provision of community-based care.   
 
Gaps in the literature 
Other than some papers which suggested that there is insufficient evidence to 
support the introduction of POCT into primary care (Gialamas et al., 2009), there 
was a paucity of research that concentrated on the extent of adoption of POCT in 
primary care. The aim of the next chapter, Chapter Three, is to answer which 
POCT tests are conducted within UK primary care, which staff perform the tests, 
the training they received and general thoughts and opinions on its use.  
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Excluding papers that assessed the efficacy of patient self-testing using POCT, 
there was very little evidence for the use of POCT in the community. Chapter 
Four of this thesis aims to determine the impact of Health Checks using POCT in 
the community setting on CVD risk factors, as well as assessing patient well-
being, health behaviours and evaluating the participant satisfaction with the 
Health Check service, in relation to POCT in particular.  
Chapter Five of this thesis aims to qualitatively analyse the effect of community 
Health Checks on health behaviours as well as discover participant opinion of 
the NHS Health Check programme, with particular focus of the use of POCT.  
Chapter Six of this thesis assesses the quality of the POCT results generated by 
the POCT used in the community Health Checks.  
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Chapter Three: On-site pathology testing in primary care: current positioning 
of Point-of-Care Testing in the UK   
Abstract 
Introduction 
With a general shift toward a more patient-centred approach to healthcare, 
where emphasis is placed on avoiding hospital admissions and use of 
community and primary care is encouraged, it could be that POCT becomes 
more widely adopted outside of the hospital setting. Little is known about what 
POCT is done within general practice (GP) in England. This research aimed to 
identify how well established POCT is within primary care in England.  
Methods 
Online surveys and telephone interviews were designed and conducted with UK 
primary care staff. The survey consisted of 9 main questions which assessed the 
POCT undertaken; the POCT operators; their training; quality considerations and 
general attitudes towards POCT. Results of the surveys were collated and 
reported in this chapter.   
Results 
A total of 136 participants completed the survey. The majority of respondents 
(80%) were aware of POCT and most reported conducting some tests as POCT 
in their practice (86%). POCT was mostly performed by nurses and the majority 
had received device specific training (72%). 20% of practices that used POCT 
were members of external quality assessment (EQA) schemes. Attitudes 
towards some of the features of POCT were generally positive and 39% were 
open to the idea of their practice adopting POCT in the future.  
Conclusion 
Results of this survey confirm that POCT is performed within primary care and 
that it is viewed as a positive tool in the care of patients. However, without a full, 
physical audit it is impossible to uncover its true status. It appears that the cost of 
adopting POCT in primary care was the most discouraging factor as funding for 
devices and reagents; maintenance, training and local laboratory support would 
have to be allocated.  
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3.1 Introduction  
 
Over the past 20 years there has been a general, world-wide shift in healthcare 
delivery toward a system which provides a patient-centric approach, with 
emphasis on the use of primary care and avoiding hospital admissions where 
possible (Seddon et al., 2001). The 2010 – 2015 coalition between Conservative 
and Liberal Democrat governments in England brought about many changes, 
one of the most significant being the reforms made to the NHS which will affect 
all healthcare professionals as well as the patients that they treat (BMJ, 2011). 
The NHS reforms aim to create a focus on quality and improving outcomes whilst 
increasing the accountability of the NHS, strengthen clinical leadership, shift 
responsibility and decision making for public health to local authorities, promote 
outsourcing some services and create a competitive market place (Department 
of Health, 2012; National Health Service, 2013).  
 
After a review of the NHS pathology services, Lord Carter of Coles (2008) 
suggested that pathology services in England be consolidated. There are 
currently 240 full-service pathology laboratories in the United Kingdom, it has 
been suggested that they could be reduced to 60 in a ten year period (Illman, 
2013), this may also increase the need for POCT.  
 
The NHS reforms aim to create a focus on quality and improving outcomes whilst 
increasing the accountability of the NHS, strengthen clinical leadership, shift 
responsibility and decision making for public health to local authorities, promote 
outsourcing some services and create a competitive market place (Department 
of Health, 2012; National Health Service, 2013).  
The Health and Social Care Act (2012) highlights “Evolving clinical practice and 
technology means that some services that previously could only be provided in 
an acute hospital can now be provided in a local health centre, GP surgery or 
even the patient’s own home” (Department of Health, 2012). This clinical practice 
now includes some complex tests such as cardiac markers, which thanks to 
POCT can be done in a variety of locations. POCT has been well established in 
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community care for over a decade in other countries such as North America and 
Australia (Francis and Martin, 2010). 
 
Currently, little is known about what POCT is done within general practice (GP) 
in England. As highlighted in section 1.3.2 of Chapter One, innovative 
technologies, along with more community and primary based care are being 
promoted within the NHS. It is important to understand how technologies such as 
POCT will integrate with current systems and how healthcare staff might receive 
its introduction. This research aimed to identify how well established POCT is 
within primary care in England. This paper reports the results of a questionnaire 
survey involving health care professionals. The objectives of the survey were to 
identify the POCT undertaken; the POCT operators; their training; quality 
considerations and general attitudes towards POCT.  
 
Research ethical approval for the study was granted through the Manchester 
Metropolitan University.  
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3.2 Method 
 
To establish data on current POCT usage in primary care, a questionnaire was 
designed as an online survey, using Bristol Online Surveys (BOS). The 
questions focused on which tests are done as POCT, who performs these tests 
in primary care, user training, quality issues, consideration of POCT in the future 
and thoughts and attitudes toward POCT. The target audience was general 
practitioners, nurses, healthcare assistants and practice managers. The survey 
can ben seen in Appendix 3.2. In addition, the survey questions were also used 
in telephone surveys of primary care practices.  
 
3.2.1 Designing the questionnaire 
Since the 1980s there have been vast changes in the way in which surveys are 
designed due to cognitive psychology research on questionnaire design 
(Bradburn et al., 2004). Computer-assisted survey information collection (CASIC) 
systems, such as BOS, have also helped to transform the methodology of 
surveys, allowing quick and accurate display of results. This display of results 
formed part of the reason for choosing to perform the survey in BOS.  
Questions were designed to be as unambiguous and clear as possible, whilst 
avoiding ‘loaded questions’ and other questions that could potentially bias 
responses.  
 
When designing a questionnaire it is important to consider wording in order to try 
and obtain results that are as accurate as possible and affected less by bias. The 
wording of a questionnaire is important from both the respondent and researcher 
perspective, ‘The precise wording of a question plays a vital role in determining 
the answers given by respondents’ (Bradburn et al., 2004).  Language and 
context can be ambiguous. A good questionnaire will not include any ambiguity 
so that the meaning of questions and answers can be easily understood 
(Bradburn et al., 2004).  
 
As well as ambiguity it is important to avoid politically charged terms as they can 
elicit very different responses. For example an American social survey 
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conducted by Davies et al. (2007) questioned the public about their views on 
welfare spend. For around half of the participants the term ‘welfare’ was used 
(n=1,317) and for the other half, the term ‘assistance to the poor’ was used 
(n=1,390). Responses were much kinder when the term ‘assistance to the poor’ 
was used, with 62% reporting that ‘too little’ was spent on ‘assistance to the poor’ 
compared to just 17% believing that ‘too little’ was spent on ‘welfare’ (Davis et 
al., 2007). This is likely to be due to the pejorative connotations associated with 
the term ‘welfare’.  
For this reason, questions were designed to be as clear as possible so that they 
lacked in ambiguity. 
 
 
3.2.2 Piloting the questionnaire 
The questionnaire was piloted on NHS primary care contacts as well as 
university staff to ensure all questions were clear and made good sense, n=12. 
Amendments to the questionnaire, as detailed in the results section, were made 
in accordance with the comments and suggestions made by the pilot contacts.  
 
3.2.3 Questionnaire Launch 
Contact details for all Greater Manchester GP practices were collated into an 
Excel spreadsheet.  This data was primarily taken from the NHS Choices 
website which held information for practices in the 12 Greater Manchester 
Clinical Commissioning Groups (CCGs). Information for a total of 90 postcodes, 
containing 528 GP practices, 1647 GPs and 2,682,056 registered patients were 
included from the region of Greater Manchester. GP practices which provided an 
email address on the NHS choices website had an email with the link to the 
online questionnaire was sent to them.  
In addition, paper copies were distributed at conferences such as ‘Management 
in Practice’ for practice managers. 
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3.2.4 Telephone survey 
Telephone surveys were chosen as 
a means of making contact with the 
GP practices in Greater Manchester 
as telephone numbers, unlike email 
addresses, are available to the public 
for each practice and telephone calls 
are also less likely to be ignored or 
forgotten in comparison to emails.   It 
was decided that 2 GP practices 
from each of the 90 postcodes would 
be the target for the telephone 
surveys. In each postcode, the GP 
practices were assigned a number in 
the spreadsheet. An online random 
number generator 
(numbergenerator.org) was then 
used to select 2 numbers at random 
from each postcode.   
 
 
The telephone survey was scripted and formatted into a flowchart, Figure 3.1. 
The questions were taken from the online questionnaire. The flowchart aimed to 
guide the researcher through the questions whilst allowing for different 
participant responses. The script closed with thanks for participation, opportunity 
for participant to give comments and explanation of how their responses will aid 
research after the questions.  
 
 
 
  
Figure 3.1: flowchart of POCT in 
primary care telephone survey 
questions 
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3.3 Results  
 
3.3.1 amendments arising from the pilot 
No major suggestions for amendments were made as a result of the pilot. Slight 
wording changes were made, the most common being the suggestion that the 
term ‘Near Patient Testing’ (NPT) be used in place of POCT, as this NPT is the 
terminology used by primary care staff.  
 
3.3.2 Participant characteristics 
A total of 136 participants completed the survey, either as a questionnaire or as 
a telephone survey. 44 respondents stated that they were nurses (33%), 39 
practice managers (30%), 32 GPs (24%), 7 nurse practitioners (5%), 3 practice 
receptionists (2%), 1 healthcare assistant, 1 public health specialist, 1 
community midwife, 1 retired nurse, 1 phlebotomist, 1 chemical pathologist and 1 
consultant.   
Raw results from both the online and telephone survey were collated and can be 
seen in Appendix 3.3.   
 
3.3.3 Awareness of POCT 
Participants were asked to state whether they were aware of the existence of 
POCT. 80% stated that they know what POCT was and 20% stated that they 
were not aware of it (n=84). 
 
3.3.4 POCT tests used in primary care 
The second question addresses which parameters are tested as POCT in 
primary care. As illustrated in Figure 3.2, the most common parameter to be 
tested by POCT in primary care was urinalysis (78%, n=93), followed by 
pregnancy testing (56%, n=73) and blood glucose (50%, n=66). 27% of practices 
reportedly measured INR using POCT (n=35), 15% performed POCT cholesterol 
testing (n=20), 13% POCT HbA1c (n=17), 11% POCT full blood count (n=14), 
11% POCT sexual health (n=14), 9% POCT haemoglobin (n=12) and 6% 
reported testing cardiac markers using POCT (n=6). 8% of respondents reported 
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that none of their tests were conducted using POCT (n=9) and 6% did not know 
if any tests were performed using POCT (n=5).  
 
Figure 3.2 Column chart illustrating the percentage of primary care participants that 
reported performing POCT for a variety of parameters (n=131) 
 
 
3.3.5 POCT operators 
Participants were asked who normally performs the POCT tests in their practice. 
As illustrated in Figure 3.3, nurses undertake the majority of POCT within 
primary care (69%, n=71). 26% reported that GPs undertake POCT (n=27), 23% 
reported that healthcare assistants use POCT (n=24), 14% reported that nurse 
practitioners use POCT (n=14) and 1% reported that an external company is 
used to perform POCT within the practice (n=1).  
 
Figure 3.3 Pie chart displaying the results to question 5 of the POCT survey: who 
usually performs POCT within the practice? (n=103)  
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3.3.6 Training in POCT 
Question 6 of the survey asked the participants who reported that POCT takes 
place in their practice to state whether the POCT operator had received device 
training (n=107). 72% reported that the POCT operator had been trained (n=77), 
10% stated that the operator had not been trained (n=11) and 18% did not know 
whether the POCT operator had been trained or not (n=19). 
  
3.3.7 Consideration of quality  
As an indicator of quality consideration, participants were asked whether their 
practice were members of an any EQA services for the POCT that they utilised. 
20% of respondents indicated that their practice did participate in an EQA 
scheme (n=24), 48% stated that their practice did not participate in an EQA 
scheme (n=56) and 32% stated that they did not know.  
 
3.3.8 Attitudes towards the use and adoption of POCT 
Participants were asked to rate nine factors associated with POCT as an 
advantage, a disadvantage or neutral. 88% reported that it was an advantage 
that POCT uses small devices, which are often portable (n=74), 12% were 
neutral to this (n=10) and 0 participants thought that this was a disadvantage. 
93% stated that POCT providing rapid results was an advantage (n=78), 6% 
were neutral to this factor (n=5) and 1% saw this as a disadvantage (n=1). 
85% of participants thought that POCT requirement of small, capillary samples 
was an advantage (n=71), 15% were neutral to this fact (n=13) and 0 saw this as 
a disadvantage.  
46% thought that the requirement of training to use POCT was an advantage 
(n=39), 38% were indifferent (n=32) and 15% saw this as a disadvantage (n=13).  
56% of respondents viewed the statement that test for test, POCT could be more 
expensive that laboratory testing as negative (n=47), 36% were neutral to this 
(n=30) and 8% saw it as an advantage (n=7).  
73% thought that the use of POCT resulting in fewer appointments was an 
advantage (n=61), 25% were neutral to this (n=21) and 1% saw this as a 
disadvantage (n=1).  
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73% of respondents thought that POCT providing test results on screen was an 
advantage (n=61), 27% were neutral to this (n=23) and 0 participants saw this as 
a disadvantage.  
 63% of respondents thought that the ability for patients to test themselves using 
POCT was an advantage (n=53), 31% were neutral to this (n=26) and 6% 
thought that this was a disadvantage (n=5).  
56% of participants thought that earning quality outcomes framework (QOF) 
points using POCT was an advantage (n=47), 36% were neutral to this (n=30) 
and 8% thought that this was a disadvantage (n=7).   
Figure 3.4 Column chart displaying respondent views of nine factors associated 
with POCT (n=84). Question 8 of the POCT in primary care survey.  
 
3.3.9 Future use of POCT in primary care 
The final question of the survey asked if the participant would consider their 
practice using POCT in the future. Of the 103 that responded to this question, 
39% stated that the practice staff may adopt POCT in the future (n=40), 4% 
stated that their practice may consider using an external company to conduct 
their POCT (n=4), 12% stated that they would not consider using POCT in their 
88% 
93% 
85% 
46% 
8% 
73% 73% 
63% 
56% 
12% 
6% 
15% 
38% 36% 
25% 27% 
31% 
36% 
0% 1% 0% 
16% 
56% 
1% 0% 
6% 8% 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
P
e
rc
e
n
ta
g
e
 a
g
re
e
d
 
Factor 
% Advantage % Neutral % Disadvantage
  
64 
 
practice (n=13) and 45% did not know whether they will use POCT in the future 
(n=46).  
 
 
3.3.10 Anecdotal evidence 
Some of the GPs that were emailed with a link to the questionnaire also replied 
via email giving general thoughts and comments. One GP stated: “[POCT is an] 
Interesting area. Big move towards doing stuff in primary care- better for 
patients. Look at INR for example. HbA 1c ideal BUT we found it too expensive 
to get equipment looked after. Also worth realising on other side that less delays 
from hospital labs now all connected via links”  
Another GP stated: “We do NPT urine and lab tests for different indications. NPT 
is done either because it’s cheap (urinalysis) and useful but not necessarily 
urgent. NPT also done when urgent and needed for a decision, e.g. questioning 
an ectopic pregnancy. Otherwise it's too much trouble - there is a need for quality 
control (we always re-check NPT blood glucose) which costs, NPT is always 
more expensive than the central lab (INR and HbA1c are good examples) and 
GPs do not get NPT costs fully re-imbursed (the NPT for DMARDs/warfarin is a 
good example of this). Most GPs are well aware of the costs/benefits and 
problems, if there was profit to be made or quality to improve we would already 
be doing it”.  
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3.4 Discussion 
 
Results indicate that there is an awareness of POCT within UK primary care, yet 
the uptake appears to be slow: tests which have become available as POCT in 
recent years are seldom used whereas the more historically used tests are still 
utilised, Figure 3.2. The survey found that the majority of POCT is operated by 
nurses, GPs and healthcare assistants, of which the majority (72%) had been 
trained, this leaves 10-28% potentially untrained, a figure that is unacceptable 
according to Royal College of Pathologists guidelines (Cramb, 2004). Only 20% 
of those performing POCT were registered with an EQA scheme. This could 
indicate that the quality and reliability of tests are being overlooked, which could 
potentially lead to erroneous results and undesired clinical outcomes.  
Overall, there were mixed messages in relation to respondents attitudes towards 
POCT: Figure 3.4 indicated that respondents appreciated positive attributes that 
POCT could provide, whilst the response to undertaking more POCT in the 
future was undecided and 100% of respondents found current laboratory 
services acceptable – these results are not indicative of change to the current 
pathology testing processes within primary care. Seemingly, the largest concern 
in adopting POCT in primary care was the potential expense incurred. Cost of 
devices; reagents; maintenance; training and local laboratory support must all be 
considered, the sum of which could preclude POCT testing by an individual 
practice. Cost has been identified as a disadvantage and reason to not adopt 
POCT in primary care in other studies (Butler et al., 2008). However, both the 
financial and human cost to the patient pathway could be reduced by the 
introduction of POCT due to increased patient comfort and reduced transport 
requirements.  
 
3.4.1 Strengths and limitations  
The target audience of the questionnaire was reached effectively, with nurses, 
practice managers and GPs being the majority of respondents. 
The questionnaire relied upon self-reporting and therefore the results must be 
analysed and interpreted with caution, results are limited to what the respondent 
thought their practice did or did not undertake.    
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Although care was taken in the design of the survey questions, as described in 
the methods section, interpretation can still differ and therefore affect responses. 
For example, question 4 (Appendix 3.2) refers to POCT currently undertaken, 
anecdotal evidence suggests that some thought that this question referred to any 
test provided by the practice and so included samples sent to laboratories, for 
example 11% reported conducting full blood count (FBC) as POCT, this is highly 
unlikely as POCT devices that conduct FBCs are larger, bench-top analysers 
which tend to be expensive and require extensive training to operate. However, 
the use of questionnaires in primary care research is well established: even 
though historically response rates are poor in this sector, questionnaires are still 
seen as a valid method of attaining both qualitative and quantitative data 
(McAvoy and Kaner, 1996).  
Misinterpretation was less of an issue during telephone interviews as the 
researcher was able to interrogate the answers and ensure that the participant 
fully understood the question.  
The overall response rate to the survey was low: the questionnaire may have 
gone unnoticed when sent via email, the email may have gone unopened or 
simply deleted and therefore the potential respondent has not come into contact 
with the questionnaire. Engaging primary care practitioners via surveys is a 
known challenge (Cartwright, 1978; Bowling et al., 1991) for a variety of reasons, 
such as concerned over confidentiality (Cartwright et al., 1976) or not having the 
time to participate (Silagy and Carson, 1989). 
With the consistent poor response rate from GPs and the paucity of evidence on 
the use of POCT currently done within primary care in the UK considered, the 
knowledge gained by conducting the questionnaire is valuable.  
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3.5 Conclusion 
 
Results of this survey confirm that POCT is performed within primary care and 
that it is viewed as a positive tool in the care of patients. However, without a full, 
physical audit it is impossible to uncover its true status.  
100% of respondents stated that they are happy with the service that they 
currently receive from their local pathology laboratory, however, 39% reported 
they would consider using POCT in the future.  
Although the participants of this study appeared to appreciate the benefits of 
POCT, there appeared to be little incentive for POCT to be introduced to primary 
care in any significant way in the near future. The cost of adopting POCT in 
primary care could be discouraging as funding for devices and reagents; 
maintenance, training and local laboratory support would have to be allocated. 
However, the cost of employing pathology staff is not often taken into account 
and so implementation of POCT could be cheaper to the NHS as a whole 
(Carter, 2008). It could be that POCT is better suited to locations that do not 
have links to laboratory provisions, i.e. in the community. Initiatives such as the 
NHS Health Checks are an avenue in which more POCT could be used as 
cholesterol and glucose tests are integral to the check and can be performed 
using POCT equipment and can therefore be done in a variety of settings, which 
is important as patients often struggle to find time to visit their GPs. These 
factors could help increase the numbers of checks done: the uptake of the NHS 
Health Checks is currently below target (Price, 2013).  
 
 
 
 
 
.   
 
 
 
 
  
68 
 
Chapter 4: Point-of-Care Testing in the community setting 
Abstract 
 
Introduction 
Point-of-care Testing (POCT) is frequently used to deliver cholesterol and 
glucose results as a part of the NHS Health Check (NHSHC) scheme. NHSHCs 
were introduced in 2009 to screen 40-74 year olds for risk factors of 
cardiovascular disease (CVD) with an aim of preventing future disease and 
reducing related risk factors. Recently, the NHSHC scheme has come under 
criticism for not being cost-effective and causing patients to worry. This study 
aimed to assess whether receiving a Health Check in the community reduces 
patient risk of CVD.  
Methods 
Participants were recruited in the community before receiving a Health Check 
and completed a questionnaire that assessed well-being, diet, exercise, 
intentions and experience of the health check. Follow-up Health Checks were 
conducted at three months, where another questionnaire was completed. 
Results were compared and analysed statistically using SPSS and Stata.  
Results 
122 participants were recruited at baseline and 91 attended follow-up. No 
change was observed in CVD risk score from baseline to follow-up, with the 
exception of the participants who were referred for further testing and additionally 
intended to make lifestyle changes, where a significant decrease occurred 
(P<0.0001). Two new diagnoses of hypertension and diabetes were confirmed. 
There were no statistically significant changes in other parameters tested, 
however, fewer participants were in risk categories at follow-up for BMI, waist 
circumference, total cholesterol and QRisk2 score compared with baseline. All 
participants were satisfied with the service received and preferred POCT to 
traditional pathology testing.  
Conclusion 
Health Checks conducted in the community setting using POCT were well 
received and may have captured some patients who would not normally visit 
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their GP to have one. Little effect was seen on CVD risk over a three-month 
period.  
4.1 Introduction 
 
As well as in the traditional primary and secondary healthcare setting as 
discussed in chapters one, two and three, Point-of-Care Testing (POCT) has 
applications in the community setting.  
 
4.1.1 Public Health & the NHS Health Check 
In 2009, the NHS Health Check (NHSHC) programme was implemented in the 
UK. The programme screens for risk factors of cardiovascular disease (CVD), 
diabetes, kidney disease and some forms dementia in 40-74 year olds. Patients 
are provided with tailored advice for reducing risk scores with the aim of 
preventing these diseases. The programme was initiated as a response to the 
difficulties that the UK faces with these diseases: In 2011, CVD was responsible 
for nearly 30% of all deaths and is the greatest cause of disability (Department of 
Health, 2013b). 
 
The NHSHC involves questions around lifestyle and family medical history; 
assessment of alcohol intake; measurement of glucose and cholesterol levels; 
height, weight and waist circumference; blood pressure assessment; pulse 
reading and calculation of CVD risk score. When a Health Check is performed in 
the community setting, POCT can be used for the measurement of glucose and 
cholesterol.  
 
It is estimated that the NHSHC programme could prevent over 4,000 people from 
developing Type 2 diabetes per annum and detect at least 20,000 new cases of 
diabetes or kidney disease each year (Department of Health, 2008). Disease 
prevention is extremely valuable both to patients and the NHS; it is estimated 
that diabetes costs the NHS around £1.5m an hour, equating to 10% of the entire 
NHS budget for England and Wales and is projected to rise to around 17% by 
2035 (Hex et al., 2012).  
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As well as saving money, disease prevention has a positive impact on Patient 
quality of life. A study of 9,385 patients found that patients with chronic 
conditions have decreased scores for factors such as: physical ability, social 
satisfaction, mental health, health perceptions and body pain, compared with 
those who do not have long-term conditions (Stewart et al., 1989).  
 
Current research tends to focus on the uptake of the NHS Health Checks in the 
general population. In the year 2014/2015 15,449,660 patients were eligible for 
an NHSHC across England. Of those, 3,042,478 (19.7%) were offered an 
NHSHC and 1,485,339 (48.8% of those offered) took up the opportunity to have 
one.  
In Greater Manchester, 747,670 patients were eligible for an NHS Health Check 
in the year 2014/2015. 151,661 (20.3%) of these were offered a Health Check 
and 86,943 (57.3% of those offered) took up the opportunity to have one 
(NHSHC, 2015), this data is provided by the Health Check service and cannot be 
verified.  
 
4.1.2 Delivering NHS Health Checks in the community  
In April 2013, local authorities (LAs) became responsible for public health 
services. Some LAs, such as Salford, provide mobile NHS Health Checks 
through their health service (Salford Health Improvement Service - SHIS). 
POCT, in the form of the Cholestech LDX (Alere Inc., San Diego, CA), is used to 
glucose and cholesterol as part of NHS Health Checks carried out in the 
community.  
 
The Salford Health Improvement Service employs community health 
development workers (CHDW) and health improvement project workers (HIPW). 
Amongst many other services, these staff provide Health Checks to the eligible 
population. Patients are pre-screened to assess their eligibility for the NHS 
Health Check, see Appendix 4.1 for the pre-screening form. A patient is not 
eligible for an NHSHC if they are aged below 40 or above 74 years old or have a 
pre-existing condition. If a patient is not eligible for a full NHSHC, they are 
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offered a Mini Health MOT, which involves the same procedure as the NHSHC 
excluding assessment of alcohol consumption, measurement of glucose and 
cholesterol levels and CVD risk calculation. The processes for the NHSHC and 
the Mini Health MOT are illustrated in Figure 4.1.  
 
SHIS staff receive in-house training and/or industry training to ensure their 
competency in using the Cholestech LDX and in the provision of NHSHCs. The 
transportable nature of the device allows for NHSHCs to be performed in a range 
of locations, including in the workplace, community groups and on the ‘Heath 
Bus’ (pictured in Figure 4.2).  
 
Although the staff (CHDW and HIPW) performing the Health Checks are not 
medically trained, they have had extensive, practical training from SHIS and 
industry in delivering the Health Checks – this training involves a full day session 
which covers the physiological background, introduction to the equipment, 
demonstration sessions and hand-on experience of delivering Health Checks. 
Each trainee provides a Health Check in the session and is assessed on its 
delivery. If appropriate, areas of improvement are highlighted. Staff are not 
permitted to provide Health Checks until the trainers and management are 
satisfied with their performance. When staff are deemed proficient, they are 
continually assessed during Health Check sessions to ensure the quality of 
service is maintained at a high level.  
The training undertaken by all staff providing the Health Checks places them in a 
position to give appropriate advice if abnormal results are discovered.  
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Health Check procedure in the community 
 
  
 
 
Figure 4.1 Diagram of the testing procedure for the NHS Health Check and Mini Health 
MOT when provided by the SHIS in the community setting.  
 
 
 
 
Patient arrives 
Pre-screening  
NHS Health Check Mini Health MOT 
Height (cm) 
Weight (kg) 
BMI 
3 x Blood pressure 
Pulse rhythm assessment 
Waist circumference (CM) 
Calculation of QRisk2 score 
POCT for: total cholesterol (TC), HDL 
cholesterol, TC/HDL ratio and glucose 
Height (cm) 
Weight (kg) 
BMI 
3 x Blood pressure 
Pulse rhythm assessment 
Waist circumference (cm) 
 
 
Patient completes form with their personal 
details and alcohol consumption self 
evaluation (Audit C)  
Discussion of results. Lifestyle advice and signposting (referrals) to 
other services given, where appropriate 
 
 
Patient receives copy of their results   
Results sent to patient’s GP 
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4.1.2.1 Cholestech LDX  
The Cholestech LDX is a lipid Point-of-Care Testing device. It boasts laboartory-
accurate quality as it meets National Cholesterol Education Program (NCEP an 
American programme managed by the National Heart, Lung and Blood Institute) 
guidelines and is certified by the Cholesterol Reference Method Laboratory 
Network (CRMLN).  
The device provides rapid results, with results shown on-screen 5 minutes post-
testing. It is simple to use, whole-blood capillary samples are applied to single-
use test cassettes and do not require any pre-analytical steps. The device is 
CLIA waived and so operators do not require a clinical or pathology based 
background. 
 
 
4.1.2.2 The Health Bus 
The Health Bus was specifically developed for providing Health Checks in the 
community; it has an area at the front where patients are pre-screened to assess 
if they are eligible for the full NHSHC or the Mini Health MOT, an area for 
measuring height and weight and three private bays for completion of the 
patient’s Health Check. Each bay has a Cholestech LDX with the assorted 
consumables required and an automatic blood pressure monitor.  
 
 
Figure 4.2 Picture of the ‘Health Bus’ used by the Salford Health Improvement Service 
to provide HNSHCs in the community 
 
 
  
74 
 
4.1.3 Salford Demographics 
Salford is a city within Greater Manchester. It has a registered population of 
233,900 people living across eight neighbourhoods: Claremont and Weaste; 
East Salford; Eccles; Irlam and Cadishead; Little Hulton and Walkden; Ordsall 
and Langworthy; Swinton and Worsley, and Boothstown (ONS, 2012).  
 
4.1.3.1 Deprivation  
Although Salford has some affluent areas, it is ranked as one of the most 
deprived local authority areas in England with life expectancy lower than average 
in England.  
26.8% of children in Salford (n=12,300) live in poverty (PHE, 2015). 
 
4.1.3.2 Life expectancy 
Salford men have an average life expectancy 11.5 years lower than the national 
average and Salford women have an average life expectancy 8.5 years lower 
than the national average (PHE, 2014). 
Vast differences are seen across the city itself, men living in the most deprived 
areas have over 10.6 years shorter life expectancy than those from the least 
deprived areas, and there is a difference of 10.3 years amongst women (PHE, 
2015).  
 
4.1.3.3 Health inequalities 
The number of alcohol-related hospital admissions and premature deaths from 
heart disease and stroke in Salford are also amongst the worst in England 
(Salford CCG, 2014). 27% of the adult population were classified as obese in 
2012.  
As illustrated in Figure 4.3, Salford scores significantly worse than the national 
average for many indicators of inequality, deprivation and poor health (PHE, 
2015).  
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Figure 4.3 Bar chart displaying a comparison of Salford and UK average indicators of 
poor health and deprivation. Information source: Salford Health Profile 2015 (PHE, 
2015).  
 
47.2% of Salford residents live in the 20% most deprived areas in England, this 
is significantly worse than the England average. 26.8% of children (under 16) live 
in households that receive means-tested benefits for low income compared 
England’s national average of 19.2%, this is significantly worse. Approximately 
8.9% of the Salford population aged 16-64 are have been out of work for 12 
months or longer, which is significantly worse than the national average of 7.1%.   
21.4% of children aged 10-11 are classified as obese in Salford, which is 
significantly higher than the 19.4% average in England. A significantly higher 
portion of Salford’s residents smoke compared with the national average (22.9% 
and 18.4%, respectively). It is reported that 48.5% of people in Salford achieve a 
minimum of 150 minutes exercise each week, which is significantly lower than 
the national average of 56% of people.  
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23% of people are classified as obese in England, in Salford this is significantly 
higher at 27%. 
The only indicator published in the Salford Health Profile 2015 (PHE, 2015) that 
was significantly better in Salford than the national average is the recorded 
number of people with diabetes (6% and 6.2%, respectively). However, these 
figures do not include patients who have undiagnosed diabetes as the 
information was taken from GP disease registers, therefore it could be that in 
reality Salford does not have lower rates of diabetes.  
The number of hospital stays due to alcohol related abuse in England in 2013/14 
was 645 per 100,000 of the population, in Salford this number was 954 per 
100,000.  
Between 2011-2013 the number of smoking related deaths in England was 288.7 
per 100,000, in Salford this number was 415 per 100,000.  
 
There is a significantly higher rate of early deaths from CVD in Salford compared 
with the national average (PHE, 2015). This evidence provides greater evidence 
for making the prevention of CVD a priority. 
 
Data on demographics was taken from a non-peer reviewed source as this was 
the only data available, it therefore cannot be verified.  
 
 
4.1.4 Published research 
Like many public health schemes, the checks have faced both praise and 
criticism. There have been many life-saving, success stories reported in 
association with the scheme but there have also been publications condemning 
the checks to be a waste of time and money, a cause of unnecessary worry and 
a task that some healthcare professionals have little interest in performing 
(Krogsbøll et al., 2012; Capewell et al., 2015). Nevertheless, the World Health 
Organization (WHO) estimate that better use of existing preventative measures 
such as Health Checks could reduce the global burden of all diseases by up to 
70% (Van Lerberghe, 2008).  
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Screening for CVD risk factors is seen by many as a part of normal primary care: 
general practitioners identify risk factors in their patients that are visiting them for 
other issues and initiate CVD screening (Gøtzsche et al., 2014). There is also 
potential for Health Checks to produce harmful outcomes, for example, some of 
the medications used to manage diabetes, which could be prescribed as a result 
of an NHSHC, have been shown to increase cardiovascular mortality (Nissen, 
2012) – the very thing that these checks are aiming to prevent.  
 
Previous research suggests that those who accept the invitation for a Health 
Check tend to be the ‘worried well’. These people often have a higher 
socioeconomic status (Attwood et al., 2015), lower cardiovascular risk, less 
cardiovascular morbidity, and lower mortality than others (Krogsbøll et al., 2012). 
The impact of screening the ‘worried well’ is less beneficial than screening those 
who might actually be at a higher risk of CVD e.g. those living in deprived 
communities (WHO, 2007). Engagement rates in deprived communities are 
generally lower (Thorogood et al., 1993), suggesting that engaging the target 
audience for NHSHCs is challenging. The SHIS provide Health Checks in a 
potentially more appropriate way than traditional primary care based Checks as 
they bring the Health Checks to the patients. By providing Health Checks in the 
community, e.g. on the ‘health bus’ or in the work place, this reduces the amount 
of effort required by the patient in order to receive a Health Check. The patient 
does not need to contact their GP surgery to make an appointment, they do not 
need to take time off work or make a special journey to the GP surgery in order 
to attend the appointment. Additioanlly, due to the use of POCT, the patient 
receives the results of their cholesterol and glucose tests whilst in consulation 
with the SHIS and so they do not need to contact the GP surgery to receive their 
results. As discussed in Chapter Two there is eveidence to suggest that 
receiving tests results during the original consultation can have a more positive 
effect of the patient and encourage better health outcomes (Laurence et al., 
2010). 
The overall Health Check experience provided by the SHIS is very convenient for 
the patient. This, teamed with the fact that the advisors employed by the SHIS 
are often from the same community as the patients, may encourage those more 
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hard-to-reach patients who are theoretically at higher risk of CVD to have a 
Health Check.   
 
4.1.5 Rationale for current study  
Much time and research is spent analysing the uptake of the NHS Health Checks 
but little has been done to evaluate patient impact.  
As all previous research found is based on health screening performed within 
healthcare organisations, it is important to investigate the impact of screening 
provided by other organisations, such as Local Authorities, in a variety of settings 
outside of primary care.   
 
4.1.5.1 Research question 
Does receiving a Health Check in the community setting have a positive effect on 
patient risk of cardiovascular disease?  
 
4.1.6 Research aims 
This research aimed to: 
 
1. Determine the impact of the Health Check on CVD risk factors over a 3 
month period, using Qrisk2 score as a primary outcome 
2. Assess the impact of the Health Check on participant reported well-being 
3. Assess the impact of the Health Check on the health behaviours 
behaviours of the participants 
4. Evaluate participant satisfaction with Health Check and Health MOT 
service, in relation to POCT in particular 
5. Identify potential areas for service improvement  
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4.2 Methods 
 
This study was designed to have minimal impact on normal patient care. As 
described in section 4.1.2, in normal circumstances a patient must be aged 
between 40 and 74 years and without previous diagnosis of heart disease, 
stroke, diabetes or kidney disease to be eligible for an NHSHC. For the purposes 
of this research, anybody eligible for a Health Check delivered by the SHIS was 
also eligible to participate in the study. Therefore including participants that were 
outside of the target age group when screened in a workplace screening 
initiative, for example. Workplace screening initiatives conducted by the SHIS 
are intended for any employee wishing to receive a Health Check, irrespective of 
age or medical history.  
 
The researcher and SHIS staff conducted Health Checks with recruited 
participants at baseline and at a 12-week follow-up. All results were recorded 
and anonymised. At each Health Check, participants completed a ‘Health and 
Lifestyle Questionnaire’. In addition to this, semi-structured interviews were 
conducted with a selection of participants at follow-up, as reported in Chapter 5. 
The aim of the Semi-structured interviews was to fully saturate the qualitative 
data collected from the questionnaires.   
 
NHS research ethical approval was sought through and granted by the Berkshire 
B Health Research Authority (HRA) (Appendix 4.2).  
 
 
4.2.1 Questionnaire design and pilot   
4.2.1.1 Baseline questionnaire 
The questionnaire was designed as a two-sided A4 sheet of paper in colour (see 
Appendix 4.3). The first side had two sections: well-being and health behaviours, 
this side could be completed either before or after the patient received their 
Health Check. The second side had just one section, which concentrated on the 
participant’s experience of the Health Check they had received; this side had to 
be completed after their Health Check.  
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The questionnaire had an introductory paragraph which thanked the participant 
for taking part, explained the purpose of the questionnaire, asked them to take 
their time and consider their answers, reminded them that they could ask 
questions if necessary and that all answers were confidential. Additionally, each 
section was introduced with a short paragraph explaining the theme of the 
questions that were to follow.  
To protect participant confidentiality, the questionnaire provided space for the 
participant to input their name at the end. This was removed from the 
questionnaire once the participant has been assigned an ID number.  
 
Section 1 (questions 1-5) 
The first section utilised the WHO-5 well-being index. This index was developed 
by the World Health Organisation (WHO) during the 1980s and is frequently 
used for assessing subjective psychological well-being (Topp, 2015).  
The index has been validated both clinically and psychometrically in several 
studies (Wu, 2014; Löwe et al., 2004; Henkel et al., 2003; Hajos et al., 2013).  
 
The WHO-5 well-being index is concise and asks 5 positively phrased questions 
regarding the participant’s everyday life e.g. ‘over the past 2 weeks I have felt 
cheerful and in good spirits’ to provide a self-reported measure of emotional well-
being. The index can be used to track changes in well-being over time (Löwe et 
al., 2004).  
 
Assessing the participant’s well-being is an important factor whilst conducting 
any health research, all too often mental health issues are overlooked in routine-
care and so go undiagnosed and effect the patient’s quality of life (Pouwer et al., 
2006). Evidence suggests that mental health issues, like depression, have a two-
fold risk of occurring in patients with chronic conditions like diabetes, compared 
with the general population (Barnard et al., 2006). The aim behind conducting 
the well-being section of the questionnaire was to identify patients with possible 
mental health issues and assess whether these change in correlation with 
improved or deteriorated general health. The data collected on well-being will be 
assessed against participant activity levels as previous research has suggested 
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that there is a strong correlation between physical activity and quality of life in the 
general population (Bize et al., 2007).  
 
Section 2 (questions 6-11) 
The second section focused on the participant’s health behaviours and 
perceptions of themselves. Questions 6 and 7 aimed to record if the participant 
routinely exercises and if so, which activities they tend to do. Question 8 aimed 
to record how often the participant consumes fresh fruit and vegetables. 
Questions 9 and 10 assessed the participant’s perception of their own health. 
Question 11 gave the participant opportunity to record any ill-health that they 
regularly suffered from e.g. shortness of breath.  
The information from baseline and follow-up questionnaires was compared and 
used to examine changes in Health Check results.  
 
Section 3 (questions 12–16) 
The last section probed the participant’s experience of the Health Check that 
day.  
Question 12 assessed whether the participant has understood their Health 
Check results and what level of explanation from the advisor was required. In the 
case of this study, ‘advisor’ refers to either a member of SHIS staff or the 
researcher. Longitudinal studies have shown a link between educational 
advantages and improved health, therefore, in theory, participants with a higher 
level of education should be healthier (Walsemann et al., 2008), this was 
assessed by Qrisk2 score in relation to employment level status.  
Question 13 provided the participant with the opportunity to record any intended 
lifestyle changes that they wish to make. 
Question 14 asked if the participant preferred receiving their Health Check in the 
community setting compared to seeing their GP and allows space for them to 
explain their answer. Patient preference and satisfaction is high on the NHS 
agenda and so it is pertinent to establish how they prefer to receive treatment 
and care.   
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Question 15 asked the participant to rate their overall experience of their Health 
Check from unacceptable to excellent and provided space for them to explain 
their answer.  
The final question, question 16, examined the participant’s attitude towards the 
use of POCT over traditional pathology testing for the measurement of their 
glucose and cholesterol levels.  
 
The questionnaire was designed to be easy to read and complete, taking a 
maximum of 5 minutes. The sans-serif font ‘Calibri’ was used as it is 
acknowledged that sans-serif fonts significantly increase the reading 
performance of individuals with dyslexia (Rello and Baeza-Yates, 2013).  
Font size 13 was used to make the questionnaire easy to read for most people. 
However, a copy of the questionnaire in size 16 font was also available for those 
who had difficulty reading size 13.  
 
The questionnaire was piloted on a cohort of 10 individuals that fit within the 
eligibility criteria for an NHS Health Check.  
 
Study participants were asked to complete the questionnaire in private on 
completion of their baseline Health Check.  
 
4.2.1.2 Follow-up questionnaire 
Sections 1 and 2 of the follow-up questionnaire (Appendix 4.4) remained the 
same as baseline. Section 3 of the questionnaire aimed to collect some 
information about what the participant had done in the time between baseline 
and follow-up.  
 
Question 11 asked ‘Have you been to visit your doctor as a result of your last 
Health Check?’ and allows a simple ‘yes’ or ‘no’ answer. Followed by question 
12, which asks ‘If yes to question 11, have you been diagnosed or are you being 
treated for any new conditions?’ Again, the respondent had the option of yes/no 
tick boxes and a space to add extra information e.g. ‘Yes – I have been 
diagnosed with diabetes’.  
  
83 
 
 
Question 13 aimed to follow-up on the participant’s stated lifestyle change 
intentions from the baseline questionnaire, it asked ‘Since your last Health 
Check, have you made any lifestyle changes?’ If the respondent answered ‘yes’, 
they also have space to explain what they have changed.  
 
Question 13 had 2 successive questions. Question 14 asked ‘If ‘yes’ to question 
13, why have you made those changes?’ Respondents had the options of: 
‘Because of the results and/or advice from the previous Health Check’, ‘Had 
already planned to make the changes’ and ‘Other’ with the addition of a free-text 
answer to further explain their motivations.  
Question 15 asked ‘If ‘no’ to question 13, has anything stopped you from making 
lifestyle changes?’, with response options of: ‘No – I did not plan on making any 
lifestyle changes’, ‘Yes – I have not had the time’, ‘Yes – I do not know which 
lifestyle changes to make’, ‘Yes – I have not been motivated enough to make 
any changes’ and ‘Other’ with a free-text space for further information.  
 
The final question, much like question 15 of the baseline questionnaire was 
based on the NHS ‘friends and family test’, it asked: ‘would you recommend 
having a Health Check to family and friends?’ with yes/no tick boxes for 
response and free-text space to explain their answer. Questions like these 
provide useful information to the service providers.  
 
The questionnaire was piloted on a cohort of 10 individuals that fit within the 
eligibility criteria for an NHS Health Check.  
 
Study participants were asked to complete the questionnaire in private on 
completion of their follow-up health Check.  
 
4.2.2 Recruitment and follow-up 
Participants were recruited on site as they arrive for their Health Check, where 
they had the study explained to them and asked if they would like to participate. 
Potential participants received a participant information sheet (Appendix 4.5) and 
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were given approximately five minutes to read through it and a further two 
minutes to ask any questions. Individuals who were interested in participating 
were given a consent form (Appendix 4.6) to read and sign. Both the participant 
and the person taking consent were required to sign the consent form in order for 
the individual to participate. Copies of all documents were available in larger text 
for participants with difficulty reading.  
Follow-up health checks were arranged depending on where the participant 
originally received their Health Check: the human resources manager was 
contacted and follow-up appointments were made for participants seen in the 
workplace, participants recruited on the Health Bus or in a community group, 
were contacted via letter and later by phone to arrange their attendance to a 
‘Health Check day’. The ‘Health Check day’ was conducted in a room hired by 
the SHIS in a community building.  
 
4.2.3 Conducting Health Checks and collecting data 
As described in more detail in Chapter One, each participant received an 
NHSHC or mini health MOT at baseline and again at follow-up, which was a 
minimum of twelve weeks later.  
 
Once the participants had been ‘pre-screened’ to determine the test that they 
would receive, full NHS Health Check or mini Health MOT, the testing process 
began. For a full NHS Health Check, the participant had to fit the eligibility 
criteria: aged between 40 and 74, registered with a Salford GP, not already be 
diagnosed with the conditions that the Health Check screens for and not have 
had a previous Health Check in the last 12 months. The participants did not have 
to fit the criteria to receive an NHSHC in the workplace setting.  
 
4.2.3.1 Testing process 
At the start of each Health Check, the participant provided some basic 
information such as name, DOB, address, contact number, ethnicity, gender, 
GP/practice name and socio-economic classification by completing the first side 
of the ‘patient assessment form’ (Appendix 4.7). Once they had done this, the 
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participant completed the Audit C questionnaire (Appendix 4.8), which assesses 
how much alcohol they normally consume.  
 
Participants had their height measured in centimeters using a Leicester Height 
Measure (Seca, Hamburg, Germany) and were weighed in kilograms using a 
calibrated scale. Body Mass Index (BMI) was calculated using these results.  
Waist circumference was measured in centimeters using a retractable tape.   
Seated, the participant was asked to remain calm, silent and breathe normally 
with their legs uncrossed whilst three blood pressure and pulse readings were 
taken using an electronic blood pressure meter (sphygmomanometer). 
Additionally, an assessment of the participant’s pulse rhythm is conducted using 
the pulse in their wrist. The assessor looked for regular, strong, equally spaced 
beats. If the pulse felt weak and/or erratic, it was recorded as irregular.  
 
For those who were eligible for a full NHSHC, non-fasting cholesterol and 
glucose was measured. For this test, their finger was cleansed using an alcohol 
wipe (Sterets skin cleansing swab, 70% isopropyl alcohol) and a 40L capillary 
blood sample was taken from the fingertip using a 21 gauge lancet with a 
2.00mm depth (Unistik 3 extra). The first drop of blood was wiped away with a 
gauze swab and the rest was collected using a capillary tube (Fig. 4.4), the 
capillary tube only allows a 40L sample to be collected. The sample was 
transferred onto the appropriate lipid panel cassette (TC – HDL – GLU) (Fig. 4.5) 
and then inserted into the Cholestech LDX POCT device (Fig. 4.6).  
 
   
 
Figures 4.4 to 4.6 Pictures illustrating the POCT process used for the assessment of 
cholesterol and glucose levels during the NHS Health Check performed by the SHIS. 
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Once all Health Check results had been recorded, the advisor used the online 
QRisk2 2015 calculator (www.qrisk.org) to calculate the participant’s 10-year risk 
of CVD. The information required for the calculations consists of: age, sex, 
ethnicity, postcode, smoking status, diabetes status, medical history, TC/HDL 
ratio, systolic blood pressure, height and weight.  
The QRisk2 score provided an indication of an individual’s risk of having a 
myocardial infarction or cerebrovascular accident (stroke) over the next ten 
years. The QRisk2 calculation uses an algorithm that has been developed by UK 
NHS physicians and academics using data collected routinely from thousands of 
general practitioners from all over the UK.  
 
At the end of the Health Check, the advisor discussed the results with the 
participant, highlighting any areas that may require attention. The advisor 
discussed the patient’s lifestyle and provide healthy living advice, where 
necessary.   
 
If the participant had any results that require further attention, the advisor had 
opportunity to refer the participant on to appropriate services.  
At this point, the participant had time to complete their questionnaire.  
A copy of each participant’s Health Check results were recorded on to an 
encrypted, password protected laptop. These results were pseudo-anonymised 
using participant identification (ID) numbers in place of identifiable data. The 
participant ID numbers were stored on a separate, encrypted file on the laptop. 
Participant contact details were stored on another separate, encrypted file on the 
password-protected laptop using ID numbers in place of names.  
 
Completed questionnaires, in their paper-based form, had their participant’s ID 
number assigned to them and any identifiable data removed from them. These 
were taken off-site, along with the laptop and stored securely in a locked 
cupboard in a locked room.  
All results were analysed statistically using SPSS, Minitab, stata and Excel.  
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4.3 Results 
 
A total of 122 participants were recruited to the study. 13 of these were recruited 
through community groups, 16 were recruited on the Health Bus and 93 were 
recruited in the workplace (4 from one workplace and 89 from another).  
 
4.3.1 Participant characteristics 
108 of the participants received full Health Checks and 14 received Mini Health 
MOTs.  
 
Patient characteristics are reported in Table 4.1, these results were self-reported 
on the patient assessment form. 
 
Characteristic Results 
Gender 78% male (n=95), 22% female (n=27) 
 
Age Range: 17-71 years old, mean: 42.6, 
mode: 46, median: 43 and a standard 
deviation of 11.74 years 
Ethnicity White British (n=94), Other White 
Background (n=11), Chinese (n=2), 
Other South Asian (n=1), African 
(n=1), Indian/Pakistani (n=1), Irish 
(n=1) and 11 did not disclose their 
ethnic background 
Employment status 39 in managerial/professional role, 35 
in routine and manual role, 22 in an 
intermediate role, 4 retired, 2 
unemployed and 20 did not state their 
employment status 
Smoking status 80 non-smokers, 16 ex-smokers, 6 
light smokers (<10/day), 2 moderate 
smokers (10-19/day), 3 heavy 
smokers (>20/day) and 15 did not 
state their smoking status  
Table 4.1 Table containing self-reported characteristics of the Health Check participants 
at baseline. This data was provided by the participant and therefore cannot be verified.  
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The information contained in the above table (Table 4.1) was not required for the 
Mini Health MOT.  
 
4.3.1.1 Alcohol consumption 
A total of 103 participants completed an Audit C alcohol consumption 
assessment questionnaire. This information is not required as part of the Mini 
Health MOT. Of those that completed it, 14 scored 0, meaning that they did not 
regularly drink alcohol or did not drink alcohol at all. 52 scored 1-5 which places 
them in a low risk category for problem drinking. 37 scored 5+, places them in a 
higher risk category for problem drinking.  
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4.3.2 Baseline Health Check Results 
The results of the mean blood pressure (n=122), weight (n=122), height (n=122), 
BMI (122), waist circumference (n=118), total cholesterol (n=108), HDL 
cholesterol (n=108), total cholesterol/HDL cholesterol ratio (n=107), blood 
glucose (n=108) and Qrisk2 (n=112) measurements are show in Table 4.2. 
 
Table 4.2 Participant Health Check result data recorded at baseline (n=122) 
Measurement Mean  Mode  Median Standard 
Deviation 
Range 
Systolic blood 
pressure 
(mmHg) (average 
of 3) 
131.63 122 132 15.36 99-182 
Diastolic blood 
pressure 
(mmHg) (average 
of 3) 
78.18 75 77 10.39 47-112 
Weight – Male 
(kg) 
83.1 56.3 80.9 18.48 56.3-180.1 
Weight – Female 
(kg) 
68.5 N/A 66.5 13.46 49.4-97.8 
Height -Male 
(cm) 
 
175.91 178 176 7.71 152-198 
Height –Female 
(cm) 
163.4 164 162.5 0.08 152 – 182 
BMI  26.5 25.5 
 
25.5 5.03 18.8 – 54.3 
Waist 
circumference – 
Male (cm) 
92.93 84 91 12.17 71 – 139 
Waist 
circumference – 
Female (cm) 
86.94 86 86 9.61 71 – 107 
Total Cholesterol 
(mmol/L) 
4.96 4.32 4.86 0.98 2.77 – 7.83 
HDL– Male 
(mmol/L) 
1.21 1.13 1.15 0.34 0.47 – 2.39 
HDL – Female* 
(mmol/L) 
1.48 1.28 1.4 0.42 0.84 - >2.59 
HDL/TC ratio 
 
4.23 3.3 3.8 1.4 1.9 – 9.7 
Blood glucose 
(mmol/L) 
5.69 5.17 5.31 1.52 4.28 – 16.4 
QRisk2 Score 
(%) 
4.42 0.3 2.6 5.24 0.1 – 22.5 
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4.3.2.1 Baseline risk categories 
Participants were organised into risk categories for blood pressure (NICE, 
2006a), total cholesterol (NICE, 2008a), blood glucose (NICE, 2008c), BMI 
(WHO, 2000), waist circumference (NICE, 2006b) and QRisk2 score (NICE, 
2008b) based on their results in relation to NICE guidelines and WHO 
publications for each parameter.  
 
0 participants had a systolic blood pressure (BP) that indicated hypotension 
(<90mmHg). 91 participants had ideal systolic BP (90-140 mmHg).  30 
participants had an average systolic BP reading that indicated pre-hypertension 
(141-179 mmHg), the guidance for which is to recommend they see GP within 1 
month. 1 participant had an average systolic BP that indicated hypertension 
requiring a GP appointment within 1 week (180-219 mmHg). None of the 
participants had an average systolic BP (≥ 220 mmHg) that required urgent 
attention and referral to A&E.  
 
1 participant had a diastolic blood pressure that indicated hypotension 
(<50mmHg). 108 participants had ideal diastolic BP (50-90 mmHg). 12 
participants had an average diastolic BP reading that indicated pre-hypertension 
(91-109 mmHg), the guidance for which is to recommend they see GP within 1 
month. 1 participant had an average diastolic BP that indicated hypertension 
(110-120 mmHg), requiring a GP appointment within 1 week. None of the 
participants required urgent attention and referral to A&E due to their diastolic BP 
(>120 mmHg).  
 
0 participants had a BMI that indicated that they were underweight (<18.5), 46 
were of ideal weight (18.5-<25), 58 were classified as overweight (25-<30) and 
18 were classified as obese (≥ 30). Of the participants in the obese category, 11 
were classified as grade 1 obese (30-<35), 3 were grade 2 obese (35-<40) and 4 
were grade 3 obese (40+). Proportionally, more males than females were 
classified as overweight or obese (51% vs. 37% and 16% vs. 11% respectively).  
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The results placed the majority of male participants, 64.1%, in a low risk waist 
circumference (<94 cm) category (n=59), 20.7% in a high-risk category (94 – 102 
cm) (n=19) and 15.2% in the very high-risk category (>102 cm) (n=14).  
 
By contrast, just 26.9% of female participants fell in the low risk category for 
waist circumference (<80 cm) (n=7), 30.8% were classified as high risk (80 – 88 
cm) (n=8) and 42.3% classified as very high risk (>88cm) (n=11).  
 
Total cholesterol (TC) risk categories were grouped in association with Qrisk2 
scores. 101 participants had a total cholesterol of <7.5 mmol/L with a Qrisk2 of 
<20%, these participants are considered to be low risk and do not require follow-
up. 0 participants had a total cholesterol of <7.5 mmol/L with a Qrisk2 of >20%, 
which would have placed them in a higher risk category where they would be 
advised to make a GP appointment within one month and given healthy lifestyle 
reinforcement. 3 participants had a total cholesterol of >7.5 mmol/L, these 
participants were advised to arrange a GP appointment for a familial 
hypercholesterolemia screening within one month, regardless of their Qrisk2 
score. 4 participants had a TC of <7.5 mmol/L but did not have a calculated 
Qrisk2 score and so they do not fit in to any of these risk categories, the 
assumption is that they were low risk as their TCs were all less than 5mmol/L 
(2.77 - 4.98mmol/L).  
 
There are no risk categories used for HDL cholesterol. Females tend to have 
greater levels of HDL compared to males (Singh, 2014) One participant had a 
HDL reading of ‘>2.59 mmol/L’ and so 2.6 mmol/L was used in its place for the 
purpose of analysis. 
The balance between cholesterols relates to the overall balance between 
atherogenic lipoproteins and antiatherogenic lipoproteins and therefore risk of 
cardiovascular disease (Sniderman et al., 2006).  
TC/HDL ratio is a clinical indicator of coronary heart disease (CHD). According to 
the American Heart Association, men with a TC/HDL of 5 are at average risk of 
CHD and men with TC/HDL of 9.6 are at double that risk. Similarly for women, a 
TC/HDL of 4.4 indicates average risk and TC/HDL of 7 indicates that those 
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women are at twice the risk of CHD. The American Heart Association states that 
TC/HDL ratio should ideally be around 3.5 for both men and women. 43 
participants (40.2%) achieved a TC/HDL of 3.5 or lower.  
37 participants (34.6%) had a TC/HDL of less than 5. The remaining 27 
participants (25.2%) had a TC/HDL of over 5. 
87 participants (80.5%) had a random blood glucose result that falls within the 
‘normal’ category of ≤ 6.0mmol/L. 20 participants (18.5%) had a random blood 
glucose result between 6.1 – 11.0 mmol/L, these participants were referred to 
their GP for a fasting blood glucose or HbA1c test within one month.  
1 participant had a random blood glucose result between 11.1 – 17.9 mmol/L, 
they were referred to their GP for a fasting blood glucose or HbA1c test within 
one week. 0 participants had a random blood glucose result which required 
urgent emergency attention (>18 mmol/L).  
 
103 Qrisk2 scores were calculated from full result data sets. 8 Qrisk2 Scores 
were calculated from partial result data sets, for example, where a participant’s 
smoking status or family medical history was not known, non-smoking status and 
no medical history were used in the calculator in these cases. 11 participants did 
not have a Qrisk2 score calculated for them as they either were under the age of 
25 (n=4), no age was recorded (n=6) or their BMI was too high for the calculator 
to provide an accurate score (n=1).  
Of the 111 calculated, 9 participants had a QRisk2 score between 15 and 19%, 
placing them in a moderate risk category and one participant had a QRisk2 score 
>20%, placing them in a high risk category.  
 
4.3.2.2 Baseline referrals 
It was recorded that 31 participants were advised to seek further testing or 
advice as a result of their health check. 6 participants were referred to see their 
GP for more than one reason. 18 participants were advised to see their GP to 
recheck their blood pressure, the QRisk2 Score of these participants ranged 
from 0.6 – 18.7%, with an average of 6.5%. 9 were advised to have a fasting 
cholesterol checks, the QRisk2 score of these participants ranged from 0.9 – 
15.6%, with an average of 6.3%. 5 participants were advised to have a fasting 
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glucose check; these had QRisk2 scores ranging from 5.9 – 15.6% with an 
average of 9.1%. 4 participants with QRisk2 scores ranging from 2.8 – 19.7% 
and an average of 11.3% were referred to the smoking cessation service. One 
participant with a QRisk2 score of 14.9% was referred to their GP for symptoms 
unrelated to the Health Check. 
4.3.3 Follow-up Health Check results 
A total of 91 of the original 122 participants received a follow-up Health Check, 
achieving a follow-up rate of 75%. 74 were male, 17 female.  
As shown in the consort diagram, Figure 4.7, participants that received their 
Health Check on the Health Bus or in a community group at baseline received 
their follow-up Health Check on a follow-up Health Check day held in a 
community location, achieving a follow-up rate of 48%. Participants that received 
their baseline Health Check at their workplace received their follow-up Health 
Check in their workplace, achieving a follow-up rate of 83%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Consort diagram illustrating the attendance of the community and workplace 
Health Check study population from baseline to follow-up 
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The results of the mean blood pressure (n=91), weight (n=91), height (n=91), 
BMI (n=91), waist circumference (n=89), total cholesterol (n=85), HDL 
cholesterol (n=85), total cholesterol/HDL cholesterol ratio (n=83), blood glucose 
(n=85) and Qrisk2 (n=88) measurements are show in in Table 4.3.  
 
Table 4.3 Participant Health Check result data recorded at follow-up (n=91) 
 
 
Measurement Mean  Mode  Median Standard 
Deviation 
Range 
Systolic blood 
pressure 
(mmHg) (average 
of 3) 
134.77 139 135 16.19 108-196 
Diastolic blood 
pressure 
(mmHg) (average 
of 3) 
81.08 74 80 11.18 60-120 
Weight – Male 
(kg) 
81.04 65.6 79.5 14.31 57.9-146.5 
Weight – Female 
(kg) 
67.91 N/A 66.8 12.62 46.7-85.5 
Height -Male 
(cm) 
 
176.04 178 177 7.86 157.5-198 
Height –Female 
(cm) 
164.8 164 163 7.49 155 – 182.5 
BMI  25.9 26 
 
25.6 3.76 19.4-41 
Waist 
circumference – 
Male (cm) 
91.6 91 91 9.24 75 – 124 
Waist 
circumference – 
Female (cm) 
83.03 84 84 6.83 69-94 
Total Cholesterol 
(mmol/L) 
4.88 4.18 4.65 0.9 2.58 – 8.03 
HDL– Male 
(mmol/L) 
1.24 1.16 1.16 0.34 0.71 – 2.12 
HDL – Female* 
(mmol/L) 
1.54 1.58 1.58 0.43 0.94 - >2.59 
HDL/TC ratio 
 
4.03 4.8 3.9 1.14 2.2 – 
7.2 
Blood glucose 
(mmol/L) 
5.58 5.16 5.36 1.08 3.95 – 10.6 
QRisk2 Score 
(%) 
 
4.15 0.2 2.3 5.05 0.1 – 26.4 
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4.3.3.1 follow-up risk categories 
0 participants had a systolic blood pressure (BP) that indicated hypotension 
(<90mmHg). 64 participants had ideal systolic BP (90-140 mmHg).  25 
participants had an average systolic BP reading that indicated pre-hypertension 
(141-179 mmHg. 2 participants had an average systolic BP that indicated 
hypertension (180-219 mmHg). None of the participants had an average systolic 
BP (≥ 220 mmHg) requiring emergency attention.  
 
0 participants had a diastolic blood pressure that indicated hypotension 
(<50mmHg). 75 participants had ideal diastolic BP (50-90 mmHg). 14 
participants had an average diastolic BP reading that indicated pre-hypertension 
(91-109 mmHg). 2 participants had an average diastolic BP that indicated 
hypertension (110-120 mmHg). None of the participants required urgent attention 
and referral to A&E due to their diastolic BP (>120 mmHg).  
 
0 participants had a BMI that indicated that they were underweight (<18.5), 38 
were of ideal weight (18.5-<25), 43 were classified as overweight (25-<30) and 9 
were classified as obese (≥ 30). Of the participants in the obese category, 6 were 
classified as grade 1 obese (30-<35), 2 were grade 2 obese (35-<40) and 1 was 
grade 3 obese (40+).  
 
The results placed the majority of male participants, 65%, in a low risk waist 
circumference (<94 cm) category (n=47), 25% in a high-risk category (94 – 102 
cm) (n=18) and 10% in the very high-risk category (>102 cm) (n=7).  
At follow-up, 24% of female participants fell in the low risk category for waist 
circumference (n=4), 52% were classified as high risk (80 – 88 cm) (n=9) and 
24% classified as very high risk (>88cm) (n=4).  
Total cholesterol (TC) risk categories were grouped in association with Qrisk2 
scores. 81 participants had a total cholesterol of <7.5 mmol/L with a Qrisk2 of 
<20%, these participants are considered to be low risk. 1 participant had a total 
cholesterol of <7.5 mmol/L with a Qrisk2 of >20%, which placed them in a higher 
risk category. 1 participant had a total cholesterol of >7.5 mmol/L. 
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30 participants achieved the target ratio of 3.5 or lower for TC/HDL, 39 
participants had a TC/HDL between 3.6 and 5 and 14 participants had a TC/HDL 
of over 5. 
 
63 participants had a random blood glucose result that falls within the ‘normal’ 
category of ≤ 6.0mmol/L. 22 participants had a random blood glucose result 
between 6.1 – 11.0 mmol/L, 0 participants had blood glucose levels higher than 
this.   
 
Of the 88 calculated QRisk2 Scores, 4 were between 15 and 19%, placing them 
in a moderate risk category and 1 was >20%, placing that participant in a high 
risk category. 
 
4.3.3.2 Comparison of baseline and follow-up Health Check results 
Table 4.4 shows the percentage of participants falling within risk categories for 
the parameters assessed at baseline and follow-up. Although there was a slight 
decrease in the percentage of participants in moderate and high QRisk2 score 
categories from baseline to follow-up (8% and 6%, respectively), there was an 
increase seen in other risk categories such as high blood pressure and blood 
glucose.  
 
 Systolic 
blood 
pressure 
Diastolic 
blood 
pressure 
BMI Waist 
circumference 
Total 
cholesterol 
Blood 
glucose 
QRisk2 
score 
(>15%) 
Baseline 
 
25% 11% 62% 44% 3% 19% 8% 
Follow-
up 
30% 18% 57% 43% 2% 26% 6% 
 
Table 4.4 comparison of participants falling within risk categories from baseline to follow-
up. Categories are based on SHIS referrals guide (Appendix 4.9) and NICE guidance. 
Risk categories include any patient that would have been referred for further testing. 
Percentages calculated from 122 participants at baseline and 91 at follow-up.  
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The change in individual participant results from baseline to follow-up is shown in 
the statistical analysis, section 4.3.6.1.  
 
4.3.3.3 Referral attendance 
Of the 31 participants that were signposted to see their GP as a result of their 
baseline Health Check, 21 were seen again at follow-up. Of those 21, 5 reported 
that they saw their GP between baseline and follow-up and the remaining 16 
reported that they did not seek further medical attention or testing.   
As a result of those 5 participants seeking further testing, there was 1 new 
diagnosis of diabetes, 1 new diagnosis of high blood pressure and 1 patient 
awaiting further investigation for suspected high blood pressure.  
 
4.3.4 Questionnaire results 
The Health and Lifestyle Questionnaire, version 4, (27/11/14) (Appendix 4.3) was 
generally well received at pilot. All respondents said that they understood all the 
questions and found the questionnaire easy to complete in a short amount of 
time. Small word changes were suggested with the addition of an extra line for 
participants to enter more free text responses for question 13. The questionnaire 
was amended in accordance with the suggestions made.  
 
All 122 study participants completed the questionnaire at baseline. 90 of the 91 
participants completed the questionnaire at follow-up, 1 did not as they did not 
wish to answer questions on their current well-being due to a recent 
bereavement. 
 
4.3.4.1 Well-being assessment  
The baseline and follow-up responses to questions 1 to 5, the WHO-5 Well-being 
Index, are shown in tables 4.5 To 4.7.  
 
The results of this section were reasonably positive overall, with the majority of 
participants selecting the second most agreeable answer, ‘most of the time’ for 
each question, both at baseline and follow-up. Question 4, pertaining to the 
feeling of being ‘refreshed and rested’ after sleep received the largest spread of 
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responses and a higher frequency of less agreeable responses compared with 
the other questions.  
There appeared to be a general shift toward the selection of more positive 
responses for all five questions on the follow-up questionnaire. This may suggest 
some improvement in the well-being of the participants in this study after the 
three month follow-up period.  
 
Question 1. In the last two weeks, I have felt cheerful and in good spirits 
Response % of participants at baseline % of participants at follow-
up 
All of the time 13 12 
Most of the time 52 61 
More than half of the time 24 19 
Less than half of the time 4 6 
Some of the time 6 2 
At no time 1 0 
Table 4.5 Participant answer selection to question 1 of the health and lifestyle 
questionnaire, n=122 at baseline and 90 at follow-up 
 
Question 2. Over the last two weeks, I have felt calm and relaxed 
Response % of participants at baseline % of participants at follow-
up 
All of the time 15 9 
Most of the time 43 57 
More than half of the time 22 23 
Less than half of the time 13 8 
Some of the time 6 2 
At no time 1 1 
Table 4.6 Participant answer selection to question 2 of the health and lifestyle 
questionnaire, n=122 at baseline and 90 at follow-up 
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Question 3. Over the last two weeks, I have felt active and energetic 
Response % of participants at baseline % of participants at follow-
up 
All of the time 14 10 
Most of the time 36 53 
More than half of the time 30 26 
Less than half of the time 10 8 
Some of the time 8 3 
At no time 2 0 
Table 4.7 Participant answer selection to question 3 of the health and lifestyle 
questionnaire, n=122 at baseline and 90 at follow-up 
 
Question 4. Over the last two weeks, I have woke up feeling refreshed and 
rested 
Response % of participants at baseline % of participants at follow-
up 
All of the time 8 4 
Most of the time 28 37 
More than half of the time 25 30 
Less than half of the time 27 20 
Some of the time 10 9 
At no time 2 0 
Table 4.8 Participant answer selection to question 4 of the health and lifestyle 
questionnaire, n=122 at baseline and 90 at follow-up 
 
Question 5. Over the last two weeks, my daily life has been filled with things that 
interest me 
Response % of participants at baseline % of participants at follow-
up 
All of the time 9 13 
Most of the time 48 51 
More than half of the time 26 21 
Less than half of the time 9 11 
Some of the time 7 3 
At no time 1 1 
Table 4.9 Participant answer selection to question 5 of the health and lifestyle 
questionnaire, n=122 at baseline and 90 at follow-up 
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Each participant’s raw WHO-5 well-being scores were multiplied by four to give a 
percentage score out of 100. At baseline, the average WHO-5 score was 67.4%, 
rising to 69.5% by follow-up, an increase of 2.1%. 15% of participants had no 
change in their WHO-5 score from baseline to follow-up (n=15). 48% of 
participants had well-being scores that increased by follow-up (n=43) and 37% of 
participants’ wellbeing scores declined from baseline to follow-up (n=33).  
 
 
4.3.4.2 Lifestyle assessment  
Questions 6 to 11 of the Health and Lifestyle questionnaire assessed the 
participant’s current exercise and diet choices.  
 
Question 6 asked the respondent to state which kind of physical exercises they 
undertake, if any. As shown in Figure 4.8, the most popular form of exercise at 
baseline amongst these respondents was walking, with over 61% of the 
participants (n=74) reporting that they regularly walk. 34% of respondents (n=41) 
reported that they regularly cycled, 33% regularly ran (n=40), 22% lifted weights 
(n=27), 17% played team sports such as football (n=21), 15% attended fitness 
classes (n=18) and 11% swam regularly (n=14). A further 11% (n=13) selected 
the ‘other’ box. These respondents further reported using exercise DVDs, 
attending the gym, gardening, yoga, skiing, kayaking, home workouts, shadow 
boxing, boxing, karate and rock climbing. 7% of participants (n=9) reported 
undertaking no regular exercise.  
The responses at follow-up for question 6 produced similar results to baseline. 
The most popular form of exercise, again, was walking, 58% of the participants 
(n=52) reporting that they regularly walk. As with baseline, running, cycling and 
weightlifting were amongst the more popular activities at follow-up (38%, 31% 
and 24% respectively reporting undertaking those activities). 19% reported 
playing team sports such as football (n=17), 14% attended fitness classes (n=13) 
and 13% swam regularly (n=12). A further 17% (n=15) selected the ‘other’ box. 
These respondents further reported using exercise DVDs, attending the gym, 
gardening, yoga, skiing, kayaking, home workouts, shadow boxing, boxing, 
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karate, rock climbing and playing golf. The percentage of participants 
undertaking no regular exercise fell from 7% at baseline to 4% (n=4) by follow-
up. 
 
Figure 4.8 Exercise activities reportedly undertaken by the study participants at baseline 
and follow-up, data collected from the Health and Lifestyle Questionnaire, question 6. 
 
The number of activities that each participant performed was also recorded. 
As Figure 4.9 illustrates, there was a tendency for fewer people take up multiple 
physical activities at baseline, with only 9% (n=11) undertaking three or more 
activities regularly. By follow-up, the majority of respondents, 37%, reported that 
they undertook 3 or more physical activities regularly (n=33). 28% performed two 
physical activities regularly (n=25) and 31% performed only one physical activity 
regularly (n=28). 4% stated that they undertook no regular physical activities 
(n=4). When these individual results were compared with the baseline results, it 
would appear that there was a split between those participants whose exercise 
habits had become healthier (n=4) i.e. they had taken up exercise from 
previously not doing any and those participants whose habits had become less 
healthy (n=2), i.e. they partook in fewer exercise activities at follow-up compared 
with baseline.  
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Figure 4.9 Number of physical activities reportedly undertaken by the study participants 
at baseline and follow-up, data collected from the Health and Lifestyle Questionnaire, 
question 6.  
 
Question 7 of the Health and Lifestyle Questionnaire aimed to assess how many 
hours per week each participant spends exercising. As illustrated by Figure 4.10, 
47% (n=58) reported exercising 3 hours or more each week, rising to 50% 
(n=45) by follow-up. 29% (n=35) exercised 1-3 hours/week at baseline, rising to 
40% (n=36) at follow-up. There was a decrease in the number of participants 
reporting less than 1 hour of exercise per week from 14% (n=17) at baseline to 
4% (n=4) by follow-up. At baseline, 10% (n=12) reported never exercising, this 
decreased to 6% (n=5) at follow-up.  
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Figure 4.10 Number of hours reportedly spent performing physical activities by the study 
participants at baseline and follow-up, data collected from the Health and Lifestyle 
Questionnaire, question 7. 
 
Question 8 aimed to ascertain the frequency in which the participants consumed 
fresh fruit and vegetables. At baseline 40% (n=49) reported eating fresh fruit and 
vegetables ‘everyday’, rising to 47% (n=42) at follow-up. 44% (n=54) reported 
eating fresh fruit and vegetables ‘most days’ at baseline, decreasing to 40% 
(n=36) by follow-up. A similar percentage of participants reported eating fresh 
fruit and vegetables ‘every now and then’ at baseline as at follow-up (11 and 
10%, respectively). A similar percentage selected ‘hardly ever’ at baseline and 
follow-up (4% and 3%, respectively). At baseline, 1 participant reported that they 
never consumed fresh fruit and vegetables, 0 participants reported this at follow-
up.  
 
Question 9 aimed to ascertain the participant’s perception of their own body 
weight. At baseline, 5% believed that they were ‘underweight’ (n=6), decreasing 
to 1% (n=1) at follow-up. At baseline 50% believed that they were ‘just right’ 
(n=61), this increased to 56% (n=50) by follow-up. At baseline and follow-up, a 
similar percentage believed that they were overweight (43%, n=53 and 42%, 
n=38, respectively). 
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Question 10 pertained to the participant’s perception of their own health. At 
baseline, 70% of participants reported that they thought of themselves as 
‘reasonably healthy’ (n=86), rising slightly to 74% at follow-up (n=67). Similar 
percentages reported feeling ‘slightly unhealthy’ at baseline and follow-up (15%, 
n=18 and 16%, n=14, respectively), 10% reported feeling ‘very healthy’ (n=12) at 
baseline, with a similar percentage reporting the same (9%, n=9) at follow-up.  A 
decrease was seen in the percentage of participants feeling ‘very unhealthy’ from 
baseline to follow-up (5% decreasing to 1%).   
 
 
4.3.4.2.1 Responses to baseline specific questions 
Question 11 of the baseline Health and Lifestyle questionnaire asked the 
participant to report any regular symptoms of ill health that they suffered with. 
7 participants reported ‘shortness of breath’, 4 reported arthritic pain, 3 reported 
asthma, 3 reported back pain and 2 reported chest pain.  
 
In response to question 12 of the baseline questionnaire, the majority of 
participants, 61%, reported that they understood their Health Check results after 
they had received explanation from the advisor (74%). 33% reported that they 
understood their results without explanation, one participant reported having 
‘some idea’ of the meaning of their results after explanation and 0 participants 
reported having no idea of what their results meant. 6% did not answer this 
question (n=7).  
 
Question 13 asked the participants to record whether they intended to make any 
health or lifestyle changes and which changes they intended to make. 71% of 
participants recorded that they intended to make lifestyle changes (n=87), 25% 
stated that they did not intend to make any changes (n=31) and 4 did not answer 
this question.  
Of those that stated they intended to make lifestyle changes, 50 cited that they 
would like to increase exercise levels, 28 stated that they intend to improve their 
diet, 12 said that they wanted to either quit or cut down on smoking and 12 
stated that they intended to reduce alcohol consumption.  
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In response to question 14, 70% of participants (n=81) stated that they preferred 
receiving their Health Check in the community setting compared to having one at 
their GP practice. 30% reported that it makes no difference where they receive 
their Health Check (n=34). No participants reported preference to receiving 
health Checks in primary care.  
 
Question 15 of the baseline questionnaire aimed to evaluate the participant 
experience the Health Check. Of the 117 participants that answered, 81% rated 
the experience of their baseline Health Check as ‘excellent’ (n=95) and 19% 
rated it as ‘good’ (n=22).  
 
The final question of the baseline questionnaire was intended for participants 
that had received a full NHS Health Check only, as it refers to their experience of 
the POCT. 67% of the 108 participants that received a full NHS Health Check 
stated that the POCT procedure was ‘painless’ (n=72), 18% reported that it was 
‘slightly uncomfortable’ but better than providing a venous blood sample (n=19) 
and 1 participant stated that it was ‘more painful’ than giving a venous blood 
sample. 17% also stated that the process was ‘convenient’ (n=18). 4 participants 
did not answer this question. 
 
 
4.3.4.2.2 Responses to follow-up specific questions 
Questions 11 to 15 of the follow-up Health and Lifestyle questionnaire were used 
to record what changes, if any, the participant had achieved since their first 
Health Check and the reasoning behind them.   
 
By follow-up, 12% of participants reported that they had been to see their GP 
(n=11), 85% reported that they had not (n=76) and 3% did not answer the 
question (n=3). Of the 11 that visited their GP, 2 were diagnosed with a new 
condition, one diagnosis of high blood pressure and one diagnosis of type 2 
diabetes. The remaining 9 had no new diagnoses at the time of follow-up, 
however, one participant was awaiting further testing for high blood pressure.  
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Question 13 of the follow-up questionnaire asked the participants if they made 
any lifestyle changes after their initial Health Check. 53% stated that they did not 
make any changes (n=48), 45% stated that they did make lifestyle changes 
(n=40) and the remaining 2% did not answer (n=2). Of the 40 participants that 
reported making lifestyle changes, 50% (n=20) stated that they had already 
intended to make the changes, 35% stated they made the changes because of 
the results of their previous Health Check (n=14), 13% stated other reasons such 
as changes in the seasons and having a baby (n=5) and 1 participant did not 
answer.  
Of the participants that did not make lifestyle changes 57% stated that this was 
because they had not intended to (n=28), 23% stated that they did not have 
enough time to make changes (n=11), 14% stated that they had no motivation 
(n=7) and 6% stated that they did not know which changes to make (n=3).   
 
The final question of the follow-up questionnaire asked if the participant would 
recommend having a Health Check to their family and friends, of those that 
answered the question 100% answered ‘yes’ (n=86). 4 participants did not 
answer the question.  
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4.3.5 Results of participants aged 40+ subgroup 
In this study participants ranged in age from 17 to 71 years. Normally to be 
eligible for an NHSHC, a patient must be aged 40 to 74 years. 69 of the 122 
baseline participants and 53 of the 91 participants seen at follow-up were aged 
40 to 74, achieving a follow-up rate of 76.8%. This section reports the results of 
the participants who were aged 40 years and over, ergo the participants who 
would normally be eligible for an NHSHC, only.  
 
4.3.5.1 Lifestyle change intentions (40+) 
Of the participants that were aged 40+ and completed the full study, 77% stated 
that they intended to make some sort of lifestyle change (n=41) and the 
remaining 23% stated that they did not intend to make any changes (n=12).  
 
There was an equal spilt between participants that reported achieving their 
intended lifestyle changes by follow-up and those that did not (n=19 for both). 
Reasons given for making lifestyle changes included: because of the results of 
initial Health Check (n=11), because they had already intended to make changes 
(n=7) and 1 participant stated ‘other reasons’.  
Reasons given for not making intended changes included: lack of time (n=5), 
lack of motivation (n=3) and not knowing which changes to make (n=1). 9 
participants that stated they intended to make lifestyle changes at baseline later 
stated at follow-up that they had not made those plans.  
 
4.3.5.2 Change in 10-year cardiovascular risk (40+) 
At baseline, QRisk2 scores ranged from 0.6 to 22.5% in the participants that 
were aged 40+. The average QRisk2 score was 6.47%, with a mode of 5%, 
median of 4.59 and standard deviation of 5.57 (n=67).  
By follow-up, the QRisk2 scores ranged from 0.9 to 26.4% and the average 
dropped to 6.3%.  
At follow-up, 100% of the QRisk2 scores ≥5% belonged to participants in the 40+ 
years age category (n=23).   
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4.3.5.3 Change in other risk categories (40+) 
For the participants that were 40+, there was little change between baseline and 
follow-up in the numbers falling within the risk categories for the measurements 
taken, as shown in Table 4.10.  
 
A greater number of participants were in a high-risk category due to their systolic 
BP being higher than 140 mmHg at follow-up than at baseline (n=17 and 16 
respectively).  
Exactly the same numbers of participants were classified as ‘overweight’ (n=34) 
and ‘obese’ (n=5) at baseline as they were at follow-up. 
There was a reduction in the number of participants classified as having high 
cholesterol levels from baseline (n=2) to follow-up (n=0).   
From baseline to follow-up, there was an increase seen in the number of 
participants entering risk categories for blood glucose (n=13 at baseline and 
n=15 at follow-up).  
The number of participants in a ‘high’ risk category for waist circumference 
remained the same (n=19), however the number in a ‘very high’ risk category 
decreased from baseline (n=8) to follow-up (n=7).  
 
Measurement % of participants in risk 
category at baseline 
% of participants in risk 
category at follow-up 
Blood pressure 30 32 
BMI 74 74 
Cholesterol 4 0 
Glucose 25 28 
Waist circumference 51 49 
 
Table 4.10 Percentage of participants falling in Health Check risk at baseline and 
follow-up, for participants aged 40+ 
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4.3.5.4 Referrals to GP  
Of the 53 participants that we aged 40+, 21 were advised to seek further testing 
through their GP. 17 of the 21 were advised to get one parameter re-checked, 3 
were advised to get 2 parameters re-checked and one participant was advised to 
get 3 parameters re-checked.  
The most frequent referral was due to raised blood pressure (n=17). 8 participant 
were advised to have a fasting cholesterol test carried out, 5 were advised to 
have a fasting blood glucose or HbA1c test conducted and one participant was 
referred to GP for symptoms unrelated to the Health Check.  
 
Recorded referrals for blood pressure agree with the number of participants in a 
high-risk category for blood pressure (n=17). However, there were more referrals 
for cholesterol (n=8) than there were participants in a high-risk category for that 
parameter (n=2). This could be as a result of advisors referring from the 
cholesterol ratio, rather than the total cholesterol guidelines.  
Worryingly, there were fewer referrals for blood glucose (n=5) than participants in 
the high-risk category for that parameter (n=13). Analysis of the written notes 
suggests that this under-referral could be down to the advisor deciding that the 
raised glucose results are due to the participant having recently eaten or having 
a sugary drink.  
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4.3.6 Statistical analysis (all participants)  
 
4.3.6.1 Change in 10-year cardiovascular risk  
88 participants had a Qrisk2 score calculated at baseline and follow-up.  
To eliminate effect of age increase, the Qrisk2 scores were re-calculated for any 
participants that had a birthday between baseline and follow-up so that the same 
age was used in both calculations for that individual. This is a method that has 
been adopted in previous research (Richardson et al., 2011). If all other variables 
remain constant, an increase in age results in increased Qrisk2 scores.  
 
As detailed in tables 4.2 and 4.3, the mean QRisk2 score decreased from 4.42% 
at baseline to 4.15% at follow-up. A Kolgomorov-Smirnov test was performed on 
the difference between the QRisk2 data at baseline and follow-up, this confirmed 
that it was not normally distributed and was positively skewed (p=0.000). 
However, because it was evenly distributed around the mean, parametric testing 
was used.  
 
As the primary outcome of this study, the null hypothesis was that there is no 
difference between zero and the mean change in Qrisk2 (difference).  
 
To compare the individual participants results at both time points, a paired t-test 
was performed resulting in a p value of 0.684. This value does not indicate 
statistical significance in the difference from baseline to follow-up Qrisk2 scores, 
therefore, the null hypothesis cannot be rejected.  
 
 
4.3.6.2 Change in blood pressure 
All 91 participants that were seen at baseline and follow-up had their blood 
pressure measured three times, the average of which was recorded and 
analysed.  
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Systolic blood pressure increased from baseline to follow-up. As shown in tables 
4.2 and 4.8, the mean systolic blood pressure increased from 131.63 mmHg to 
134.77 mmHg.  
The data was normally distributed according to a Kolmogorov-Smirnov test 
(p=0.200). A paired t-test confirmed that there was significant increase between 
baseline and follow-up results (p=0.046).  
 
4.3.6.3 Change in BMI 
All 91 participants that were seen at baseline and follow-up had their BMI 
measured. As shown in tables 4.2 and 4.8, the average BMI decreased from 
26.5 at baseline to 25.9 at follow-up. As this data was not normally distributed, it 
was transformed using Log10. A paired t-test was performed on the transformed 
data to confirm that the decrease seen was not statistically significant (p=0.501).  
  
 
4.3.6.4 Change in total cholesterol 
83 participants had their total cholesterol measured at baseline and follow-up. 
On average, there was a decrease seen from baseline to follow-up, 4.96 mmol/L 
to 4.88 mmol/L. A Kolgomorov-Smirnov test confirmed that the difference was 
normally distributed and so a paired t-test was performed. The t-test indicated 
that there was no statistically significant change in total cholesterol between the 
two time points (p=0.097).  
 
4.3.6.5 Change in blood glucose 
Average blood glucose levels decreased from 5.69 mmol/L at baseline to 5.58 
mmol/L at follow-up.  
A Kolmogorov-Smirnov test performed on the difference between the baseline 
and follow-up data confirmed that it was not normally distributed and was 
positively skewed (p=0.015). However, because it was evenly distributed around 
the mean, parametric testing was used. A paired t test indicated that the 
decrease seen was not statistically significant, p=0.379.  
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4.3.6.6 Change waist circumference 
Across all participants, the average waist circumference was 90.7 cm at 
baseline, this decreased to 90.1 cm at follow-up. A Kolmogorov-Smirnov test 
confirmed that the difference was normally distributed (p=0.200) and so a paired 
t-test was performed. The t-test indicated that the observed decreased was not 
statistically significant, p=0.248.  
 
 
4.3.6.7 Referrals and change in QRisk2 score 
The graph shown in Figure 4.11 and Table 4.11 illustrate the results of an 
analysis of covariance, ANCOVA, test of the effect of referral for further testing 
and/or intention to make lifestyle changes on the change in QRisk2 score.  
 
No real change was seen in CVD risk scores from baseline to follow-up in all 
groups, with the exception of the group that intended to change and were 
referred for further testing (orange line). The CVD risk score in the group which 
were referred for further testing and intended to make lifestyle changes decrease 
significantly from baseline to follow-up, P<0.0001.  
 
These results suggest that participants experiencing both referral for further 
testing and intention to make lifestyle changes have the greatest chance of 
decreasing their CVD risk score in the short-term.  
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Figure 4.11 Graph illustrating the ANCOVA analysis of the mean CVD risk change in 
four groups of participants: those not intending to make lifestyle changes and not being 
referred for further testing (blue line), those intending to make lifestyle changes and not 
being referred for further testing (green line), those not intending to make lifestyle 
changes and being referred for further testing (red line) and those intending to make 
lifestyle changes and being referred for further testing (orange line).  
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Group Mean 
baseline 
QRisk2 
Mean 
Follow-up 
QRisk2 
Mean 
change 
p-value 95% Confidence 
Interval 
     Lower Upper 
No intention to change + 
no referral 
1.5278 1.65 
 
0.122 0.678 -0.455 0.699 
No intention to change + 
referral 
6.6875 7.2 
 
0.5125 0.246 -0.353 1.378 
Intention to change + no 
referral 
3.642 3.8489 
 
0.2067 0.267 -0.158 0.572 
Intention to change + 
referral 
7.5647 6.1412 
 
-1.4235 <0.0001 -2.018 -0.829 
 
Table 4.11 Change in QRisk2 from baseline to follow-up in four participant groups: those 
not intending to make lifestyle changes and not being referred for further testing, those 
intending to make lifestyle changes and not being referred for further testing, those not 
intending to make lifestyle changes and being referred for further testing and those 
intending to make lifestyle changes and being referred for further testing.  
 
4.3.7 Statistical analysis (participants aged 40+) 
4.3.7.1 Change in 10-year cardiovascular risk (40+) 
53 participants of the participants that were seen at both time points were aged 
40 years or older and were eligible for a full NHS Health Check by normal 
standards. As described in section 4.3.5.2, the mean baseline QRisk2 score was 
6.47% decreasing to 6.3% at follow-up.  
A Kolmogorov-Smirnov test was performed on the difference between the 
QRisk2 data at baseline and follow-up, this confirmed that it was not normally 
distributed and was positively skewed (p=0.000). However, because it was 
evenly distributed around the mean, parametric testing was used. A pared t test 
indicated that the observed decrease in QRisk2 score was not statistically 
significant, p=0.716.  
 
4.3.7.2 Change in blood pressure (40+) 
On average, the systolic blood pressure of the 53 participants aged 40+ 
increased from baseline to follow-up (134.42 and 135.83 mmHg respectively). 
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The difference in the data was normally distributed according to a Kolmogorov-
Smirnov test (p=0.200). A paired t-test indicates that the increase was not 
significant (p=0.326).  
 
4.3.7.3 Change in BMI (40+) 
The average BMI decreased from 26.28 to 26.08 baseline to follow-up (n=53). A 
Kolmogorov-Smirnov test confirmed that the difference in the data was not 
normally distributed, however, it was evenly distributed across the mean. A 
paired t test confirmed that the decrease was not statistically significant 
(p=0.297).  
 
4.3.7.4 Change in total cholesterol (40+) 
On average, there was a decrease seen from baseline to follow-up, 5.16 mmol/L 
to 4.97 mmol/L. A Kolmogorov-Smirnov test confirmed that the difference in the 
data was not normally distributed, however, it was evenly distributed across the 
mean. The t-test indicated that there was almost a statistically significant change 
in total cholesterol from baseline to follow-up (p=0.052).  
 
4.3.7.5 Change in blood glucose (40+) 
The average blood glucose decreased from 5.81 to 5.73 mmol/L in the 
participants aged 40+. A Kolmogorov-Smirnov test confirmed that the difference 
in the data was not normally distributed, however, it was evenly distributed 
across the mean A paired t test confirmed that the decrease was not statistically 
significant, p=0.742.  
 
4.3.7.6 Change waist circumference (40+) 
The average waist circumference in the participants aged 40+ was 91.42 cm at 
baseline, this decreased to 90.68 cm at follow-up. A Kolmogorov-Smirnov test 
confirmed that the difference was normally distributed and so a paired t-test was 
performed. The t-test indicated that the observed decreased was not statistically 
significant, p=0.297.  
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4.4 Discussion 
 
It is not possible to determine the similarity of the study participants to the 
general Salford population. It would appear that the participants of this study 
were healthier than the general population in England and the population of 
Salford. 18.4% of adults in England and 22.9% of adults in Salford smoke, 
whereas the prevalence of smokers in this study was 10%. 23% of adults in 
England and 27% of adults in Salford are obese, whereas only 15% of the study 
participants were obese.  56% of adults in England and 48.5% of adults in 
Salford achieve one hour or more of exercise each week, 76% of participants in 
this study achieve the same goal. However, this data cannot be validated. The 
population data is derived from one source (PHE, 2015), some of the data is self-
reported and not all participants in this study disclosed their smoking status 
(n=15). It could be that the study participants are more similar in nature to the 
Salford and England demographics than they first appear. For example, the 
percentage of overweight and obese adults in this study (62%) more closely 
matches that of England (63.8%) and Salford (63.3%).  
 
Of the 88 participants that had a QRisk2 score calculated at each time point, a 
greater percentage, 43% (n=38), saw a decrease in CVD risk from baseline to 
follow-up, compared with those participants that had an increased CVD risk at 
follow-up compared with their baseline result, 40% (n=35). Reductions in QRisk2 
score ranged from -0.1% to -5% and increases ranged from 0.1% to 3.9%. 17% 
of participants saw no change in their CVD risk (n=15).  
Although this is a positive outcome, no statistically significant changes were seen 
from baseline to follow-up in the CVD risk score of the study participants as a 
population. This finding agrees with other studies that have assessed the impact 
of dietary change on CVD risk. Howard et al. (2006) conducted a randomised 
controlled trial of 48,835 participants over an average of 8 years.  This trial found 
that a dietary intervention that reduced fat intake and increased vegetable, fruit, 
and grain intake did not significantly reduce the risk of CHD, stroke, or CVD in 
postmenopausal women and achieved only modest effects on CVD risk factors 
(Howard et al., 2006). However, other studies assessing the impact of the NHS 
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Health Check scheme have shown a greater decrease in QRisk2 scores over a 
longer period of time, 2% over one year (Artac, 2013).  
 
There was a statistically significant increase in blood pressure from baseline to 
follow-up (p=0.046), placing a greater percentage of participants a higher risk 
category (Table 4.4). There was also an increase in the number of participants 
that were categorised as higher risk due to their blood glucose measurement at 
follow-up than there was at baseline. This could indicate that the Health Check 
has little, or even a detrimental effect on these disease indicators. This could be 
explained by the potential for health screening to reassure patients in to a false 
sense of security and thereby prevent the adoption of healthy lifestyle choices 
(Kinlay and Heller, 1990), discussed in greater detail in Chapter Five. However, it 
is not possible to determine the cause of this change as blood pressure and 
random blood glucose readings depend on numerous variables such as physical 
activity, stress and recent food consumption (Barr, 2010).  
 
Although there were no statistically significant changes in the other parameters 
tested for by the Health Check, the overall picture is that of slight improvement: 
fewer participants were in risk categories at follow-up for BMI, waist 
circumference, total cholesterol and QRisk2 score compared with baseline.  
 
Slight improvements were seen in the well-being of the study group, with a 
greater percentage of participants achieving increased WHO-5 well-being scores 
compared with those whose score decreased (48% vs. 37%). Tables 4.5 to 4.9 
illustrate the areas in which the scores changed in the group, however, none of 
the questions produced markedly different results from one time point to another.  
 
There did not appear to be any change in the type of physical activities 
undertaken from baseline to follow-up, however, the number of activities and the 
hours spent performing them (Figs 4.9 and 4.10) was increased by follow-up. In 
addition, some increase was seen in the percentage of participants that reported 
eating fresh fruit and vegetables on a daily basis, all indicating the adoption of 
healthier lifestyles. This is supported by the positive change seen in the 
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participants’ perception of their health, with a general shift toward feeling 
healthier at follow-up.  
 
Just under half of the participants that completed the entire study made healthy 
lifestyle changes by the follow-up Health Check (n=42). This outcome is contrary 
to the intentions recorded at baseline, with more participants, 69%, originally 
stating that they intended to make changes (n=62).  
The results of the follow-up questionnaire suggest that the Health Check 
influenced the decisions of one third (n=14) of the study participants, whereas 
48% stated that they had already planned to make the changes.  
 
The majority of the participants preferred receiving their Health Check in the 
community setting and many stated that they simply would not have had a 
Health Check in general practice as they do not visit their GP, this is discussed 
further and evidenced in Chapter Five.  
All participants reported a positive Health Check experience and POCT was 
preferred to the traditional pathology testing process. This suggests that the 
community is a convenient setting for patients receiving an NHSHC.   
 
Of the 91 participants that were seen at both baseline and follow-up, two 
received diagnoses of new conditions: one of hypertension and one of diabetes, 
meaning that there was a new diagnosis as a result of 1.1% of the Checks 
performed. A recent study of 214,295 patients that received an NHS Health 
check between 2009 and 2012 was conducted by Robson et al. (2016) and 
found that new diagnoses of hypertension occurred in 3.8% of Checks and new 
diagnoses of diabetes in 0.9% of Checks (Robson et al., 2016).  
If all 31 participants that were referred for further testing at baseline sought 
consultation with their doctor then the number of new diagnoses could potentially 
be higher. Only 35% of participants referred for further testing reported visiting 
their GP post Health Check, the results of this study would be more in line with 
studies of larger cohorts had there been a greater number of new diagnoses. 
However, Robson et al. (2016) only included at Health Checks performed in 
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primary care, where patients would not have to take the extra step of arranging a 
GP appointment for further testing and/or diagnosis as they are already there.  
 
The results of this study would suggest that being referred for further testing as 
well as having intentions to make healthy lifestyle changes, whether this was 
actualised or not, had positive impact on the health of the individual. Figure 4.11 
illustrates the statistically significant reduction seen in CVD risk of the 
participants that were referred for further testing and had intentions to change at 
baseline. This could be because those participants had evidence to suggest that 
they needed to make changes and therefore started to take their health more 
seriously as a result of this.  
Although the identification of risk factors and diagnosis of related conditions are 
seen as a positive outcome in that they meet the primary objective of the 
screening programme, there is evidence to suggest that the treatment that 
potentially follows can have little benefit or even be detrimental to the patient. A 
systematic review conducted by Diao et al. (2012), concluded that primary 
prevention of mild hypertension (systolic BP 140-159 mmHg and/or diastolic BP 
90-99 mmHg) with hypertensive drugs did not reduce mortality and did not 
reduce CVD events in 79% of participants (n=7,080). 9% of participants 
experienced adverse side effects from the drug treatment, causing them to 
withdraw from the study (n=802) (Diao et al., 2012).  
Drugs used to prevent hypercholesterolaemia also face criticism. Currently, the 
NICE guidance for the primary prevention of hypercholesterolaemia is for 
patients to be offered statin treatment (20mg atorvastatin) when their 10-year 
CVD risk score, as calculated by QRisk2, is ≥ 10% (NICE, 2014a). Although 
there is a strong evidence base suggesting that statin therapy among individuals 
with established coronary heart disease (CHD) not only prevents complications 
related to atherosclerosis but also reduces all-cause mortality, the use of statins 
in primary prevention has come under debate. A meta-analysis, including 65,229 
participants, found that statins had no effect on all-cause mortality when used in 
a prevention setting i.e. how they would be used for participants flagged with 
having high cholesterol as part of the NHSHC (Ray et al., 2010). Abramson et al. 
(2013) highlight that the use of statins can also elicit adverse effects, e.g. 
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nausea, joint pain, as well as an increased risk of diabetes, again raising 
questions of the appropriateness of their use on patients without history of CHD 
(Abramson et al., 2013).  
 
4.4.1 Criticisms of the Health Check procedure 
The Health Check procedure, as described in section 4.2.3.1, is not without fault.  
Although BMI is widely accepted as a useful tool in assessing body weight, other 
measurements, such as waist-to-height ratio, are deemed by some to be a more 
reliable screening tool for CVD risk factors (Ashwell et al., 2012). A meta-
analysis conducted by Ashwell et al. (2012) found robust statistical evidence, 
assessing more than 300,000 adults, to show waist-to-height is superior to BMI 
and waist circumference (WC) for detecting CVD risk factors. 
In addition, the position in which the measuring tape is placed on a participant’s 
waist can vary, making the WC measurement highly subjective.  
 
Due to the ‘drop-in’ nature of the Health Checks provided by the SHIS, the 
participant does not always have their blood pressure checked in the 
recommended manner, normally because there is not enough time to provide 
breaks between the BP measurements. The latest NICE guidelines state that 
any result of 140/90 mmHg or higher be retaken a few minutes later and that if 
that is different to the first reading, a third reading should be taken a few minutes 
after the second, recording the lowest if these readings. NICE also recommends 
that BP should be measured in both arms in the first instance and if the readings 
are markedly different, that the measurement be taken in both arms again. If the 
readings remain markedly different, this should be noted and the arm that 
provided the highest reading be used for BP measurement in the future (NICE, 
2011). 
 
The cholesterol and glucose measurements are non-fasting in these NHSHCs. 
Although using non-fasting samples for total cholesterol and HDL cholesterol 
measurements has been deemed appropriate for screening of CVD (Craig et al., 
2000), blood sugar levels can vary greatly depending on when the participant 
last ate, especially  if they consumed carbohydrates. This is problematic when 
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comparing baseline and follow-up glucose results if they were performed at 
different times of day, i.e. one before a meal and one after a meal.  
 
The use of a CVD risk calculator is necessary for these tests as it is used as a 
guide for the advisor when making decisions on advice and referrals, they also 
help provide context for the participant as the QRisk2 calculator additionally 
provides an average result for an individual of the same age, sex and ethnicity. 
However, risk calculators have faced criticism for being low in specificity and 
sensitivity, with most risk calculators missing over one-third of people who 
subsequently have a heart attack or stroke (Collins and Altman, 2009). A review 
of the QRisk calculator by Collins and Altman (2009) concluded that the 
calculator tends to underestimate 10-year CVD risk, yet it is still an improvement 
on the Framingham risk score. Another review compared the accuracy of the 
QRisk2 calculator against that of the NICE version of the Framingham and 
QRisk1. This review concluded that QRisk2 was better at predicting 10 year CVD 
risk than the NICE version of the Framingham score and marginally better than 
QRisk1 (Collins and Altman, 2010). Both reviews analysed data sets that had 
missing data and so the results must be considered with caution.  
 
It is important that the measurements taken as part of the Health Checks be as 
accurate as possible as they are used to inform decisions that could affect the 
health of that participant in the future.  
 
As the participants of this study knew that their results were being observed and 
recorded, it is possible that the Hawthorne effect was elicited, causing 
participants to modify their behaviours in an unrealistic way. This could have 
impacted on the Health Check results, as positive health behaviour changes will 
generally generate healthier results.  
 
4.4.1.1 Suggestions for Health Check procedure improvement 
The evidence generated by this study indicates high participant satisfaction with 
the Health Checks that were performed by the SHIS, however, some changes 
could be made in order to improve the service provided.  
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An observation of the height and weight measurement process was that some 
SHIS staff asked the participants to remove their shoes before stepping on the 
weighing scales and assessment by the height measure. This produced some 
variation within the results and also provided inaccurate BMI results in some 
cases. It is therefore recommended that the service adopts one approach for 
these measurements, with all staff utilising the same method e.g. shoes 
removed.  
 
It is also recommended that the SHIS staff refer back to the signposting and 
referral guidance (Appendix 4.9) when making decisions on whether a patient 
requires follow-up and/or further testing. Whilst recorded referrals for blood 
pressure agree with the number of participants in a high-risk category for blood 
pressure (n=17), more referrals were made for cholesterol (n=8) than there were 
participants in a high-risk category for that parameter (n=2) and fewer referrals 
were made for blood glucose (n=5) than participants that were in the high-risk 
category for that parameter (n=13). It could be that the SHIS staff over-referred 
participants for cholesterol testing because they were concerned with their 
TC/HDL ratio rather than their total cholesterol, which the referral guidance is 
based on. Analysis of the written notes suggests that the under-referral for blood 
glucose testing could be because the SHIS advisor decided that the raised 
glucose results are due to the participant having recently eaten a meal or had a 
sugary drink.  
 
4.4.2 Strengths and weaknesses of the study 
The results of this study are not generalisable as the participants were not 
representative of the general population due to, for example, the split between 
male and female participants (78% and 22%, respectively).  
 
While the questionnaire was designed in a manner to reduce ambiguity, as with 
any questionnaire, the meaning of the questions is susceptible to some variation 
in interpretation. For example, at baseline 7% did not select any exercise 
activities that they undertake (question 6), whilst 10% stated that they do not 
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spend any time exercising when answering question 7 regarding hours spent 
exercising. This 3% difference could be explained a differing perception of what 
is classified as exercise i.e. that 3% of participants do not classify walking as a 
form of exercise.  
 
This study had a relatively short follow-up period of three to four months. Other 
studies of this nature have adopted longer follow-up periods, for example Artac 
(2014) looked at CVD Risk change over one year and saw an overall reduction in 
high risk patients of 2% (Artac, 2013). A randomised controlled trial (RCT) 
conducted by the OXCHECK study group (1995) found significant decrease in 
cholesterol and self-reported dietary fat intake over a four year period 
(P<0.0001) (OXCHECK, 1995). Richardson et al. (2011) found significant 
reductions in blood pressure, anxiety and depression scores over an eighteen 
month period (all P<0.0001) (Richardson et al., 2011). Perhaps a greater 
decrease in CVD risk and other associated risk indicators would be seen in this 
study had the follow-up period been extended. 
 
The actions of the participants may have been influenced by the knowledge that 
they would be receiving another Health Check in the near future. Participants 
may have adopted healthier lifestyles in order to improve on their result by 
follow-up, thereby resulting in better results than they may have been in normal 
circumstances. However, it is impossible to control for this effect as a control 
group would still require some form of measurement and it is the measurement, 
and results of, that are likely to because the cause of the effect.   
 
QRisk2 scores increase when diabetes and/or blood pressure treatment are 
selected on the calculator. For the participants who received diagnosis of 
diabetes and hypertension between baseline and follow-up, their QRisk2 scores 
are increased as a result. This appears to be a negative outcome, when in reality 
it is positive as it proves that the Health Checks are achieving their aim to detect 
and prevent those diseases.  
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The results generated by the Health and Lifestyle Questionnaire were entirely 
self-reported. This is a weakness, as the data can in no way be verified, 
potentially leading to unreliable results. However, the semi-structured interviews 
conducted with 28 of the participants in this study (reported in Chapter Five) go 
some way in explaining the results of the questionnaires as the concentrate on 
the influences and barriers to making healthy lifestyle changes.  
 
In this study, the participants with the higher QRisk2 scores and the participants 
that received new diagnoses of long-term conditions were all over the age of 40 
years, this supports the decision to target the 40+ age group as the NHSHC 
scheme does.  
 
To date, this study is the only research to investigate the effect of local authority 
delivered Health Checks on patients seen in the community setting. The findings 
of this research provide some insight into the short-term effects of these 
particular Health Checks and observations made will be used to help improve the 
service provided.  
 
 
  
  
125 
 
4.5 Conclusion 
 
This study has shown some slight, but not statistically significant, reduction to the 
CVD risk of the overall participant population after they received a Health Check, 
provided by a local authority health team, in the community setting. The only 
exception to this was the significant CVD risk reduction observed in the 
participants who intended to make lifestyle changes and were referred for further 
testing (P<0.0001). Overall, there were high levels of satisfaction with the service 
and the health of participants improved slightly. Nevertheless, this evidence does 
not offer any rebuttal to the argument that the scheme is failing to meet its 
primary objectives of preventing CVD, stroke and dementia whilst helping 
patients reduce their risk of future disease, nor the argument that the scheme is 
not cost effective, now costing approximately £450 million per year (Capewell et 
al., 2015).  
 
As the NHSHC scheme seems to be set to continue, the community setting in an 
opportune place for the checks to be conducted, facilitated by POCT, as it 
captures patients who would not normally visit their GP (as evidenced in Chapter 
Five).  
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Chapter 5: The influence of workplace Health Checks on health behaviour 
Abstract 
 
Introduction 
One of the main objectives of the NHS Heath Check programme is to reduce 
patient risk of cardiovascular disease by providing appropriate health advice. 
This research focuses on why individuals chose to make health behaviour 
changes, or not, and the aim of this research was to explore the factors that 
influence lifestyle choices and assess the role of NHS Health Checks in the 
workplace, including the impact of POCT use.  
Methods 
32 participants were chosen at random from a pool of participants that had been 
split in to two groups, intended to make lifestyle changes (Group One) and did 
not intend to make lifestyle changes (Group Two). Semi-structured interviews 
lasting approximately 30 minutes were conducted with those participants. 
Interviews were recorded using Dictaphone and transcribed verbatim. 
Transcripts were analysed using thematic network analysis.  
Results 
28 of the 32 invited participants completed the interview, 18 from Group One and 
10 from Group Two. The main stimuli for health behaviour change were: 
education, season, challenge, family, standards, availability and enjoyment. The 
main barriers to health behaviour change were: lack of motivation, commitments, 
convenience, condition, work, existing health and cost. Participants regarded the 
NHSHC scheme as important and valuable, appreciating the use of POCT and 
convenience of having them conducted in the workplace.  
Conclusion 
Participant decision to make healthy lifestyle changes was often made prior to 
the Health Check, suggesting that having an NHS Health Check did not influence 
the conscious health behaviours of the study participants. Local authority 
provided NHSHCs could address more of the barriers and encourage more of 
the stimuli of health behaviour change than primary care NHSHCs through 
promotion of other community health initiatives.   
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The biggest barrier to the adoption of healthier lifestyles was lack of time, which 
is something that is unlikely to be resolved by a Health Check programme.  
5.1 Introduction 
 
With advancing healthcare and living conditions in England, children born today 
can expect to a live longer and healthier life than ever before. Over the last 30 
years, average life expectancy has increased from 70.8 to 79.1 years for men 
and 76.8 to 82.2 years for women (ONS, 2015). However, major health issues 
still exist, with a third of all deaths occurring before the age of 75. Cancer, heart 
disease, stroke, respiratory disease and liver disease are the five main causes of 
premature death in England (Department of Health, 2014). 
Cardiovascular disease (CVD) is a general term encompassing diseases of the 
heart or blood vessels. In 2011, CVD was responsible for nearly 30% of all 
deaths and is the greatest cause of disability (Department of Health, 2013a). 
Many of the risk factors for CVD, such as smoking, high blood pressure, physical 
inactivity, poor diet and high cholesterol are modifiable through healthy lifestyle 
choices. This means that it is possible to delay and/or prevent onset of CVD 
through lifestyle changes.  
Another important intention in preventing CVD is screening for known risk 
factors, high cholesterol and high blood pressure for example, which is the aim of 
the NHS Health Check scheme.  
As previously described, some local authorities now conduct NHS Health Checks 
(NHSHCs) in workplaces and in the community, for example in supermarkets or 
at activity groups. The idea behind this is to attract the ‘hard-to-reach’ individuals 
who may not visit their GP regularly and so would be less likely to receive a 
Health Check in primary care.  
As well as clinical outcomes, for example change in cholesterol levels, it is 
important to know the influence that NHS Health Checks have on health 
behaviours. Screening is used to improve health by early detection of disease 
and/or risk factors. It may also influence health behaviours either by intention or 
as a side effect (Deutekom et al., 2010).  
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Health behaviours are behaviours that may affect an individual’s physical health 
or behaviours that the individual believes will affect their health (Sutton, 2004).  
 
Previous investigations of health behaviour in screening programmes have 
produced conflicting results. 
 
Miles et al. (2003) highlighted that having colorectal cancer screening had 
positive effect on health behaviours. Miles et al. (2003) found that, despite 
confirmation that they were healthy, improvements were still seen in exercise 
rates, fruit and vegetable consumption as well as a reduction in smoking (Miles 
et al., 2003).  
 
Bankhead et al. (2003) conducted a systematic review of studies between 1980 
and 2000, which investigated behaviour change post-screening. 55 papers were 
identified, reporting a total of 56 individual studies investigating the effect of 
cholesterol screening. It was concluded that cholesterol screening had a positive 
effect on health behaviours with a general move towards the adoption of 
healthier diets, increased exercise, weight loss and reduction in cholesterol 
levels (Bankhead et al., 2003).  
However, as highlighted by this review, studies in to behaviour change often 
have methodological issues, for example baseline data was not always recorded. 
Therefore determination of true cause and effect cannot be made.  
 
Few randomised controlled trails (RCTs) have been conducted on the impact of 
screening on health behaviours; Deutekom et al. (2010) conducted a review of 
such trials. This review included seven RCTs, four of which investigated the 
effects of different CVD screening programmes on health behaviours. Three of 
the trials investigated Health Checks delivered in primary care (OXCHECK, 
1995; Wood et al., 1994; Hutchison et al., 1998) and one in the workplace 
(Strychar et al., 1998). Whilst the four trials of interest included a large sample 
size, 18,587 participants, there are significant differences in methodologies and 
outcome measures and so results cannot be pooled to provide an overall 
outcome. Deutekom et al. (2010) concluded that screening for risk factors 
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provides some positive effect on the health behaviours assessed, namely 
smoking, diet and exercise assessed (Deutekom et al., 2010). 
 
Conversely, there is some evidence to suggest that risk factor screening may 
have a negative effect on health behaviours. A study conducted by Kinlay and 
Heller (1990) found that participants who did not have high cholesterol levels 
were less likely to respond to population strategies for the reduction of dietary fat 
intake (Kinlay and Heller, 1990).  Barlow (1993) reports that positive screening 
results for CVD risk factors can have a negative impact on health behaviours 
such as lowering activity levels as well as a negative impact on mental health 
due to worry caused (Barlow, 1993). 
 
Screening programmes such as the NHS Health Checks have also been 
criticised for providing a false sense of security. It has been proposed that 
patients may think that they can maintain a healthy lifestyle simply by visiting 
their doctor or receiving Health Checks (Marteau et al., 1996; Stewart-Brown and 
Farmer, 1997). The ‘certificate of health effect’ may also elicited by those who 
receive normal results from a Health Check; this is where the individual is 
resistant to health behaviour change because they view their results as 
confirmation that their existing lifestyle behaviours are healthy (Tymstra and 
Bieleman, 1987).  
 
Although there is a strong research base on the impact of screening 
programmes, to date, there has not been any research on the effect of local 
authority delivered NHS Health Checks on health behaviours. 
Whilst Chapter Four concentrates on what happens to the individuals that 
receive an NHS Health Check, this chapter focuses on why those outcomes may 
occur. The aim of this research was to explore the factors that influence lifestyle 
choices and assess the role of NHS Health Checks in the workplace.  
Objectives: 
1. Explore the stimuli for health behaviour change for patients screened in 
the workplace 
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2. Explore the barriers to health behaviour change for patients screened in 
the workplace 
3. Discover the opinion of workplace participants of the workplace screening 
programme 
4. Discover participant’s opinion of NHS Health Check programme, with 
particular focus of the use of POCT 
 
NHS research ethical approval was sought through and granted by the Berkshire 
B Health Research Authority (HRA).  
5.2 Methods 
 
5.2.1 Design of interview questions and prompts  
Interview questions were designed to assess the participant’s reasons for 
making, or not making, their intended lifestyle changes after their first Health 
Check. Questions were open-ended in order to avoid bias and to promote full 
answers. Participants who had intended to make lifestyle changes were grouped 
into ‘Group One’ and participants who had not intended to make lifestyle 
changes were classified as ‘Group Two’.  
Figure 5.1 illustrates the questions used in the semi-structured interviews. The 
first question was used to remind the participant of what had happened at their 
first Health Check and their intentions at that time. Participants from both groups 
could continue down the left (achieved) side of the flow diagram providing that 
they completed their original intentions i.e. participants from Group Two who did 
not intend to make lifestyle changes could achieve this by not making any 
lifestyle changes and therefore graduate on to the question that asks how they 
reached that decision.  
For participants struggling to answer the question regarding their motivation 
behind their intention to make lifestyle changes, prompts were used in the form 
of suggestions e.g. specific results Health Check results, pre-existing intentions, 
existing sense of health.  
For participants who did not achieve their original intentions, the next question 
tries to ascertain why that may have happened. Example prompts for Group One 
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participants struggling to answer this include: what issues did you come across? 
Did anything affect your motivation, and if so, what? Example prompts for Group 
Two participants struggling to answer this question include: What factors do you 
think made you change your mind? Was it a conscious decision or do you think it 
happened due to a change in seasons for example?  
In the case of participants who had achieved some original objectives but not 
others, all four questions in Fig 5.1 were asked. 
 
 
Figure 5.1 Semi-structured interview question flow diagram 
 
Some participants were asked additional questions, as shown in Figure 5.2, 
which aimed to ascertain their thoughts and opinions on the NHS Health Check 
scheme as a whole and how it is utilised in the workplace.   
For participants struggling to answer the questions concerning the advantages 
and disadvantages of receiving a Health Check in the workplace as opposed to 
in a GP practice factors such as time/convenience, safety, testing procedures 
and staff were used as prompts.  
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Fig 5.2 A flow chart of additional questions regarding participant opinions on the NHS 
Health Check 
 
5.2.2 Pilot 
Interview questions and prompts were piloted on two of the participants that had 
consented to interview, one from each group. In addition to the predefined 
questions the pilot participants were also asked if they understood the questions 
and asked to make suggestions of improvements.  
The purpose of piloting the semi-structured interviews was to make sure all 
questions were appropriate and specific enough to address the objectives of the 
interview, without excluding the opportunity for the participants to provide extra 
supporting information. 
 
5.2.3 Sampling and data collection 
The consent form used for participants recruited to the Health Check study 
(Chapter Four) additionally asked participants if they would like to participate in a 
semi-structured interview on completion of their follow-up Health Check. Those 
who selected ‘yes’ to this question were recorded as ‘consented to interview’. 
Participants that had their Health Check conducted in the workplace setting 
(n=89) were divided in to two groups: intended to make lifestyle changes (Group 
One, n=59) and did not intend to make lifestyle changes (Group Two, n=28) 
based on information provided in the ‘Health and Lifestyle Questionnaire’, 
version 4, (27/11/14) (Appendix 4.9). The workplace was in the manufacturing 
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sector and employed approximately 300 staff, 72% male, 18% female. Both 
managerial and manual staff were included.  
 
21 participants from group one and 11 participants from group two were selected 
at random, using a random number generator, from the pool of ID numbers of 
participants that had consented to interview. This was done to provide a spread 
of opinion that was relative to the overall numbers that stated intention to change 
and those who did not. 
Semi-structured interviews were carried out immediately after the participant’s 
follow-up Health Check. Prior to the interview commencing, the participant was 
reminded that they had consented to be interviewed and for that interview to be 
audio recorded. At this point, the participant was given the opportunity to 
withdraw their consent and therefore the interview would not go ahead.  
Participants who provided verbal consent at this point were then read a short 
introduction (Appendix 5.1) that informed them of the aim of the interviews and 
how the information gained will be used. No participants withdrew consent at this 
point.  
Participants were then asked questions relevant to their original intentions, as 
described in section 5.2.1, Figure 5.1 and Figure 5.2. At the end of each 
interview, participants were given the opportunity to ask their own questions 
and/or provide any additional thoughts, concluding with thanks for their 
participation. Interviews were audio recorded using a Dictaphone and transcribed 
verbatim. Once transcribed, audio recordings were deleted. The transcripts were 
stored using the participant ID numbers, as assigned in Chapter Four (section 
4.2.3.1), without identifiable data.  
 
5.2.4 Analysis 
The transcribed interviews were analysed thematically and results were 
described using thematic networks. As an analytical tool, thematic networks draw 
on core features that are common in many qualitative research methods (Attride-
Stirling, 2001) such as grounded theory (Corbin and Strauss, 1990) and 
frameworks (Ritchie and Spencer, 1994). Broadly speaking, thematic network 
analysis is based on argumentation theory (Toulmin, 1958). Argumentation 
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theory aims to analyse negotiation processes using a structured method, which 
defines and elaborates the formal elements of arguments. In doing so, 
argumentation theory explores the connections between explicit statements and 
implicit meanings found within discourse.  
The first stage of thematic analysis was data coding, which involved identifying 
key words and terms that emerged repeatedly throughout the texts. Themes 
were extracted from the coded data. A theme should be discrete, yet broad 
enough to encapsulate a set of ideas (Attride-Stirling, 2001). The initial level of 
themes identified were classified as ‘basic themes’. Basic themes were grouped 
together in to similar topics, called ‘organising themes’. Organising themes were 
given names that encapsulated all of the basic themes that sat under them. 
Finally, the main point of the text, which encapsulates the principle metaphor, 
was deduced, this is known as the ‘global theme’. An example of the resulting 
network can be seen in Figure 5.3.  
 
 
Figure 5.3 Example of a thematic network 
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5.3 Results 
 
5.3.1 Result of pilot  
The semi-structured interviews were well received by both pilot participants, both 
reporting that they understood all questions. One participant suggested that 
more explanation should be added around the final question regarding opinions 
of the Health Check scheme as a whole. The interview script was amended in 
accordance with the suggestions made. 
 
5.3.2 Uptake and characteristics 
As depicted in the consort diagram (Figure 5.4), 28 of the 32 participants that 
were randomly selected attended the semi-structured interview.  
 
 
 
 
Figure 5.4 Participant selection and uptake 
 
None of the selected participants refused consent on the day of interview.  
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Table 5.1 shows the participant characteristics for this study. 25 of the 
participants were male and 3 were female, this was similar to the division of 
gender at the workplace. All participants were white British. Age ranged from 21-
59 with a mode of 42 years. 10 of the participants were aged under the normal 
inclusion criteria for an NHS Health Check, though the majority of these were 
30+ (n=7).  
 
Characteristic Number 
Male 25 
Female 3 
Aged <40 10 
Aged 40+ 18 
Underweight (BMI <18.5) 0 
Ideal weight (BMI 18.5 - 24.9) 10 
Overweight (BMI 25 – 30) 14 
Obese (BMI 30+) 4 
Non-smoker 20 
Ex-smoker 6 
Light smoker (<10/day) 2 
Table 5.1 Semi-structured interview participant characteristics 
 
 
5.3.3 Stimuli of positive health behaviour changes 
Seven main domains were identified from the texts that provided insight into the 
stimuli for making healthy lifestyle changes, these were: education, season, 
challenge, family, standards, availability and enjoyment (Figure 5.5).  
The age of each participant is provided after each statement along with their 
participant ID numbers, to be used for reference with the transcripts (Appendices 
5.2 and 5.3). 
 
  
137 
 
 
Figure 5.5 Thematic networks displaying the stimuli for positive behaviour change  
 
5.3.3.1 Availability 
The availability of technologies, equipment and health foods was frequently 
mentioned as factor that drove and/or aided the participants in making healthy 
lifestyle choices.  
Mobile technologies were mentioned on numerous occasions:  
“I monitor my steps on my phone, you know” Male, 50 
(2448) 
“I’ve actually got an app on my phone now, and well, 
I’ve got one for me heart rate… one’s called heart rate 
monitor and it gives you your pulse…And I’ve got 
another one what’s like keeping an eye on what ya 
eat” Male, 59 (1820)  
“I’ve got this thing [shows device], which has been 
good to me, counting me steps and stuff and, err, it 
monitors your sleep and stuff like that” Male, 33 
(2307).  
Four participants stated that they had blood pressure monitors at home that they 
used to monitor their blood pressure on a regular basis: 
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 “Yeah, yeah got one of them monitors” male, 59 
(1947).  
Occasionally, a lack of technology was accredited with increasing participant 
physical activity: 
 “my car’s in the garage this week so I’ve been cycling 
to work” female, 37 (2349).  
 
Equipment available to some participants also appeared to have positive impact 
on health behaviours:  
“Got one of those teppanyaki grills” Male, 57 (1744) 
This encouraged the participant to cook healthier meals. Sports equipment had 
influence on participant choices: one participant intended to start cycling:  
“Get a bike, I keep sayin’ I’ll get a bike so I need to. 
Go cyclin’” male, 59 (1947),  
“I’ve got roller skates and I go out in the for two or 
three hours in the nice weather. A gym at home too” 
male, 27 (2470) 
“If I bring my trainers. I can have them sitting there 
staring at me and when I can see them, I think, “oh, 
well I have to put them on…” female, 35 (1800).  
Smoking cessation aids such as nicotine patches and e-cigarettes were also 
mentioned as effective when attempting quitting or a reduction in smoking  
“The patches work, they’re the only thing that do…” 
male, 43 (1705)  
“Yeah, Yeah went on to the e-cigs about a year or two 
ago” male, 39 (1743).  
 
The availability of healthy food was another thing that was quoted as a positive 
health behaviour:  
“have a handful of nuts every day and a little anti-
cholesterol yoghurt” male, 51 (1758).  
 
5.3.3.2 Challenge 
The challenge of achieving goals was often stated as a focus that encouraged 
healthy behaviours, examples of this include:  
 “Well, I’ve got a race coming up so I thought it would 
be a good idea to keep an eye on what I’m eating and 
stuff” male, 59 (1820),  
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 “I did the Manchester 10K… I was the three hundred 
and twentieth man over fifty” male, 51 (1758)  
For some it was also about proving others wrong: 
“I bought it [Insanity DVD] my wife for Christmas and 
she said she couldn’t do it, that you needed to be an 
athlete to do it. I hadn’t ran for two years and I was 
just about starting up again so I said “well I’ll do it” and 
I did it” male, 42 (1900).  
For one participant, the new season for American Football was motivation to 
become fitter: 
 “it’s like the new season starts in less than a year so 
I’ve been given my goal to get ready because I’m 
gonna go play” male, 32 (2111).  
 
Some of the participants talked about the progression to meet an objective or 
challenge, for example participant 1800, female, 35, stated that the Couch to 5K 
programme continues to help her improve her fitness. Couch to 5K is a free nine-
week programme that aims to help anyone, regardless of fitness, run the 
distance of 5 kilometres.  
Another participant talking about how long they had been kickboxing for: 
 “Just over ten years I think. Got me back belt in it and 
then September I’m supposed to be doin’ ma 
instructor grade” male, 46 (1623).  
Progression and quantifiable achievements encourages the adoption and 
continuation of a healthier lifestyle.  
 
Weight loss groups were mentioned by three participants (1800, 1993 and 2307):  
“tryin’ to follow some of the Slimming World food 
guidelines…You just don’t realise how much [bread] 
you eat it until you start cuttin’ it out” female, 35 
(1800).  
Weight loss groups are a good way of tracking progress and could even create 
some friendly competition between attendees.  
 
 
 
 
  
140 
 
5.3.3.3 Family 
The opinion of family and friends was described by some of the participants as 
something that made them, and others, make positive lifestyle changes. One 
participant talking about smoking:  
“I gave up last year and I keep telling him that he 
smells so he has finally given up [laughs]” female, 31 
(1811).  
Another participant stated:  
“My boyfriend won’t let me not go” to the gym, female, 
37 (2349).  
Another participant suggests that he has taken his wife’s opinion in to account: 
 “I just know it’s not good to drink too much. Wife goes 
on about it too” male, 48 (1677).  
 
Physical activities arose as another basic theme relating to family:  
“An’ I’ve been goin’ on walks with the dog. Well it’s me 
daughter’s dog” male, 59 (1957),  
“football with the kids and stuff” male, 39 (1873)  
“kids keep us active” male, 50 (2448).  
 
The history of family health appeared to be an influencing factor on participant’s 
lifestyle choices. When one participant was asked if his father’s “bland diet”, lack 
of exercise and numerous heart attacks had influenced his choice to be more 
physically active, he said: 
 “Erm, yeah it probably has actually. I don’t really think 
about it like that but I suppose it has done really” male, 
43 (1506).  
One participant saw his father as being particularly unhealthy “overweight, 
smoked, drank” as a reason to be more healthy and to get regular health checks: 
 “Because of my dad, I’ve got to see my doctor 
deliberately over the past five to eight years or so, just 
for cholesterol checks. And then obviously I jump at 
the opportunity to come here and have it done” 
because “don’t want to turn out like that. So you know, 
you can’t do anything about the hereditary bit but it 
may be that his lifestyle was something that played in 
to it and it was completely different to mine” Male, 51 
(1758). 
  
141 
 
One participant’s parents were both diabetic. She quoted that as being 
something that had influenced her to have a healthier diet:  
“Yeah, seeing it all happen to my mum and dad is a bit 
scary…and I don’t want to end up like that” and that 
having a young child provides extra impetus to be 
healthy “Especially because of my daughter, you 
know, I want to be fit and healthy for her” female, 35 
(1800). 
 
As well as the history of family health, family traditions also seemed to play a 
part in participant’s current choices:  
“from a drink point of view, my dad didn’t really 
drink…My mum didn’t, as such. You know, maybe a 
glass of wine at New Year or something. So it wasn’t 
really prevalent in the house” male, 49 (1967).  
  
 
5.3.3.4 Season 
Seasons, or more specifically weather conditions, were a trend that emerged 
from the texts in relation to physical activity and diet. Some participants quoted 
warmer weather as having a positive influence on their diets: 
 “Few more salads and stuff with it being warmer” 
male, 43 (1705).  
However, it appeared that warmer, sunnier weather had a bigger influence on 
the amount and type of outdoor physical activity undertaken:  
“Better weather maybe. I used to do more events in 
the summer so your trainin’ kinda goes up” male, 48 
(1677) 
I started running again now that the weather has got a 
bit better male, 39 (1873) “I already do runnin’ and 
biking already. I suppose I’ve done more of both since 
the weather has got a bit better” male, 42 (2131)  
“do a bit more cyclin’ like with the weather bein’ nice” 
male, 47 (1855).  
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5.3.3.5 Standards 
The participant’s self-image was theme that emerged from the texts as 
something that encouraged them to consider their diet and exercise regimen, to 
attain a goal of how they imagined they should look. When one participant was 
asked why they wanted to lose weight, they replied:  
“I just want to look better. Fit in my clothes better” 
female, 31 (1811).  
Another participant was encouraged to lose weight when he decided that buying 
clothes from a retailer that specialises in ‘plus size’ clothing was below the 
standards that he had set for himself:  
“I mean, at the moment I can’t buy any clothes 
because I’m mid-sized, so I’m gonna drop again. I’ll 
tell ya how bad it got, and this is what made me go on 
a diet…Jackamo” male, 33 (2307) 
 
Going on holiday was another basic theme that emerged from the texts in 
relation to standards set by the participants. One participant decided to cut down 
on unhealthy foods because they wanted to look good for their holiday, male, 59 
(1947). Another participant decided to restart an intense exercise regimen in 
preparation for their holiday:  
“So I think I’ll start this again before I go on holiday, a 
few weeks before to get ready” male, 42 (1900).  
It appears as though participants had a clear idea of what they saw as an 
acceptable body image for themselves whilst on holiday, which inspired them to 
adopt healthier lifestyle choices in an effort to achieve these standards.  
 
Participants with knowledge of their own ability seem to be spurred on by it, one 
participant, who is a distance runner, on entering a marathon:  
“I know, someone said “are you mental, at your age?” 
and I was like “no, I’ve done ‘em before so…” male, 59 
(1820).  
 
Some participants wanted to restore a former physique and fitness that they 
were happier with, for example, one participant did not originally plan to make 
lifestyle changes but has become unhealthy due to work commitments, so now 
feels he needs to make changes to restore his standard, male, 33 (2320).  
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For some participants it was the standards set by others that motivated them to 
make lifestyle changes. A participant that had previously made positive health 
behaviour changes stated:  
“yeah, it was the cholesterol. I had worse cholesterol 
than people who were much older. Like me dad who 
was in his sixties” female, 37 (2349).  
 
 
5.3.3.6 Knowledge 
Having an NHS Health Check provided participants with information about their 
health. For some, this knowledge created concern, which in turn instigated some 
healthy behaviour changes. One example of this is a participant who had 
previously discussed statins with his GP due to his cholesterol levels and 
decided to change his diet and increase exercise first before taking statins:  
“I’m fifty-one…I am aware of my cholesterol bein’ a 
little high. I had discussed statins with my doctor but I 
don’t really wanna go down that route just yet” male, 
51 (1758).  
 
For other participants, an awareness of what is, and what is not healthy has 
provided enough impetus for change: 
 “You know, I’m aware that obviously in time, as you 
get older, you need to change certain things though” 
male, 33 (1506)  
“I was always dead skinny growin’ up, right the way 
through my twenties. But then once I hit thirty, it just 
started piling on” female, 37 (2349).  
Other participants feel as though if they had previously had more information, 
they would have made better lifestyle choices at the time: 
 “Maybe, maybe I wouldn’t have started smokin’ in the 
first place is I were to have known how bad it is for 
you” male, 43 (1705).  
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5.3.3.7 Enjoyment 
Some participants explained that they practiced healthy behaviours because of 
the enjoyment that they get from doing so.  
The enjoyment of physical activity was mentioned on numerous occasions, one 
participant expresses his enjoyment of riding his bicycle: 
 “I enjoy it quite a lot”, which he does “four, five times a 
week” in all weather, male, 57 (1744).  
For others, regular physical activity is a habit that has lasted twenty-seven years:  
“I cycle in here every day. That’s about three an’ a half 
miles each way” male, 57 (1777).  
 
With regards to regular exercise classes one participant, who has been attending 
kickboxing classes for over ten years, explains that: 
 “it makes a big difference if you enjoy it” male, 46 
(1623).  
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5.3.4 Indicators of negative health behaviour changes or no changes  
Seven domains that provided insight into reasons for not adopting intended 
positive behaviour changes (Figure 5.6) these were lack of motivation, 
commitments, convenience, condition, work, existing health and cost.  
 
 
 
Figure 5.6 Thematic networks displaying the barriers to positive behaviour 
change 
 
5.3.4.1 Lack of motivation 
Lack of motivation was a key organising theme emerging from the text.  
Exercise was the most frequently cited factor that the participants of this study 
wanted to increase, Chapter Four (Chapter Four, section 4.3.3.3), yet it also 
seemed to be one of the more difficult things to adopt:  
“yeah, so it was like six, seven o’clock when I was 
having to go”...”And you know, sometimes you just 
can’t be bothered getting up” female, 37 (2347) 
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One participant admitted that their reason for not exercising was often laziness: 
“It’s just being lazy” male, 27 (2470) 
 
Some participants appeared to lack the will power to persue their intentions. One 
participant on the topic of smoking cessation: 
 “I was takin’ them [Champix] an’ thinkin’ I’m not 
actually gonna go the full hog here” male, 47 (1855)  
Another participant who intended to follow Slimming World more 
rigorously:  
“But sometimes I just think, ah well, what’s the point?” 
male, 42 (1993) 
 
Some participants had unhealthy habits that they simply did not want to change, 
whether they were aware of its consequences or not:  
“this won’t sound good but I get a Subway every 
morning. But I don’t have sauce” “So like, just beef 
with salad. And I eat that at like quarter to nine and 
then I don’t eat here then for the rest of the day” male, 
42 (1993) 
“Still doin’ a mix of tryin’ to eat healthy and then piggin’ 
out on curries and burgers and stuff “Just what I’ve 
always done” male, 46 (1623) 
 
5.3.4.2 Commitments 
Other commitments were often obstructive to implementing healthier lifestyle 
behaviours. The four most often described in this study were family, holidays, 
birthdays and DIY.  
 
Participants that stated family as being a reason for not implementing healthier 
behaviours tended to be the parents of young children:  
“I’m just busy, got young children” male, 44  (2108) 
“Errr, well….not much exercise really. I’ve got four 
kids, they keep me busy” male, 39 (1743) 
For some, elderly relatives also added to this barrier, for example participant 
1993 (male, 42) has four young children and frail parents, all of whom require 
regular care.  
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Although holidays were motivators of healthy lifestyle changes for some, they 
caused delays and setbacks for others: 
“Well, I’ve just been on holiday back home so lots of 
drinking an’ eating” male, 27 (2470) 
“we went to Tenby with the granddaughter. So I 
probably ate a bit too much then” male, 59 (1820) 
 
Birthdays and parties were another cause of delay or reversal of progress: 
“then I come back off holiday and it was my birthday 
and you’re thinkin’ and before you know it, that three 
months has just gone” male, 43 (1583) 
“Well I’ve been to a lot of parties recently so lots of 
food and lots of drink” male, 46 (1623). 
 
Problems around the house and improvement work arose as another basic 
theme that the participants were committed to, which obstructed their intentions 
of lifestyle change: 
“I have to do everybody else’s DIY too. Can you just 
do his trellis? the daughter will be like’ can you do this, 
can you do that?” male, 57 (1744) 
“These last…probably last 12 months I been err, 
renovating me house and it’s err coming to the end 
now” male, 59 (1947) 
 
Participating in DIY appeared to be seen as a replacement for exercise in some 
cases: 
 “Only from the fact that I’ve been doing the back 
garden so I’ve been doin’ a lot of diggin’ and stuff like 
that” male, 43 (1583).  
 
5.3.4.3 Convenience 
Diet was the main factor affected by convenience, with participants opting to 
consume food that were readily available. Some were tempted by restaurant and 
hotel catering as they spent a lot of time in hotels and restaurants because of 
work: 
“it’s hard to keep the diet on when the food is like 
right in your face” female, 31 (1811) 
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Rather than plan healthy meals or particularly consider the nutritional value of 
what they ate, some participants tended to eat whatever was available in their 
house at the time:  
“I tend to be at the whim of what’s in the fridge” male, 
39 (1873) 
“It just tends to be whatever you can get out of the 
freezer” male, 59 (1820) 
 
5.3.4.4 Condition 
Several participants reported that they had not increased the amount of exercise 
that they did or that they had to stop exercising due to illness or injury: 
“I had a heavy fall and cracked all my ribs a while 
ago so couldn’t run for a month” male, 59 (1820) 
“Well, I actually injured my knee when doin’ Tough 
Mudder so that’s why I had a break for a few years” 
male, 42 (1900) 
For some, alternative exercises were not as appealing as their preferred form of 
exercise, and so they did not do as much exercise: 
 “I saw the surgeon a few weeks back and he told me to do cyclin’ but I’d rather 
do running, I like running” male, 44 (2108).  
For some participants, it was weather conditions that negatively affected their 
exercise regimen, in wet weather:  
“I managed to do it [run] a couple of times a week for 
about three weeks but then the weather just go really 
cold an’ rainy an’ horrible an’ you don’t wanna run in 
the rain, coming back looking like a drowned rat and 
having to come back in to work for the rest of the day 
[laughs]” female, 35 (1800) 
For some, hot weather had a negative impact on exercise:  
“Obviously we’re all tired at some stage, it’s just 
keeping going. Especially in this weather, ‘cause 
we’re more winter runners and it’s really hot at the 
moment” male, 59 (1820) 
 
More temperate weather influenced other, less healthy lifestyle choices such as 
smoking: 
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“An’ now it’s sunny, it’s easier to go out an’ smoke. I 
mean you don’t wanna go outside smokin’ in the rain 
do ya?” male, 47 (1855) 
 
Several participants stated that potential unwanted side effects were a factor that 
influenced their decision not to make healthy lifestyle changes. One participant 
had previously seen marked improvements in weight loss whilst taking a 
powdered dietary supplement: 
“well that has worked for me before, I lost six and a 
half…erm, but, err…me hair were fallin’ out, I didn’t 
feel good ‘n’…yeah, I just came off” male, 33 (2307) 
Other participants were concerned with the adverse side effects from smoking 
cessation aids:  
“‘cause I’d tried patched before and they, well they’re 
ok but you end up with throbbin’ in your arms…it’s 
really weird, can be really painful. You know, you 
wake up and all the top of your arm is achein” male, 
47 (1855) 
 
“I mean with those the work, ten out of ten but then 
you read the leaflet and see some of the side effects 
like suicide, you know if you’re thinkin’ suicidal then 
stop immediately” male, 47 (1855) 
 
5.3.4.5 Work 
For some participants in this study, working away from home was a regular 
occurrence, which impacted on the time that they had to exercise: 
“from Monday to, to Thursday, I am in Leicester so 
when I come home, I just want to be home” female, 
31 (1811) 
“Well I’m here most days six am to seven pm and in 
a lot of Saturdays, so it’s just time” male, 32 (2111) 
As well as the time they had to cook healthy meals: 
“we both work so we’re limited as to what we can do” 
male, 59 (1820) 
 
Work induced stress was also cited as a reason for adopting less healthy lifestyle 
choices: 
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“I’m in Leicester two weeks out of every three at the 
minute and at the minute its’ er, it’s very stressful. 
The management are actually getting involved a lot 
and stuff like than so I think my alcohol intake has 
increased” male, 33 (2320) 
 
Working environment also negatively influenced the choices of some 
participants; one participant had started to smoke again after quitting: 
“everyone else here smokes so it’s so easy to just go 
along with that” male, 27 (2499) 
Another participant was subject to drink related peer pressure: 
“Like one day we had a stressful night and my boss’s 
boss decided to get the Sambuca out and the chilli, 
chilli vodka. And that was just a Wednesday night” 
male, 33 (2320) 
 
5.3.4.6 Existing health 
Another key organising theme that emerged from the text was that some 
participants had a pre-existing sense of health, which lead them to believe that 
they did not need to make health behaviour changes. For some, this was as a 
consequence of the Health Check, some participant stated that the pervious 
Health Check had confirmed their health and helped them decided not to make 
healthy changes:  
“I mean, I’ve never really had health issues so never 
worried about it, but it was nice knowing that there 
was nothing to worry about as a fact sort of thing” 
male, 48 (1677) 
“So I thought I could just yeah, relax a little bit. Have 
that extra whatever…” male, 49 (1967) 
For others, this sense of health came from pervious experience. One participant 
rarely exercised and found that they did not have to consider their diet:  
“I’ve just always had a…had a really good 
metabolism” male, 50 (2448) 
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5.3.4.7 Cost 
There can be a cost associated with adopting some healthier lifestyle 
behaviours, for example, smoking cessation aids and gym memberships: 
 “I was on those Champix weren’t I? But it got too 
expensive. I’m not payin’ eight pound when everyone 
else’s was free so…” male, 47 (1855) 
“Err, I was going to the gym three or four times a 
week but I’ve cancelled me gym membership 
because it was getting a bit expensive and I’ve not 
joined another one yet” female, 37 (2349) 
For these participants, the cost associated with smoking cessation and gym 
membership contributed to their decision to stop with those particular lifestyle 
choices.  
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5.3.5 Participant opinion on NHS Health Checks  
Six domains provided insight into participant opinion of the NHS Health Check 
scheme, with particular focus on workplace screening (Figure 5.7), these were 
knowledge, change, convenience, comfort, value and target.   
 
Participants were asked not only what their experience and thoughts of the HC 
were but also what they thought HCs do to the bigger picture and other people.  
 
 
 
 
Figure 5.7 Thematic networks displaying participant opinions of the NHS Health Check 
scheme 
 
5.3.5.1 knowledge 
Many participants spoke of the knowledge gained from their health Check as a 
positive outcome. For most, it seemed to either satisfy an interest, provide focus 
or provide reassurance that they were healthy: 
“Well, they make me feel happier anyway. And if there 
was something else wrong, then I’d want to know 
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about it. Comes back to peace of mind again” male, 
57 (1777) 
“it’s just nice knowing that you’re ok. So it can help 
mentally I suppose. If you’re ok that is” male, 39 
(1743) 
“Err, it’s just interesting. Nice to be healthy, I suppose” 
male, 21 (2321) 
“Just good really. Sometimes life takes over and you forget 
about your health a little bit, this check err, it helps remind 
you and makes you stop and think a little. Even if your 
results are ok” female, 31 (1811) 
 
 
5.3.5.2 Change 
When participants were asked what they had based their decision on when they 
decided to make lifestyle changes, there were mixed opinions. Some stated that 
they had planned on making the changes for other reasons, before they had a 
health check: 
“No, obviously I’m fifty-one…I am aware of my 
cholesterol bein’ a little high. I had discussed statins 
with my doctor but I don’t really wanna go down that 
route just yet… definitely, don’t want to turn out like that 
[father]. So you know, you can’t do anything about the 
hereditary bit but it may be that his lifestyle was 
something that played in to it and it was completely 
different to mine” male, 51(1758) 
 
Some participants said that they made changes solely because of their Health 
Check results: 
“It was just seein’ my BMI last time, seeing it in the 
overweight category” male, 44 (2108) 
 
And some participants stated that they had previous intentions and that the 
Health Check reaffirmed them and helped them reach a decision: 
“Err, bit of both really. Always want to do it but then having 
a check reinforces it” male, 43 (1705) 
“I think I would ‘ave looked at it [diet] anyways but it was 
interesting to know that the other results were healthy and 
that [diet and exercise] was what I needed to focus on 
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without being worried about anything else” female, 35 
(1800). 
 
One participant even reported that their colleagues were comparing 
heart age results, post-check: 
“Really good. It’s been really interesting. A few of the 
people in the office have been goin’ round comparing heart 
ages” male, 33 (2320) 
The competition created by this could have heightened interest and created 
more impetus for change.  
 
5.3.5.3 Convenience 
The availability of immediate results during a workplace Health Check was a 
positive theme emerging from the interviews: 
“this way is just better. I like getting my results quickly. I get 
nervous if I have to wait for my results” male, 50 (2448) 
“it’s nice to not have to wait for results, get it all over an’ 
done with at once” male, 57 (1744) 
 
Several participants would be far less likely to receive an NHS Health Check if 
they were not done in the workplace as booking a GP or nurse appointment 
appeared to be an issue for some:   
“I don’t go to my GP to be honest, not unless I really have 
to. It’s just such an arse getting in” male, 33 (2307) 
“Not been to my doctor in ages, I’d probably only go if I 
were dyin’. I’ve just not got the time. Even my wife 
struggles to get the kids in when she needs to so I’d have 
no luck” male, 27 (2499) 
“Just good to know isn’t it? Havin’ it done here is good 
because I wouldn’t bother goin’ to the doctors for it to be 
honest…because I only go to then doctors if there’s 
something definitely wrong wi’ me. That’s just the way it is” 
male, 47 (1855) 
 
However, the point was raised that if a workplace Health Check raised any 
concerning results, the participant would still have to make an appointment to 
see their GP, which is less convenient:  
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I would say that’s a disadvantage but it’s still better to know 
and have to go to a few appointments. I just suppose it’s 
not as good as, err, going to your doctor in the first place” 
male, 27 (2470) 
“Suppose if something was properly wrong, I’d still have to 
make a doctor’s appointment wouldn’t I?” male, 43 (1705) 
 
5.3.5.4 Comfort 
Many participants spoke of their preference of having a blood sample taken from 
their finger rather than providing a venous sample:  
“Yeah and I like having them here too…far easier. And I 
don’t like needles either. So these are perfect with the little 
finger prick things are great” male, 42 (2131) 
“Err, I’m not a big fan of needles or seeing blood so this 
way is better than out of my arm” female, 31 (1811) 
Other participants stated that they are interested in all forms of health checks but 
do not have the confidence to go through with them all, whereas an NHS Health 
Check was a comfortable concept to them: 
“I’d, I’d love to have the confidence to go for a full men’s 
health kinda of check of things like that…that’s what my 
peers do, sort of every 6 months…yeah, some of them do, 
the Well Man’s Health Clinic. But yeah, I’m not that 
confident” [laughs] 
Researcher: “Is it more the testing procedures that you’re 
not comfortable with?” 
Interviewee: “Err, I’d say so, yeah. Just not comfortable I 
suppose” male, 39 (1873).  
 
5.3.5.5 Value 
The Health Checks were generally well received by all participants, with many 
stating that they think the scheme is a good idea:  
“I like things like this. I know I’m young but it’s always good 
to know about your health” male, 32 (2111) 
I know there are people here who aren’t bothered about 
having it done and I think they’re crazy” male, 51 (1758) 
 
Some participants saw the results of their follow-up Health Check as 
quite rewarding: 
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“I knew I was ok, or I thought I was anyway but having that 
sort of confirmed has been really pleasing” male, 44 (2108) 
Yeah, it shows me that my effort has been working. Feels 
good” female, 31 (1811) 
However, the power and seriousness of the Health Checks could be 
questioned when signposting and referrals are not sought. One 
participant was signposted to their GP for further cholesterol testing, 
but they did not go, stating: 
“I just didn’t think it was that bad” male, 43 (1583) 
 
5.3.5.6 Target  
Some participants raised a criticism of the NHS Health Check scheme, that it 
does not target those most at risk of CVD effectively:  
“Like I said, I’m ok for now but there’s people here who 
aren’t coming for these and they’re the ones who need 
to…like being overweight and stuff. Surely they’re not as 
healthy” male, 48 (1677) 
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5.4 Discussion 
 
The previous chapter, Chapter Four, aimed to assess what happens when 
individuals receive Health Checks in the community and workplace setting. This 
chapter aimed to provide some information as to how and some reasoning as to 
why those outcomes came about.  
 
Thematic analysis of the semi-structured interviews provides insight into the 
reasoning behind why some people engage in the message of the NHSHCs and 
make healthy lifestyle changes. As depicted in Figure 5.5, the stimuli for health 
behaviour change for patients screened in the workplace were season, 
challenge, family, standards, availability, enjoyment and knowledge. Of these, 
one of the most commonly cited themes was challenge. It appeared that many 
participants were motivated by the idea of setting new goals such as completing 
a race or losing a stated amount of weight and/or gained satisfaction from 
maintaining a certain level of health derived from achieving previous goals.  
Participants also liked to use the knowledge that they gained from their Health 
Check to help set more tailored goals that were relevant to the areas they 
needed to improve.  
 
Analysis of the interviews also provided suggestions as to why others do not 
engage in making lifestyle changes. Some participants had no intention of 
making lifestyle changes due to their belief that it would be unnecessary as they 
were already healthy. However, several participants stated at baseline that they 
wished to make some changes but did not achieve them by follow-up. The 
organising themes emerging from the interviews that explained this were lack of 
motivation, commitments, convenience, condition, work, existing health and cost. 
Of those organising themes, the one cited most often, as a barrier to making 
lifestyle changes, was work. All participants in this study worked for the same 
employer and some were implementing a new system at another site. The 
participants that were directly affected by this often said that they were stressed 
and that trying to be healthier would be too difficult at that time as they were 
working and staying away from home several nights each week, where there 
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was greater availability of unhealthy food and drink, which was convenient for 
them to access. However, the greatest barrier overall was lack of time, with 
almost all participants stating that it was an issue.  
 
A number of the themes highlighted in Figures 5.5 and 5.6 can be directly 
addressed using an NHS Health Check. One of the main aims of an NHSHC is 
to educate the participant on which, if any, of the participants’ results can be 
improved upon and how. Through thorough and appropriate explanation of 
results, an NHSHC can directly influence the knowledge, and therefore concern 
and awareness, of the participants. As knowledge has been shown to play a key 
role in behaviour change, ensuring that each patient understands their results 
and is provided with appropriate advice is an essential element of the Check that 
should be continued and promoted amongst staff. Other themes that the 
NHSHCs can influence are challenge and availability. As part of the wider Health 
Improvement Service, the SHIS funds and organises a range of community 
based health initiatives ranging from smoking cessation counselling to healthy 
cooking classes and fitness classes.  Advisors providing SHIS Health Checks 
can inform patients of these groups and encourage their attendance, thereby 
impacting on the availability of equipment, technology and health foods whilst 
also providing challenge through weight loss and running groups, for example.    
The provision of the aforementioned community groups can also address some 
of the barriers to positive behaviour change, for example attendance of a 
community group could provide some motivation, which may have previously 
been lacking. The groups run by SHIS are free of charge, overcoming another of 
the stated barriers, cost.  
 
Another objective of the research was to discover participant opinion of the NHS 
Health Check scheme both within the workplace setting and in general.   
The opinions of the participants on the NHSHC scheme in general were positive 
and tended to focus on the knowledge provided by the checks and how that has 
helped influenced positive changes for them. Some participants remarked on 
how the Checks would be of more value to those who purposely avoided them 
because they knew that their results would indicate that they were not healthy.  
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Opinions of the workplace Health Checks centred around the convenience of the 
initiative. Many participants remarked on how they would not have had a Health 
Check in primary care, either because they had no impetuous to make an 
appointment or because they find it difficult to attend an appointment within 
primary care, for example because they cannot get an appointment or do not 
want to take time off work.  
The use of Point-of-Care Testing (POCT) for the workplace NHSHCs was well 
received by the participants, with many stating that they found the process more 
comfortable and convenient than traditional pathology testing.  
 
As well as raising awareness of potential problems for some participants, the 
Health Checks reassured other participants that they were healthy. Although this 
may seem like a positive outcome, this reassurance could actually provide false 
security and provide patients with reason to continue with potentially unhealthy 
habits because they view their results as confirmation that their existing lifestyle 
behaviours are healthy (Kinlay and Heller, 1990; Tymstra and Bieleman, 1987), 
this is known as the ‘certificate of health effect’.  
 
5.4.1 Limitations of the study 
 
Participants may have felt the need to provide more positive answers to the 
questions in this study because the researcher who delivered some of the Health 
Checks conducted this study. This could mean that some key information has 
been omitted.  
Participants knew that they would be receiving a follow-up Health Check, this 
could have influenced choices and actions, thereby having an impact on their 
thoughts and opinions of the scheme. For example, a participant may have made 
more effort to lose weight after their first Health Check because they knew that 
they would be having another Health Check three months later, potentially 
resulting in more positive results and more positive feelings towards the scheme 
than they would have had if there was no follow-up.  
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5.5 Conclusion 
 
Although attitudes towards the workplace NHS Health Checks were entirely 
positive and there was a move towards healthier lifestyle choices, the majority of 
participants stated that their decision to make the changes was something that 
they had previously decided upon, prior to the Health Check. This finding is in 
agreement with the results of the ‘Health and Lifestyle questionnaire’ (Appendix 
4.11), reported in section 4.3.4.2.2 of Chapter Four, suggesting that having an 
NHS Health Check did not influence the conscious health behaviours of the 
study participants.  
 
NHS Health Checks provided by local authorities have advantages over primary 
care NHS Health Checks as they can influence some of the stated stimuli and 
barriers shown in Figured 5.5 and 5.6 through promotion of other health 
schemes provided by the local authority. NHS Health Checks provided by local 
authorities are also more likely to use POCT to measure cholesterol and 
glucose, which has not only been shown to have a greater influence on patient 
response (Laurence et al., 2010) but has also been shown in this study to be 
preferred over traditional pathology testing due to comfort and convenience.  
However, something that local authority Health Check cannot overcome is the 
most commonly stated barrier to the adoption of improved heath behaviours, lack 
of time. This barrier raises questions around the ultimate power of the scheme in 
any setting as how much time an individual has cannot really be influenced.  
 
It would appear that the provision of NHS Health by local authorities in the 
workplace setting is an appropriate approach for the NHSHC programme. Many 
participants stated that they would not make any effort to have an NHS Health 
Check in primary care and so many eligible patients would go unscreened if 
workplace initiatives were unavailable.  
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Chapter Six: Analytical and operator performance of a Point-of-Care Testing 
device used in the community setting 
Abstract 
Introduction 
POCT is used in the delivery of NHS Health Checks (NHSHCs). Some local 
authorities are now providing NHSHCs in the community and workplace setting, 
with the aim of screening ‘hard-to-reach’ patients for cardiovascular disease 
(CVD). This study aimed to assess the accuracy and reproducibility of the 
cholesterol and glucose results generated by the POCT device used – the 
Cholestech LDX (Alere San Diego, CA).  
Methods 
Three groups tested and recorded the results of historic external quality 
assessment (EQA) samples, all of which had a reference value to compare 
against. To assess the reproducibility of the results intraclass correlation 
coefficients and coefficient of variation (CV) were calculated. Agreement 
between the two methods (group versus reference value) was assessed using a 
one-sample t-test of the difference score of the methods. Results were plotted as 
Bland-Altman plots displaying an additional regression line. Shift tables were 
used to display any clinical significance arising from variation in results.   
Results 
Repeatability of the measurements was excellent. However, as shown in the 
CV% and the t-test results, the accuracy was poor. The one-sample t-test results 
indicate that there were statistically significant differences between the reference 
value and the group results. The CV results were >4%, indicating that the 
dispersion of results was widespread. The only exception to this was Group Two 
glucose results (p=0.437) and CV <4%.  
Conclusion 
The results generated by POCT in this study were not entirely reliable and could 
result in the production of false negative results. In a screening setting, a false 
negative could make it seem as though a patient is at less risk then they are in 
reality, potentially resulting in missed opportunities for further testing or 
treatment.  
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6.1 Introduction  
 
Due to economic pressures and a general drive for more patient-centred care, 
the global healthcare environment is changing. Many countries, including the 
United Kingdom, are being forced to limit or reduce healthcare budgets. One 
method of doing this is to reduce the number of patients treated in the relatively 
expensive hospital environment by encouraging more patients to be assessed 
and treated in primary care or the community. 
It is thought that healthcare should be organised around the patient, not the 
provider, something that centralised pathology testing does not really achieve, as 
the testing process and consultation process are often disconnected and 
generally less convenient for the patient.  
Point-of-care testing is increasingly being utilised to facilitate a more patient-
centred healthcare model that can be delivered in the community (St John and 
Price, 2014).  
 
Today, cardiovascular disease (CVD) is responsible for approximately one-third 
of deaths worldwide (Deaton et al., 2011; Naghavi et al., 2014) and in England it 
is the greatest cause of disability (Department of Health, 2013a). The global 
burden of CVD is set to increase with the increase of the associated risk factors: 
dyslipidaemia, hypertension, obesity, diabetes, physical inactivity, poor diet, and 
smoking.  
 
More than 80% of CVD is attributable the above risk factors. The good news is 
that the risk factors are modifiable, meaning that health promotion, screening, 
early detection and treatment are effective in reducing the numbers of cardiac 
events. The presence of one risk factor increases the risk of CVD two-fold, the 
presence of dyslipidaemia, smoking, hypertension and diabetes together, 
increases the risk of CVD forty-fold (Yusuf et al., 2004).  
 
As previously explained, Chapter One section 1.6, the NHS Health Check 
(NHSHC) scheme aims to reduce the prevalence of CVD by screening for the 
risk factors, whilst also promoting patient health through advice and education.  
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Lipids, primarily total cholesterol, and blood glucose are measured during an 
NHSHC and provide key information used by CVD risk calculators such as 
QRisk2. There is a proven positive relationship between total cholesterol 
concentrations and the risk of future coronary events and mortality as a result of 
CVD (Shephard et al., 2007).  
 
In order to attract ‘hard-to-reach’ patients, NHSHCs are increasingly being 
delivered in community settings e.g. at supermarkets, pharmacies, workplaces 
and on mobile testing facilities like ‘health buses’. Point-of-Care Testing (POCT) 
is often used to facilitate the ‘one stop shop’ community delivered Health Check 
approach.  
 
The Salford Health Improvement Service (SHIS) are an arm of the local authority 
in Salford, who, amongst many other health related activities, perform NHSHCs 
in the community setting. SHIS staff are trained in the use of the Alere 
Cholestech LDX (Alere San Diego, CA) for the analysis of the patient’s blood 
glucose and cholesterol. The staff are not required to have any professional 
healthcare or pathology-based qualifications.   
 
6.1.1 The POCT device 
There are a number of POCT devices available to test the parameters required 
by the NHS Health Checks. In a publication by the NHS’s Centre for Evidence 
Based Purchasing (CEP, 2009), guidance is provided for the procurement of 
POCT devices that test for cholesterol. The document provides information on 
the technical, operational and economical considerations, as well as market 
reviews of four transportable devices; the Accutrend Plus (Roche Diagnostics), 
BeneChek PLUS (General Life Biotechnology Co., Ltd.), CardioChek PA (PTS 
Diagnostics) and the Cholestech LDX (Alere, San Diego, CA). The guide also 
reviews two desktop POCT cholesterol analysers; the Piccolo Xpress (Abaxis 
Inc. CA, US) and the Reflotron Plus (Roche Diagnostics).  
The device used by SHIS to perform POCT blood tests for cholesterol and 
glucose is the Cholestech LDX. Table 6.1 summarises the CEP review.  
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Device Cost Advantages Disadvantages 
Accutrend Plus 
 
 
 
 
Device: 
£199  
 
£49 for 
25 test 
strips 
- Cheap 
- Reagents 
stored at room 
temperature 
- Capillary 
blood sample 
-Fast 
measurement 
time (3 
minutes) 
- weighs 140g 
- Sample 
applied directly 
to strip 
- Not CRMLN 
certified 
- Does not test 
for HDL 
- Tests 
performed 
individually 
BeneCheck PLUS 
 
Device: 
£75  
 
£18.90 
for 10 
test 
strips 
- Cheap 
- Reagents 
stored at room 
temperature 
- Capillary 
blood sample 
-Fast 
measurement 
time (30 
seconds) 
- weighs 45g 
- Sample 
applied directly 
to strip 
- Not CRMLN 
certified 
- Does not test 
for HDL 
- Tests 
performed 
individually 
- Manual lot 
calibration 
CardioChek PA 
 
 
Device: 
£479 
 
£106.37 
for 25 
TC and 
HDL 
strips 
 
£67.20 
for 15 
TC, 
HDL 
- CRMLN 
certified 
- Reagents 
stored at room 
temperature 
- Capillary 
blood sample 
- Fast 
measurement 
time (2 
minutes) 
- weighs 122g 
- Manual lot 
calibration 
- Sample 
applied to strip 
using capillary 
tube 
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and 
glucose 
strips 
Cholestech LDX 
 
 
Device: 
£950 
 
£76.45 
for 10 
TC and 
HDL 
cassette
s 
 
£85 for 
10 TC, 
HDL 
and 
glucose 
cassette
s 
- CRMLN 
certified 
- Capillary 
blood, venous 
or plasma 
sample 
- Automatic lot-
specific 
calibration 
-Fast 
measurement 
time (5 
minutes) 
- weighs 1kg 
- Reagents 
require 
refrigeration or 
can be stored at 
room 
temperature for 
30 days 
- Sample 
applied to strip 
using capillary 
tube 
Piccolo Xpress 
 
 
Device: 
£13,490 
 
£106.40 
for 10 
centrifu
gal 
reagent 
rotors 
- CRMLN 
certified 
- Reagents 
require 
refrigeration 
- Lithium 
heparinised 
venous blood, 
serum or 
plasma 
- larger sample 
volume required 
(100 – 120 µl) 
- no lot specific 
calibration 
- 12 minute 
measurement 
time 
- weighs 5.1 kg 
- Large sample 
applied to test 
chamber using 
pipette  
-Desktop (less 
portable) 
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Reflotron Plus 
 
 
Device: 
£3,600 
 
£29.10 
for 30 
TC test 
strips 
 
 
£35.40 
for 30 
HDL 
test 
strips 
- Reagents 
stored at room 
temperature 
- Capillary or 
venous whole 
blood, serum 
or plasma 
- Automatic lot-
specific 
calibration 
-Fast 
measurement 
time (2-3 
minutes per 
test) 
- Not CRMLN 
certified 
- HCD and TC 
tests performed 
separately 
- weighs 5.3kg 
- Sample 
applied to strip 
by pipette 
-Desktop (less 
portable) 
 
Table 6.1. Summary of the market review covered in the buyer’s guide for Point-of-Care 
Testing for Cholesterol Measurement.  
 
The particulars of each device in Table 6.1 have been arranged into ‘advantages’ 
and ‘disadvantages’ in relation to performing an NHS Health Check in the 
community. For example, it adventageous for the reagents to be stored at room 
temparture as refrigeraion is not aways available in the community setting. It is 
also advenatgeous for the device to measure HDL, as this result is used to 
calculate the patient’s 10 year cardiovasular risk score. A device that is CRMLN 
certified is approved by the Cholesterol Reference Method Laboratory Network 
for the measurement of total cholesterol, high-density lipoprotein (HDL) and low-
density lipoprotein (LDL).   
The NHS’s Centre for Evidence Based Purchasing (CEP) highlights the 
advantages of the Cholestech LDX as being: a Cholesterol Reference Method 
Laboratory Network (CRMLN) certified device, able to measure a wide range of 
lipid based parameters, automatically performs lot specific calibration and small 
sample sizes required (CEP, 2009).  
 
However, at the time of publication, the Cholestech LDX is also the most 
expensive of the small (non-desktop) devices reviewed by the CEP, costing £950 
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without a printer, excluding VAT. By comparison, the CardioChek PA cost £479 
and is also CRMLN certified. The Cholestech LDX uses the most expensive 
reagents of the devices reviewed - £85 for 10 cassettes that test TC, HDL and 
glucose, compared with the reagents for the CardioChek PA , which cost £67.20 
for 15 strips that test the same parameters.  
 
The Cholestech LDX is CLIA waived. When a device is deemed to be simple and 
have a low risk for erroneous results by the Food and Drug Administration (FDA) 
Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) then it can be 
CLIA waived. For a test to be classified as ‘simple’ it must be fully automated and 
provide a direct read-out of results, without interpretation (Corbin et al., 2012). A 
CLIA waived device can be operated by individuals without a professional 
pathology testing (FDA, 2014).  
 
The aim of this research was to assess the accuracy and reproducibility of lipid 
and glucose results generated using POCT in the community setting. The results 
were analysed statistically as well as analysed for their clinical significance. 
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6.2 Methods 
 
6.2.1 Setting and participants 
Participants were selected purposively from a cohort of consenting SHIS staff 
(n=12). These participants formed group one and were asked to perform testing 
using the Cholestech LDX on known external quality assessment (EQA) samples 
in the community setting and to record the results. Group two consisted of the 
researcher performing the same tests on the same EQA samples and device in 
the community setting. Group three consisted of the researcher conducting the 
same tests on the same EQA samples, using the same device but this time in 
the laboratory setting.   
 
6.2.2 Testing process 
Historic EQA samples were provided by the UK National External Quality 
Assessment Service (UKNEQAS). The samples are liquid human serum, 
prepared from serum obtained through National Blood Service. 
 
Figure 6.1 Testing process carried out by each group, Group One – SHIS staff in 
community, Group Two – Researcher in the community and Group Three – Researcher 
in the laboratory, using sample 148a as an example.  
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Samples from 5 distributions (148, 149, 151, 152 and 153) were provided. Each 
distribution contained three different samples (a,b and c), resulting in 15 
individual samples, all with a different known values for TC, HDL, TC/HDL and 
glucose. In this case, the known value was the ‘All Laboratory Trimmed Mean” 
(ALTM), which was calculated by UKNEQAS as part of their Health Check EQA 
scheme. The ALTM was used as the reference standard or ‘gold standard’ result. 
Nine copies of the 15 individual samples were provided in individual vials.  
 
Figure 6.1 depicts the testing process, using one sample as an example.  
The individual vials were marked with a unique, randomly generated 3-digit 
identification code, which corresponded to the sample identity e.g. ‘148a’ on a 
secure spreadsheet. This was done so that the participant did not know the 
identity of the sample at time of testing and so that the sample results could be 
translated back to their original sample for comparative analysis.  
 
Participants were instructed to test the sample as if it was a capillary blood 
sample, using a capillary tube and plunger to collect 40L of sample from the vial 
and introduce it to the cassette, as shown in Chapter Four, section 4.2.3.1.    
 
The samples were tested on a Cholestech LDX POCT device using the TC-HDL-
GLU cassettes, which provide readings for total cholesterol, high-density 
lipoprotein (HDL), total cholesterol : HDL ratio (TC/HDL) and glucose, meaning 
that each sample tested produced four values.  
 
Each sample was tested nine times (three times by each group) and so 135 tests 
were performed, which resulted in 540 individual result values.  
 
Results recorded on the results forms were transferred on to the spreadsheets 
for the corresponding samples and parameters. Individual results can be seen in 
Appendices 6.1 to 6.4.  
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6.2.2.1 Cholestech LDX test principle 
Once a cassette is placed in to the Cholestech LDX, the cassette separates the 
plasma from any blood cells. Following precipitation by dextran phosphate and 
magnesium acetate, HDL is separated from LDL and VLDL (very low-density 
lipoprotein). The precipitate containing HDL and glucose is transferred to the 
HDL and glucose reaction pads.  
As depicted in Figure 6.2, the cholesterols TC and HDL are hydrolysed by 
cholesterol esterase in the filtrate to form free cholesterols and fatty acids. In the 
presence of oxygen, cholesterol oxidase oxidises the free cholesterol to cholest-
4-ene-3-one and hydrogen peroxide. The peroxide reacts with 4-aminoantipyrine 
and N-ethyl-N-sulfohydroxypropyl-m-toluidine (TOOS), in the presence of 
horseradish peroxidase to form quinoneimine dye. The resulting dye is used to 
determine lipid concentrations using reflectance photometry on analyte-specific 
reaction pads.  
 
 
Figure 6.2 Test principle for cholesterol using the Cholestech LDX 
 
Glucose is also measured using an enzymatic reaction. As depicted in Figure 
6.3, glucose is oxidised to gluconolactone and hydrogen peroxide. As with the 
cholesterol reaction, Fig 6.2, the peroxide reacts with 4-aminoantipyrine and N-
ethyl-N-sulfohydroxypropyl-m-toluidine (TOOS), in the presence of horseradish 
peroxidase to form quinoneimine dye. The resultant colour in the dye is 
measured by reflectance photometry.  
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Figure 6.3 Test principle for glucose using the Cholestech LDX 
 
The Cholestech LDX is pre- calibrated by the manufacturer and the brown 
magnetic strip on the side of the cassette contains encoded calibration 
information. 
 
6.2.2.2 Cholestech LDX operating conditions 
The POCT device was used in accordance with the Alere Cholestech operating 
guide. The temperature of the room was between 20 and 31 °C for all testing 
environments, as measured by a portable room thermometer. The device was 
used on a stable work surface, in a location with no direct heat or light. The 
optics check cassette was used before testing at each new location or day and 
results were recorded in the appropriate log. The device was only used if the 
optics check was in range.  
Cassettes were in date and stored in a refrigerator (5°C) from day of receipt until 
day of use. Before use, cassettes were allowed to come up to room temperature 
for at least 10 minutes.  
 
6.2.2.3 EQA sample storage and operating conditions 
UKNEQAS EQA samples are delivered via postal service. Upon receipt, it is 
advised that the samples are analysed immediately, if this is not possible, the 
samples should be stored in a refrigerator at 4°C.  
 
Samples that have been refrigerated should be allowed to come up to room 
temperature and thoroughly mixed by inverting the vial ten times prior to 
analysis.  
 
EQA samples should be analysed as if they were blood samples, keeping the 
Cholestech LDX on the ‘whole blood’ setting
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6.2.3 Analysis 
 
6.2.3.1 Comparator  
Results generated by the three groups were compared to the All Laboratory 
Trimmed Mean (ALTM). The ALTM was provided by UKNEQAS for each 
sample. ALTM is calculated by assessing all results generated by participating 
EQA laboratories/sites, removing any outliers that could distort the distribution 
and then calculating the mean of the remaining results. ALTM usually agrees 
closely with the “true value” in schemes with a large number of participants (Hill 
et al., 1996).  
For the distributions provided (148, 149, 151, 152 and 153), UKNEQAS reported 
results for laboratories using the Reflotron, CardioChek and Cholestech, (Table 
6.1).  
 
6.2.3.2 Repeatability of measurements 
Intraclass correlation coefficients (ICC) were calculated for each set of results. 
ICCs describe how strongly units in the same group resemble each other and 
are therefore seen as a measure of repeatability. An ICC of <0.4 indicates poor 
reproducibility, an ICC of 0.4 - 0.75 indicates good reproducibility and an ICC of 
>0.75 indicates excellent reproducibility (Dale et al., 2008). Results are shown in 
Table 6.2.  
 
The coefficient of variation (CV) was calculated (standard deviation/mean x 100) 
for each result and reported in Table 6.2 as a percentage. CV is a measure of 
dispersion of a distribution and is a standardisation of the standard deviation, 
which allows comparison of variability estimates regardless of the magnitude of 
analyte concentration (Reed et al., 2003). The lower the CV%, the better. It is 
generally accepted that a CV of ≤5% shows a good level of method performance 
(Zady, 2009).  
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6.2.3.3 Plotting the data (accuracy) 
Agreement between the two measurements was initially assessed using a one-
sample t-test of the difference score of the two methods, group results versus 
ALTM.  
In place of displaying the results using simple XY plots, Bland-Altman plots were 
used for each set of results, as they are a better measure of agreement. XY plots 
comparing method ‘A’ to method ‘B’ by design, show the data to cluster around 
the regression line, especially if a wide-spread data set is analysed (Altman and 
Bland, 1987).  
Bland-Altman plots are difference plots that display the agreement between two 
different assays. The Bland-Altman plots displayed in this chapter (Figs. 6.4 – 
6.15) have additional bivariate lineal regression lines (green line), which show 
the difference between the score (Y) and the average of the score (X). As 
explained in section 6.3.1.1, a regression line showing good levels of agreement 
will typically be flat; a slope would suggest proportional bias. For example a 
positive slope indicated that the group results become less accurate as the result 
score increases.  
 
6.2.3.4 Impact on clinical significance  
Shift tables were devised to display the number of results that were in agreement 
and disagreement with the reference standard, the ALTM. These were firstly 
categorised using referral cut-off points as used by the SHIS in the NHS Health 
Checks that they provide. A total cholesterol (TC) of <7.5 mmol/L does not 
warrant referral to GP, whereas a TC of >7.5 mmol/L does. A random blood 
glucose of <6.0 mmol/L does not warrant referral, a result of 6.1-11.0 mmol/L 
warrants referral to GP for a fasting blood glucose test or HbA1c within 4 weeks, 
a result of 11.1-17.9 mmol/L warrants a one week referral to GP and a result ≥ 
18 mmol/L warrants referral within 48 hours. See Appendix 4.9 for more details 
of SHIS referral and signposting guidance.  
 
As discussed in Chapter One (section 1.6) the NHS Health Check includes 
calculation of CVD risk scores using the results generated during the check. The 
SHIS tends to use the QRisk2 score for this purpose, however, as QRisk2 is 
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calculated using an algorithm it was not applicable to use with a shift table as 
discrete result boundaries are needed. Therefore, the results were categorised in 
accordance with the Framingham general CVD (10-year risk) profile (Wilson et 
al., 1998), which predicts absolute CVD risk over a 10-year period from the 
following variables: age, sex, treated- and untreated-systolic blood pressure, 
total cholesterol, HDL cholesterol, smoking status and presence of diabetes. 
 
The Framingham 10 year risk score works on a points basis with healthier results 
receiving negative or zero points and less healthy results receiving positive 
points, therefore the higher the overall score, the higher the risk score, which is 
indicative of an increased likelihood of a cardiac event. For total cholesterol, the 
5 categories are as follows: <4.14 mmol/L, 4.15 - 5.17 mmol/L, 5.18 – 6.21 
mmol/L, 6.22 – 7.24 mmol/L and ≥7.25 mmol/L, lower results are preferred for 
this parameter and so receive negative Framingham points. For HDL cholesterol 
the categories are: <0.9 mmol/L, 0.91 – 1.16 mmol/L, 1.17 – 1.29 mmol/L, 1.30 – 
1.55 mmol/L and ≥1.56 mmol/L. Higher results are preferred for HDL and so they 
receive negative Framingham points.  
 
6.3 Results 
 
6.3.1 Accuracy and repeatability  
As shown in Table 6.2, the general repeatability of the measurements was 
excellent, with all ICCs above 0.75. However, as shown by the CV and the t-test 
for the difference between the group result and ALTM, the accuracy of the 
results was poor. The one sample t-test results indicate that there is statistically 
significant differences between the ALTM and the group results. The CV results 
were >4%, indicating that the dispersion of results was widespread. The only 
exception to this was Group Two glucose results (p=0.437) and CV <4%.  
 
There are only 42 observations for total cholesterol and TC/HDL. The 
Cholestech LDX lower limit of detection (LLD) for total cholesterol is 2.6 mmol/L. 
The results reported for sample 151a in all groups was <2.59, therefore these 
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results, along with the calculated TC/HDL result for this sample could not be 
included in analysis.  
The coefficient of variation (CV) reported in Table 6.2 is an average for each 
group.  
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Table 6.2 Assessment of the accuracy and reproducibility of community POCT 
(Groups One and Two) and laboratory based POCT (Group Three) compared to 
reference value, ALTM.  
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6.3.1.1 Interpreting the Bland-Altman difference plots 
Figures 6.4 to 6.15 are Bland-Altman difference plots, which compare the 
difference between the results generated by the three groups and the reference 
values (ALTM) for each parameter. On each plot, the two red lines indicate the 
95% limits of agreement (average difference ± 1.96 standard deviation of the 
difference), which shows how far apart measurements by the two methods are 
likely to be for 95% of operators. The blue line is where y=0 and indicates perfect 
average agreement between the methods. The purple line is the observed 
average agreement of the two methods; this will sit close to the line of perfect 
average agreement (blue line) if there is a good level of agreement between the 
two methods.  The green line represents the bivariate lineal regression line, 
which show the difference between the score (Y) and the average of the score 
(X). A regression line showing good levels of agreement will typically be flat; a 
slope would suggest proportional bias. For example a positive slope indicated 
that the group results become less accurate as the result score increases. The 
small yellow dots indicate the individual data points.  
 
A Bland-Altman plot displaying good levels of agreement will typically have limits 
of agreement that are reasonably close together. This cannot simply be 
assessed on first glance, however, as the range on the y-axis must also be taken 
in to account. For example, the Figures 6.14 and 6.15 represent the agreement 
between Group Two glucose results versus ALTM and Group Three glucose 
results versus ALTM. The upper and lower limits of agreement appear to be 
closer in for Group Three (Fig. 6.15) than they do for Group Two (Fig. 6.14) but 
the y-axis indicates that there is a larger range of values represented in Figure 
6.14 and so the limits of agreement are actually closer in Figure 6.13 (-0.918 to 
1.034 and -0.860 to 2.515, respectively). Using this example, it means that the 
difference between the measurements of Group Two compared with ALTM 
results should fall within a smaller range approximately 95% of the time, 
compared with the results generated by Group Three. Therefore, the closer the 
upper and lower limits of agreement, Table 6.2 and Figs 6.4 - 6.15, the better the 
agreement of that groups results to the ALTM.  
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If the group results were in perfect agreement with the reference value (ALTM) 
then the purple line (observed average agreement) would be on top of the blue 
line (perfect average agreement), none of the groups in this study achieved this. 
The further the blue line from the purple line, the lower the level of agreement. 
Group Two glucose results vs. ALTM, Fig. 6.14, was the closest to achieving 
perfect agreement.  
 
If the regression line is flat across the x-axis i.e. there is no slope, this would 
indicate that the expected results would not change from one end of the x-axis to 
the other. Conversely, if there were a slope present on the regression line, this 
would indicate some non-uniformity of the error, which could be down to 
concentration dependant or proportional bias. For example, a positive slope, 
such as the one seen in Fig. 6.6 Group Three total cholesterol results vs. ALTM, 
would suggest that the group results became less accurate as the concentration 
of the sample increased.   
 
6.3.2 Total cholesterol results  
Although the ICC results suggest excellent reproducibility, the TC results of all 
three groups differed significantly from the ALTM (p=0.000). The Bland-Altman 
plots (Figures 6.4 – 6.6) show a scatter of the results, with the observed average 
agreement distinctly separate to the perfect level of agreement (y=0). The 
regression line on the plots for all three groups suggests some concentration 
dependant bias. This is shown on the plot where the result points become more 
scattered toward higher concentrations (the right side of the x-axis). This shows 
that the group results are less agreeable with the ALTM at higher concentrations, 
therefore the group results are less accurate at higher concentrations. After 
assessment of the confidence limits, the plots suggest that Group One 
performed the best and Group Three the worst as the distance between the 
upper and lower limits was closest for Group One. This conclusion is supported 
by the mean difference plot shown in Figure 6.16.  
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6.3.3 HDL cholesterol results 
Although the ICC results suggest excellent reproducibility, the HDL results of all 
three groups differed significantly (p=0.000) from the ALTM.  The Bland-Altman 
plots (figs 6.7 – 6.9) illustrate this lack of agreement with the observed average 
agreement distinctly separate to the perfect level of agreement (y=0) in all 
groups.  As Group Three had the closest confidence limits and the line of 
observed average agreement is closest to the line of perfect average agreement 
in this group, it appears that this group performed marginally better than the 
other groups for this parameter. The plots for all three groups display a large 
scatter of the results across the x-axis, suggesting systematic bias and error.  
 
6.3.4 TC/HDL results 
Again, the ICC results suggest excellent reproducibility of results across all 
groups. However, the scatter of results across all three plots (Fig 6.10 – 6.12), 
and the distance between the observed average agreement and the perfect 
average agreement lines shows that the results differ significantly from the ALTM 
for all groups. All groups suffer with concentration dependant bias, with Group 
Three displaying the largest scatter and widest gap between the line of observed 
average agreement and the line of perfect average agreement.  
 
6.3.5 Glucose results 
The Bland-Altman plots (Figs. 6.13-6.15) show that the observed average 
agreement lines sit closer to the perfect level of agreement (y=0) lines in these 
plots when compared with the plots for the other parameters, this is particularly 
evident in the plots for Groups One and Two. This is because the results for 
glucose tended to be closer to the ALTM than for the other parameters, 
especially in Group Two, the only group to achieve results that were not 
significantly different to the ALTM.  The scatter in all plots for this parameter 
suggests some systematic bias/error.  
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Fig. 6.4 Bland-Altman plot displaying Group One (SHIS staff) results vs. ALTM for total 
cholesterol 
 
 
 
Fig. 6.5 Bland-Altman plot displaying Group Two (researcher in the community) results  
vs. ALTM for total cholesterol 
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Fig 6.6 Bland-Altman plot displaying Group Three (researcher in lab) results vs. ALTM 
for total cholesterol 
 
 
 
 
Fig 6.7 Bland-Altman plot displaying Group One (SHIS staff) results vs. ALTM for HDL 
cholesterol 
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Fig. 6.8 Bland-Altman plot displaying Group Two (researcher in the community) results 
vs. ALTM for HDL cholesterol 
 
 
 
 
Fig 6.9 Bland-Altman plot displaying Group Three (researcher in lab) results vs. ALTM 
for HDL cholesterol 
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Fig 6.10 Bland-Altman plot displaying Group One (SHIS staff) results vs. ALTM for 
TC/HDL 
 
 
 
 
Fig. 6.11 Bland-Altman plot displaying Group Two (researcher in the community) results 
vs. ALTM for TC/HDL 
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Fig 6.12 Bland-Altman plot displaying Group Three (researcher in lab) results vs. ALTM 
for TC/HDL 
 
 
 
 
Fig 6.13 Bland-Altman plot displaying Group One (SHIS staff) results vs. ALTM for 
glucose 
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Fig. 6.14 Bland-Altman plot displaying Group Two (researcher in the community) results 
vs. ALTM for glucose 
 
 
 
 
Fig 6.15 Bland-Altman plot displaying Group Three (researcher in lab) results vs. ALTM 
for glucose 
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Figures 6.16 to 6.19 collate the mean results for each parameter and display the 
difference between those averages and the ALTM. These plots summarise the 
performance of each group in the analysis of eac parameter. As shown in Figure 
6.16, Group One achieved results closest to the ALTM and Group Three 
generated the results that were in least agreement with the ALTM. Figure 6.17 
shows that Group Three performed marginally better than the other two groups 
for HDL results. It appears that Group Two achived results that were on average 
closer to the ALTM than the other groups for TC/HDL, Fig. 6.18. Figure 6.19 
illustrates the closeness of Group Two glucose results to the ALTM, this is to be 
expected at this was the only data set that was not significantly different to the 
ALTM when analysed statistically.  
 
 
 
Figure 6.16 Mean difference plot displaying each groups performance for total 
cholesterol in comparison to the reference value 
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Figure 6.17 Mean difference plot displaying each groups performance for HDL 
cholesterol in comparison to the reference value 
 
Figure 6.18 Mean difference plot displaying each groups performance for TC/HDL ratio 
in comparison to the reference value 
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Figure 6.19 Mean difference plot displaying each groups performance for glucose in 
comparison to the reference value 
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6.3.6 Clinical significance  
 
6.3.6.1 Effect on signposting and referral 
Tables 6.3 – 6.6 are shift tables which illustrate how the results of each group fit 
with the reference values (ALTM) and what effect the group results may have 
on patient referral and signposting to other services, such a s primary care. 
Shaded cells represent the group results that agree with the ALTM. Values 
above and below shaded cells represent results have been over (above cell) or 
under (below cell) estimated. 
     
                
                            
Table 6.3 Shift tables for group result versus ALTM by the total cholesterol referral 
guidance used by SHIS.  
 
 As illustrated in Table 6.3, the results of all groups were in agreement with that 
of the ALTM. In this case, no results warranted further testing or referral.   
 
 <6.0 mmol/L 6.1-11.0 mmol/L 11.1-17.9 mmol/L ≥ 18 mmol/L 
<6.0 mmol/L 0 0 0 0 
6.1-11.0 mmol/L 0 15 0 0 
11.1-17.9 mmol/L 0 0 25 0 
≥ 18 mmol/L 0 0 2 3 
Table 6.4 Shift table displaying the agreement between Group One glucose results and 
ALTM in reference to SHIS referral guidance 
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 <6.0 mmol/L 6.1-11.0 mmol/L 11.1-17.9 mmol/L ≥ 18 mmol/L 
<6.0 mmol/L 0 0 0 0 
6.1-11.0 mmol/L 0 15 0 0 
11.1-17.9 mmol/L 0 0 26 0 
≥ 18 mmol/L 0 0 1 3 
Table 6.5 Shift table displaying the agreement between Group Two glucose results and 
ALTM in reference to SHIS referral guidance 
 
 <6.0 mmol/L 6.1-11.0 mmol/L 11.1-17.9 mmol/L ≥ 18 mmol/L 
<6.0 mmol/L 0 0 0 0 
6.1-11.0 mmol/L 0 15 0 0 
11.1-17.9 mmol/L 0 0 26 0 
≥ 18 mmol/L 0 0 1 3 
Table 6.6 Shift table displaying the agreement between Group Three glucose 
results and ALTM in reference to SHIS referral guidance 
 
Tables 6.4 – 6.6 are shift tables that illustrate the agreement and disagreement 
of group results with the reference value (ALTM). Table 6.4 shows that two 
results were underestimated by Group One when compared to the reference 
standard. The two results should have fallen within the 11.1-17.9 mmol/L but fell 
within the 6.1-11.0 mmol/L, meaning that, had these been patient results, the 
patient would have received a less urgent referral to their GP for further glucose 
testing.  
Groups Two and Three fared slightly better only underestimating one result 
when compared with the ALTM. As with group one, this was in the 11.1-17.9 
mmol/L category, meaning that, had this been a patient result, they would have 
received a less urgent referral to their GP for further glucose testing.  
 
6.3.6.2 Effect on Cardiovascular risk score 
Tables 6.7 – 6.9 are shift tables that illustrate how the total cholesterol results of 
each group fit with the reference values (ALTM) and what effect the group 
results may have on CVD risk score categories.  
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Group 1 underestimated a total of 12 total cholesterol results. In the clinical 
setting, this would decrease the overall CVD risk score, making it appear as 
though those patients were at a decreased risk of a cardiovascular event.  
 
Group 2 had more TC results in categories that agreed with the ALTM but still 
underestimated a total of 8 results. This again would decrease the overall CVD 
risk score, making it appear as though those patients were at a decreased risk 
of a cardiovascular event, in the clinical setting.  
 
Group 3 fared the worst of all three groups by underestimating 13 total 
cholesterol results. In the clinical setting, this would decrease the overall CVD 
risk score, making it appear as though those patients were at a decreased risk 
of a cardiovascular event.  
 
 <4.14 
mmol/L 
4.15 – 5.17 
mmol/L 
5.18 – 6.21 
mmol/L 
6.22 – 7.24 
mmol/L 
≥7.25 
mmol/L 
<4.14  
mmol/L 
15 0 0 0 0 
4.15 – 5.17 
mmol/L 
0 7 0 0 0 
5.18 – 6.21 
mmol/L 
0 5 6 0 0 
6.22 – 7.24 
mmol/L 
0 0 1 3 0 
≥7.25  
mmol/L 
0 0 0 6 0 
Table 6.7 Shift table displaying the agreement between Group One and ALTM total 
cholesterol results in relation to Framingham risk score categories 
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Table 6.8 Shift table displaying the agreement between Group Two and ALTM total 
cholesterol results in relation to Framingham risk score categories 
 
 <4.14 
mmol/L 
4.15 – 5.17 
mmol/L 
5.18 – 6.21 
mmol/L 
6.22 – 7.24 
mmol/L 
≥7.25 
mmol/L 
<4.14  
mmol/L 
18 0 0 0 0 
4.15 – 5.17 
mmol/L 
0 8 0 0 0 
5.18 – 6.21 
mmol/L 
0 4 5 0 0 
6.22 – 7.24 
mmol/L 
0 0 1 1 0 
≥7.25  
mmol/L 
0 0 0 8 0 
Table 6.9 Shift table displaying the agreement between Group Three and ALTM total 
cholesterol results in relation to Framingham risk score categories 
 
Tables 6.10 – 6.12 are shift tables that illustrate how the HDL cholesterol results 
of each group fit with the reference values (ALTM) and what effect the group 
results may have on CVD risk score categories 
 <4.14 
mmol/L 
4.15 – 5.17 
mmol/L 
5.18 – 6.21 
mmol/L 
6.22 – 7.24 
mmol/L 
≥7.25 
mmol/L 
<4.14  
mmol/L 
18 0 0 0 0 
4.15 – 5.17 
mmol/L 
0 10 0 0 0 
5.18 – 6.21 
mmol/L 
0 2 6 0 0 
6.22 – 7.24 
mmol/L 
0 0 0 3 0 
≥7.25  
mmol/L 
0 0 0 6 0 
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Group One overestimated 2 and underestimated 16 results. Those that were 
overestimated would give the impression of a healthier result in the clinical 
setting, as higher HDL results are more desirable, generating a lower CVD risk 
score. Conversely, more points would be added to the Framingham score sheet 
for those with underestimated results, resulting in a falsely higher CVD risk 
score.  
Group Two overestimated 2 and underestimated 21 results. The overestimated 
results would provide a falsely low CVD risk score and those that were 
underestimated would produce a falsely higher CVD risk score.  
As with the TC results, Group Three fared the worst, overestimating 6 and 
underestimated 19 results. If these were patient results, 6 patients would have a 
falsely lower risk scores generated compared with the risk score they would 
have received from more accurate results. 19 patients would have a CVD 
falsely higher risk score generated than they would have done from correct 
results as the underestimation of HDL produces less healthy looking results. 
 
 <0.9 mmol/L 0.91 – 1.16 
mmol/L 
1.17 – 1.29 
mmol/L 
1.30 – 1.55 
mmol/L 
≥1.56 
mmol/L 
<0.9  
mmol/L 
6 2 0 0 0 
0.91 – 1.16 
mmol/L 
0 4 0 0 0 
1.17 – 1.29 
mmol/L 
0 0 0 3 0 
1.30 – 1.55 
mmol/L 
0 0 3 6 0 
≥1.56 
mmol/L 
0 0 0 3 8 
 
 
    10 
 
 
   
Table 6.10 Shift table displaying the agreement between Group One and ALTM HDL 
cholesterol results in relation to Framingham risk score categories 
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 <0.9 mmol/L 0.91 – 1.16 
mmol/L 
1.17 – 1.29 
mmol/L 
1.30 – 1.55 
mmol/L 
≥1.56 
mmol/L 
<0.9  
mmol/L 
6 1 0 0 0 
0.91 – 1.16 
mmol/L 
0 5 0 0 0 
1.17 – 1.29 
mmol/L 
0 0 0 1 0 
1.30 – 1.55 
mmol/L 
0 0 3 4 0 
≥1.56 
mmol/L 
0 0 0 7 7 
 
 
    11 
    
Table 6.11 Shift table displaying the agreement between Group Two and ALTM HDL 
cholesterol results in relation to Framingham risk score categories 
 
 <0.9 mmol/L 0.91 – 1.16 
mmol/L 
1.17 – 1.29 
mmol/L 
1.30 – 1.55 
mmol/L 
≥1.56 
mmol/L 
<0.9  
mmol/L 
6 4 0 0 0 
0.91 – 1.16 
mmol/L 
0 2 0 0 0 
1.17 – 1.29 
mmol/L 
0 0 0 2 0 
1.30 – 1.55 
mmol/L 
0 0 0 4 0 
≥1.56 
mmol/L 
0 0 0 6 5 
 
 
    13 
Table 6.12 Shift table displaying the agreement between Group Three and ALTM HDL 
cholesterol results in relation to Framingham risk score categories   
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6.4 Discussion  
Due to the push for cardiovascular screening programmes and the growing 
POCT market, it is likely that the need for POCT of lipids and other associated 
parameters, such as glucose, will increase. The current guidance from NICE 
suggests that statins should be offered to patients for the primary prevention of 
cardiovascular disease (CVD) if they: are aged 18-84 years and have a CVD 
risk score of ≥ 10%, have diabetes or have familial hypercholesterolaemia 
(NICE, 2014b).  
POCT offers many advantages for use in screening programmes like NHS 
Health Checks, it frees up clinician time as non-medical staff can be trained to 
perform the Checks, results are made available within the consultation and it is 
generally more convenient for the patient. With the NHS under constant 
pressure and stretched for resources, the provision of NHS Health Checks by 
other organisations, such as the SHIS, should, in some small way, relieve some 
of the pressure placed on the NHS. The availability of results during the 
consultation has been shown to have a positive effect on the patient, giving 
them more understanding and motivation to make changes where necessary 
(Laurence et al., 2010). Unfortunately, the population that is most likely to be 
affected by CVD is also the least likely to attend screening. Providing NHSHCs 
in the community and workplace setting goes some way to negate this problem, 
in some cases the tests are brought to the patient rather than the patient having 
to seek them out.  
This study compared the analytical performance of three groups: SHIS staff in 
the community setting, researcher in the community setting and researcher in 
the laboratory setting.  All groups used the Alere Cholestech LDX to analyse 
identical EQA samples. In theory, all three groups should be able to produce 
results that are in agreement with the reference value, the ALTM provided by 
UKNEQAS. In this study, POCT group results were generally underreported 
and none of the groups achieved agreement with the ALTM for any parameter, 
with the exception of Group Two glucose (p=0.437). Some studies assessing 
the analytical performance of this device have shown similar results, for 
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example Panz et al. (2004) found that the Cholestech LDX generally 
underreported results or TC and LDL cholesterol (Panz et al., 2004). 
 
Group Three generally performed poorest, not managing to achieve a p value 
greater than 0.000 for any set of results (Table 6.2). This could be explained by 
the change in environment and individual device. As highlighted in Figures 6.16 
to 6.19, the average results generated by Group Three were consistently further 
from the average reference value (ALTM). The Cholestech used by Group 
Three in the laboratory was the same model as the ones used by Groups One 
and Two in the community and therefore should produce results inline with the 
other two devices. Previous studies have shown that the Cholestech LDX 
performs consistently from device to device in the laboratory environment 
(Rogers et al., 1993) therefore it is likely to be an environmental factor that 
accounts for the variation in these results.  
In terms of clinical significance, had these been patient results, the results 
generated by all three groups could have caused a different outcome for the 
patient. As all group results for each of the 45 tests performed were in 
agreement with the ALTM for the referral guidance based on total cholesterol, 
no change in outcome would be seen, Table 6.3. However, the referrals based 
on glucose results would differ from their correct number, according to the 
ALTM. Of the 45 tests run by Group One, 43 tests were placed in agreeable 
categories with the ALTM and 2 were underestimated and so placed in the 
wrong category. This category change would mean that 2 patients were referred 
for further glucose testing in four weeks instead of one. Of the 45 tests run by 
Group Two, 44 were in agreement and 1 was underestimated, again resulting in 
a less urgent referral. Group Three produced the same error as Group Two.  
The inaccuracies seen in the group results would also have an impact on CVD 
risk scores. Total cholesterol results were underestimated in many cases: 
Group One underestimated 12 results, Group Two underestimated 8 and Group 
Three underestimated 13 results. An underestimation of total cholesterol, 
especially at higher concentrations, skews the CVD risk calculation and 
generates a more positive, lower risk score. For example, where a result falls 
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within the 5.18-6.21 mmol/L, when its true value is within the 6.22-7.24 mmol/L, 
if using the Framingham calculation, a male patient would receive 1 point 
instead of two points. This 1 point difference can have quite a big impact on the 
total points and therefore the corresponding risk score. A falsely low risk score 
has the potential to be dangerous. With the Framingham calculation, 6 
cholesterol points equates to a risk score of 10% in males. If just 1 point is 
dropped, the risk falls to 8%. This 2% decrease can have implications for the 
resulting clinical decisions, the latest guidance is to offer lipid-lowering 
medication for patients with CVD risk scores of 10% or higher, and so a falsely 
low risk score could mean that some patients slip through the net and may not 
receive medication that prevents them from having a future cardiac event. 
Other studies that have assessed the analytical performance of the Cholestech 
LDX have found similar results. Panz et al. (2004) found underestimations in TC 
and LDL cholesterol using this device, placing results in inappropriate risk 
categories (Panz et al., 2004).  
The HDL cholesterol results appeared to be in even less agreement with the 
ALTM, with a mixture of under and overestimations seen in all groups (Group 
One: 16 under and 5 over, Group Two: 21 under and 2 over, Group Three: 19 
under and 6 over). Underestimations of HDL would cause a falsely higher risk 
score and overestimations of HDL would cause a falsely lower risk score. Worry 
could be caused in a patient if they received a risk score that is falsely high but 
what is potentially more dangerous is when a patient receives a falsely low one. 
A falsely low-risk score makes it appear as though that patient is at lower risk 
and could reduce the chances of positive health and lifestyle changes as it 
provides the patient with a sense of health security. It could also affirm 
unhealthy behaviours, leading the patient to believe that their lifestyle choices 
have no impact in their health.   
Ideally, tests used in screening programmes should be accurate, producing 
results that are close to the true value, and precise, producing results that are 
consistent with each other. In this study, the results achieved by all groups were 
generally neither precise nor accurate.  
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The number of underestimations seen in Tables 6.7 to 6.12 and the majority of 
the group results being significantly different from ALTM, Table. 6.2 (p=0.05 in 
all except one) would suggest that the POCT results in this study were not 
accurate. For a test to be accurate, it must produce results close to a known 
value, in this case, the ALTM.  
When a patient’s results are underestimated, it can appear as though they do 
not have a the disease or risk factors being tested for, when in reality this may 
not be the case, potentially resulting in a false negative. False negatives are 
avoided in screening programmes. A false negative could mean that a patient is 
not referred on for further testing to rule out or confirm disease, which could 
mean that they do not receive further treatment or advice where it may be 
necessary.  
 
6.4.1 Limitations of the study 
It is difficult to determine the cause of the errors seen between the groups as 
different Cholestech devices were used and so it could be a result of calibration 
issues.  
The ALTM, as a comparator has its limitations. The results used to create the 
ALTM number are ‘trimmed’ which can skew the results and so shift them one 
way or another, thus changing the mean of the results. However, a ‘true result’ 
was not available to use in its place so it was seen as an appropriate substitute.   
The value of the samples available tended to be around the centre of the 
possible range and so samples with extreme results were not often tested. For 
example, none of the total cholesterol results were ≥ 7.25mmol/L. Of particular 
interest would be group results versus ALTM for samples with higher 
concentrations because the implications of underestimations at higher 
concentrations would be of even greater clinical significance.  
The samples tested in this study were serum samples. In practice, whole blood 
patient samples are tested during an NHS Health Check. This difference in 
sample type is an important consideration due to the possibility of matrix effects. 
“Matrix” refers to the components of a sample that are not of interest i.e. not the 
analyte(s) (Hall et al., 2012). The EQA serum samples will have a number of 
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common components, however, not all are known and levels may vary from 
sample to sample. The varying levels of matrix components of a sample may 
affect the result of the analyte, potentially leading to erroneous reporting of 
sample concentrations (Hall et al., 2012). This is somewhat overcome in this 
study as each group tested samples from the same distribution, which should 
have the same concentration of matrix component as well as analyte. However, 
because whole blood samples are used in practice, it is difficult to say whether 
the results would be more or less accurate than the results seen in this study.    
Although efforts were made to ensure the EQA samples were stored and used 
in the recommended way, as described in section 6.2.2.3, the stability of EQA 
samples used cannot be guaranteed. This may lead to variation in the results 
generated. 
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6.5 Conclusion 
 
Quality in pathology testing is essential to any processes where the results 
generated are used for a clinical decisions making. The findings of this study 
suggest that, whilst the results were consistent, the POCT used in the 
community for the NHS Health Checks is not entirely reliable, producing results 
that were statistically different to that of the reference value (ALTM). The 
varying quality of POCT has not gone unnoticed, with academics remarking that 
POCT devices would benefit with further development and enhancements to 
cope with the difficult testing environments in which they are used 
(Kazmierczak, 2011). 
Ideally, the test would detect only the individuals in a population who had 
abnormal lipid and cholesterol levels, as defined by the SHIS and NHS cut off 
points and would not fail to detect any of those individuals.  
The findings of this study have some clinical significance as the results 
generated were generally underreported, suggesting a lack of sensitivity and 
production of false negative results. With screening tests, importance is 
normally placed on sensitivity, as many are used as ‘rule-out’ tests. In this 
setting, a false negative could make it seem as though a patient is at less risk 
then they are in reality, potentially resulting in missed opportunities for further 
testing or treatment. However, in this screening programme, slightly more 
tolerance can be applied to the results, as the tests are not used to make 
clinical management decisions and so are likely to be of acceptable clinical 
performance. 
  
201 
 
Chapter Seven: Overall discussion and conclusion 
 
This thesis describes some of the applications of POCT and some of the factors 
associated with its implementation. There is a wealth of publications related to 
the use of POCT in emergency and secondary care, as described in Chapter 
One. There are also many papers investigating the use of POCT in community 
and primary care settings, however, these tend to be set outside the UK, where 
there is often a greater need for POCT outside of hospitals due to populations 
living in remote locations with no or little provision form central laboratories. The 
lack of literature on POCT use within UK primary and community care provided 
impetus to identify where and how POCT is currently used; to assess its impact 
on patient outcomes and experience within a community setting and to evaluate 
its performance in the community setting. 
 
Surveying UK primary care staff revealed that there is an awareness of POCT 
within UK primary care, with 86% of respondents reporting that their surgery 
used some form of POCT on a regular basis. The most popular POCT 
appeared to be urinalysis, human chorionic gonadotropin (hCG) and blood 
glucose. The survey also highlighted areas that may need addressing to ensure 
quality of results and ultimately patient safety, for example, at least 10% of 
POCT operators had not received device-specific training and only 20% of 
those performing POCT were registered with an EQA scheme. Attitudes 
towards POCT varied amongst respondents. The largest concern in adopting 
POCT in primary care was the potential expense incurred. Although positive 
attributes that POCT could provide were appreciated, the response to 
undertaking more POCT in the future was undecided and 100% of respondents 
found current laboratory services acceptable – these results are not indicative of 
change to the current pathology testing processes within primary care.   
 
The transportable nature of POCT has enables screening programmes, such as 
the NHS Health Checks, to be conducted outside healthcare settings. The 
research presented in Chapter Four, the only research to focus on NHS Health 
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checks delivered by non-NHS staff in the community setting, evaluated the 
impact of this programme on its patients. Some slight, but not statistically 
significant, reductions to the CVD risk of the overall participant population after 
they received a Health Check were observed. The only exception to this was 
the significant CVD risk reduction observed in the participants who intended to 
make lifestyle changes and were referred for further testing (P<0.0001). Of the 
91 participants that were seen at both time points, two new diagnoses were 
made. Similar studies have found similar diagnosis rates (Robson et al., 2012). 
Overall, there were high levels of satisfaction with the service and the health of 
participants improved slightly. The majority of participants stated that they 
preferred receiving their Health Check in the community setting, a service that 
could not be provided without the use of POCT, and nearly all participants 
reported that they preferred the blood sampling process for POCT to that of 
venous sampling for laboratory testing.  
 
Results of the qualitative study provide insight into the reasons for adopting, or 
not, healthy lifestyle behaviours post NHSHC. Although attitudes towards the 
workplace NHS Health Checks were entirely positive and there was a move 
towards healthier lifestyle choices, the majority of participants stated that their 
decision to make the changes was something that they had previously decided 
upon, prior to the Health Check. This suggests that the NHSHC had little 
influence on their lifestyle decisions. A positive outcome that is unique to the 
workplace and community delivered NHS Health Checks that they are able to 
capture patients who would not normally visit their GP, many participants stated 
that they would not make any effort to have an NHS Health Check in primary 
care, and therefore would not be screened.   
 
The literature review highlighted that most papers evaluate trained medical 
professionals using POCT. Chapter Six of this thesis reports the findings of an 
evaluation of the analytical and operator performance of the POCT used for the 
NHSHC, when operated by non-medical staff. The study found that both 
cholesterol and glucose results were generally underreported when compared 
with the reference value of the samples, the ALTM. None of the groups 
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achieved agreement with the ALTM for any parameter, with the exception of 
Group Two glucose (p=0.437). Some studies assessing the analytical 
performance of this device have shown similar results (Panz et al., 2004). 
These findings were clinically significant. If the results generated were from 
patient samples, the results generated by all three groups could have caused a 
different outcome for the patient in terms of referral for further testing and CVD 
risk categories.  The results suggest that the POCT results in this study were 
not accurate and could potentially make patients results appear as though they 
are without disease or risk factors, which could mean that they do not receive 
further treatment or advice where it may be necessary.  
 
Recommendations 
Whilst POCT can facilitate some initiatives that are opportunely placed in the 
community, the value of those initiatives should still be assessed in that setting. 
It is difficult to justify a scheme which only produces slight improvements in 
patient health. However, NHSHCs conducted in the community appear to 
capture patients who would not normally receive a Health Check, as they do not 
visit their GP surgery. It is recommended that community-based NHS Health 
checks exploit their ability to reach those hard-to-reach patients, who may have 
the most improvements to make, by focussing on targeting those patients, 
perhaps through incentivisation.   
As laboratory testing is well established and produces a high quality of results, it 
is recommended that POCT should only be used where it has proven to be 
more effective. Examples of this include where fast turnaround times are 
required in the emergency setting or where laboratory services are not 
available, for example, remote settings and community based testing where the 
patients may only be seen once.  
Adoption of POCT in any setting should be fully managed, ensuring that all 
users are trained and competent in its use and that the devices are well 
maintained.  
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Appendix 3.2 – POCT survey 
 
 
 
 
 
 
Chapter Three: POCT in primary care survey – screen shots from the Bristol 
Online Survey 
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Appendix 4.3 – Baseline health and lifestyle questionnaire 
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Appendix 4.3 – Baseline health and lifestyle questionnaire (page 2) 
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Appendix 4.4 – Follow-up health and lifestyle questionnaire 
 
 
 
 
 
 
 
Ques%on	1-5	are	about	how	you	feel,	for	each	ques%on	please	%ck	the	box	which	most	closely	
matches	how	you	have	felt	over	the	past	2	weeks.		
Ques%on	6-10	are	about	what	your	lifestyle	is	like	and	how	you	think	about	yourself	
6.	When	I	exercise,	I:	
q 
q 
q 
q 
q 
q 
q 
q 
q 
10.	I	believe	I	am:	
q 
q 
q 
q 
8.	I	eat	fresh	fruit	and	
vegetables:	
q 
q 
q 
q 
q 
9.	I	believe	I	am:	
q 
q 
q 
7.	Normally,	I	exercise:	
q 
q 
q 
q 
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Appendix 4.3 – Follow-up health and lifestyle questionnaire (page 2) 
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